var title_f6_60_7104="Refractile cell wall in yeast";
var content_f6_60_7104=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F62300&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F62300&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Blastomyces dermatitidis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 373px; height: 252px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The yeast phase of Blastomyces dermatitidis has a thick refractile cell wall (arrows).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Stanley W Chapman, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_60_7104=[""].join("\n");
var outline_f6_60_7104=null;
var title_f6_60_7105="Central line IJ finder";
var content_f6_60_7105=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F55560&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F55560&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Finder needle for central line placement",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 273px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This photograph depicts the use of a finder needle to locate the internal jugular vein.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     UpToDate acknowledges the invaluable assistance of the University of Massacusetts Medical School, Department of Anatomy and Department of Emergency Medicine, including Thomas Ellis, MD and Jean Marcelin, MD, for the photographs of central venous catheter placement.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_60_7105=[""].join("\n");
var outline_f6_60_7105=null;
var title_f6_60_7106="Shepherds crook deformity";
var content_f6_60_7106=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F61700&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F61700&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Fibrous dysplasia of the proximal femur with shepherd's crook deformity",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 373px; height: 516px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A radiograph of the proximal femur shows a shepherd's crook deformity caused by fractures sustained over the years. Irregular, marginated, ground-glass lucencies are surrounded by reactive bone. The shaft has an appearance that has been likened to a soap bubble.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Rubin R, Strayer DS. Rubin's Pathology: Clinicopathologic Foundations of Medicine, Fifth Edition. Philadelphia: Lippincott Williams &amp; Wilkins, 2008. Copyright &copy; 2008 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_60_7106=[""].join("\n");
var outline_f6_60_7106=null;
var title_f6_60_7107="Systemic AL amyloidosis macroglossia";
var content_f6_60_7107=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F65060&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F65060&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Systemic AL amyloidosis - macroglossia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 351px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    An enlarged tongue is present in this patient with systemic amyloidosis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_60_7107=[""].join("\n");
var outline_f6_60_7107=null;
var title_f6_60_7108="Cevimeline: Patient drug information";
var content_f6_60_7108=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Cevimeline: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/40/12932?source=see_link\">",
"     see \"Cevimeline: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F149142\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Evoxac&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F149143\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Evoxac&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10016616\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691825",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat dry mouth.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10016615\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701761",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to cevimeline or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: Asthma, glaucoma, or swelling in parts of the eye.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10016620\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697300",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have lung disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696701",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Be careful in hot weather. Drink lots of fluids to stop fluid loss.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10016621\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698257",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Nose stuffiness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697992",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Lowered night eyesight. Use care when driving or doing other tasks that call for clear eyesight. Keep work space well lit.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698038",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sweating a lot.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10016623\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699086",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sudden change in eyesight, eye pain, or irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10016618\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695786",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take as you have been told, even if you feel well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694818",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Drink lots of noncaffeine liquids unless told to drink less liquid by your doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10016619\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10016624\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10016625\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11700 Version 36.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-203.80.222.8-E31ECE9AB0-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_60_7108=[""].join("\n");
var outline_f6_60_7108=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F149142\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F149143\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016616\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016615\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016620\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016621\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016623\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016618\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016619\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016624\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016625\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?12/40/12932?source=related_link\">",
"      Cevimeline: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f6_60_7109="Chronic PE PA I";
var content_f6_60_7109=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F66676&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F66676&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Chronic pulmonary embolism",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 354px; height: 308px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Pulmonary angiogram shows mosaic oligemia with localization of pulmonary blood flow to the lower lobes. This may be regarded as a Westermark's sign with oligemia affecting the subtended pulmonary parenchyma of the upper lobes.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal chest radiograph",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 371px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Posteroanterior view of a normal chest radiograph.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carol M Black, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_60_7109=[""].join("\n");
var outline_f6_60_7109=null;
var title_f6_60_7110="Third nerve anatomy";
var content_f6_60_7110=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F76281&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F76281&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 505px\">",
"   <div class=\"ttl\">",
"    Third nerve anatomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 485px; height: 504px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The third cranial nerve begins as a nucleus in the midbrain. The fascicle of the third nerve leaves the nucleus and passes ventrally near important structures in the midbrain (eg, red nucleus, corticospinal tract). It then enters the subarachnoid space, passes into the lateral wall of the cavernous sinus, and finally divides into superior and inferior branches as it enters the superior orbital fissure in the orbit. The pupil fibers are shown; the innervation to individual muscles (superior rectus, inferior rectus, medial rectus, and inferior oblique) are not shown.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_60_7110=[""].join("\n");
var outline_f6_60_7110=null;
var title_f6_60_7111="ER early esoph cancer Endosc";
var content_f6_60_7111=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F74236&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F74236&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 570px\">",
"   <div class=\"ttl\">",
"    Endoscopic resection of an early cancer in a Barrett's esophagus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 550px; height: 354px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFiAiYDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD3v4m+PtL+HWhW+ra1b31xbz3S2ipZojPvKO+SGZRjCHv6V5n/AMNReDP+gR4k/wC/Fv8A/HqP2y/+SZ6R/wBhqL/0nnr5c8E+E7/xbqotbMeXAhBnuGGViX+rHsKTdtWVGLk+WO59c+Hf2gNC8R3EkGi+G/E91JGu58Q2yhR7lpwPwzXTx/EWaRcp4M8Ske72I/8AbmuT8FeFNO8NaPFZ2MWyNeSTy0jd2Y9zXSl0jTtisfanS6EVpuySf4kvbxtJN4O8SKi8k77H/wCSapf8LdtsZ/4RPxLj/tz/APkiue8U6kJCLeAF9py5B4HtXMzXgEeFALdeKxniWnZHpYfKoTgpTvr6f5HpEPxbt5k3ReE/EjLnHWy/+SakPxWiA58I+JR/wKy/+Sa8oa7kjBlhdo2I5A5rMl1a9lchrqRVHTGBn8qlYqfVI0/sem3pJ/18j2ofFaI9PCPiU/jZf/JNIfivEM58I+JePey/+Sa8WjvpCcCeckjoHNSxStPKq72diejMev40fW59kH9j01vJnsJ+LlsOvhXxEPq9kP8A25pw+LMJGR4S8SkeoNkf/bmvIJrRo2y0X4jBFV/NaMggEA/3OKHiproNZPQltJ/gezt8WYVGT4S8SgfWy/8Akmj/AIWxDx/xSXiXn3sv/kmvIobueMqFlbOejnrW7YXQuoyWIV14Kg0vrcuxM8opxV7v+vkd4/xftU+94U8Sj/wD/wDkiszWfj5ouiwLNqXhvxPDEx2hxFauM++2c4/GuXmCsMHms++sI722ltrmNZYnBUqwyGFaLEyvqjOWV0re63f+vI6D/hqLwb/0CPEn/fi3/wDj1dXp/wAaPD198NtX8bRWWrrpWmXS2k0LxR+ezkxAFQJCpH75erDofx+PvHXg+fw/O1xbBpdNdsBupiP91v6GvQPDH/Jn3j7/ALDUX/oVlXXGSkro8apTlTlyy3PUP+Gq/A//AECvEn/gPB/8eq3Z/tM+ErxS1toviV1BxnyLcfzmr4t0uxa9mxyIl+839B712lnF5ESJEuxBwKzqVOXY6MNhva6y2PqyP9oTw9J9zw/4kP8A2ztf/j9Sp8fdDf7vh3xKf+AWv/x+vmyyVtvzdKuNcCMAjoO1czxM/I7v7Opd3/XyPosfHbRyMjw54kx/u2n/AMkUf8L30YnH/COeI8/S0/8Akivm9tQlYfKTgUgvJh0Bo+sz7Iay6l3f4f5H0qPjjpR6eGvEh/C0/wDkinL8bNNbp4Y8Sflaf/JFfPWk6ixnSJn2CQ7cscLzXWxrJabRPGPLP3WB4qHi6i6ITy+kna7/AK+R66nxksm+74W8SH/wD/8Akipf+FvW3/Qp+Jf/ACT/APkivObOeFxgDBrSRk8vBwT3FS8ZU7ISwFLu/wAP8jtP+Fu23/Qp+Jfw+xf/ACRTk+LVu/3fCfiQ497L/wCSa4RWHmkYII4B6VYWLJByAT3qfr1TsjT+zKXd/h/kdovxYhY4HhLxLn62X/yTQ3xYhU4bwl4lB+tl/wDJNckIRImUJVh6etSxxllYH5WHXI/zxR9eqdl/XzJeXUujf9fIv+Ivj/ofh2OKTWfDfie3jlJVG8q2cE+mVnOPxrD/AOGq/A//AECvEn/gPB/8eqt4h0W21fTrjT9SgEltKMFT1HuD2I7V8t+PvCN34R1c2826WzkJa3uMYDr6H0YdxXXh8T7XSW5wYnC+y1jqj7f8ZfGfw94T0Hwxq2oWOrzW/iC1+12qW8URdE2xtiQNIADiVehPQ/jyf/DUXg3/AKBHiT/vxb//AB6vLP2gP+SY/Bj/ALAh/wDRNpXl3h3w/LflbidcW/VVP8f/ANauiUlFXZz06cqkuWJ9Y2n7Rnhq8iElvoHiZkPQ+TbDP5z1aHx+0I9PDviX/vi1/wDj9eAWsAhVV2bccdKtcCuV4mV9EerHLqdtWz3qH466RPII4vDfiVnboNtpz/5MU+X446XDnzfDHidCDghktRj/AMmK8GWQIQQfqK3ZvE15caZPaShJVmVVLugLAKMDn8B+VJYiXYJZdBbX/r5Hqp+PeiKgY+HPEoUkqDstcZH/AG39xTG/aA0Fevh7xJ/3xa//AB+vCWTbKnn7jEOu30qheSxtK5iXy4yeFznA+tUq8mN5dS7v8P8AI9+k/aL8NR8PoPiQf9s7b/4/UR/aT8KjroniT/v1bf8Ax+vmXUJP3hGapDBD7jjA4raM21qcFWjCLsj6m/4aV8K/9ATxL/35t/8A4/R/w0p4V/6AniT/AL823/x+vlqLaCdw3DGOuKfsBI25PHOfWq5mZKnc+pU/aP8ADDnC6F4lP/bK2/8Aj9Sj9onw4emgeJf+/Vt/8fr5r0q1DRl2DYzheOD6/wBK0bmzKKNu3eOSQc5HpWMq7Tsd1LAxnG92fQh/aI8OjroHiX/v3bf/AB+qE37TvhCGVo5dG8Sq6nBBt7f/AOPV4EvzLg9R61naxpaX8XZZ1Hyv/Q+1ONbXUmpgUo3g9T6Lb9qPwYoJOkeJABz/AKiD/wCPV1vxM+M3h/4ea/BpGs2Or3FzNbLdhrOKJkCM7qAS0inOUPb0r4QvYZLfzYplKuoORXuf7Yv/ACVTTcdf7Gh4/wC29xXQec01oz0//hqLwb/0CPEn/fi3/wDj1bMXx70WWNXTw34n2sMjMdqD+Rnr5j8G+FTEY77UUzL1jib+D3Pv/KvQEj2447Vx1cVyu0T18LlntI81XQ9g/wCF66R/0LXiX/vi0/8AkipB8cNLPTwz4l/75tP/AJIrxyRNwYA8VXdni4LcCsvrc+yOlZVR6t/h/ke1t8cNLUZPhnxLgf7Np/8AJFV/+F+6Hz/xTviT/vi1/wDj9eMi4DDBJrOukAm3pkIevHT3qo4qb3SCeU0krpv8P8j3Vv2gNBUZbw94lA/652v/AMfqq37R3hhThtC8SD/tlbf/AB+vD54d0DmPJ2rubpwMgf1FcdM4LHJrenVlLc4K+Ep01o2fT/8Aw0l4W/6AfiT/AL9W3/x+j/hpHwv/ANAPxL/36tv/AI/Xy2wYBSRjcMj6U6L52Axk54rXmZyKmm7H1RD+0T4cm4j0HxIx/wCudsP/AGvVgfH3Qz08O+Jf++LX/wCP186afYj7KGBw3Xg1etyU4fGM4JNczxLvoenDLYON23/XyPfh8etFPTw54l/74tf/AI/TW+P2hr97w74lH/bO1/8Aj9eLPCiXDR+ejBWx5sWWVh6jODj8KS4kifcqxusJA+UtzuA+90+v50vrMg/s6n5/18j1af8Aac8I28zxTaL4mSRDhlNvBkf+RqZ/w1F4N/6BHiX/AL8W/wD8erwbxNoMWoQb4yonA+R+/wBD7V5zcQSW8zxTKUkU4INdNOoprzPPxOGlQfkfpR4e1WDXtA0zV7NZUttQtYruJZQA6pIgYBgCRnBGcE0Vi/Cf/klng3/sC2X/AKISitDmOH/ac0RvEfhbw3pSTCE3GtpmQjO0LbXLHj1wprN8F+G7LRLKGx06ERwR/iWPdmPcn1rsPjGu4eDx660f/SK7pmnwrHEDjtWFS7lY78PJU6Tkt3oS+WijBPP8qoXRiU4BycflWhJGDuPP0rkfFOoPaWk20YZxsUj1NRLQ2w0HUlZHOa1fL51xHbklS3zH1PcCsB51t42LHDH+HimTXYt4CP4jwOeSaxZGmuNxVGc9yBnFcfxO7PofgXKi1NqLAkBuD2qjLcEZwwIPNU5HIYqylT0+bvTCWHJHT1p2DmL8NxyNxPPccVaikCyrtKr65rFSQ88nj0qdXyvOT9TRYhs25752kBS4dwOhb/69LbXEkrMCyjPryTWAJTu71YSQjlSfxpNFRslY6GN41+V9xH8qnico4kt2AccD/PeseCYvtL59A3+NWRIw6YJHof6VDRaZ1NnfC5Qq2PNX7y+vuKdvZSWH5etcolw0UwkTKkHII7Gt6LUY5YUMv7s55I5FUn0ZlOnbYdexR3ccsNxGjxSrtZWGQwPrWW+kw6Z+zX8R9NtiwhXXbcLuOSAxsTj8M1vsiuFKkHiquqKT8CfiKp6/2/Zj9NPrqw7d2eRmUIuMX5ngun2YtoE2RZjX9a2YFaZ97gDAwAO1RkiKPZ/Ee3oKsqwiiZienas5ts1pRSRaLCKP7w+lVdzSFmI47VSM5eX5gT6CrCTfwkge1RaxtctW8DSrnGFH51bFtt5U8cYJNQQ3CoArKBxxUy3CHgtx7d6nUoRrcvycAVZhuriBAnnMUHRSxI/CmxPtHzfMcnp+lLJJEVJOB3JxyKFchuxr6brRVgsh2r0zuxXV6ZdrOwKS/hXnWkRrc3zGQDHGB2rttNs4izZUD3FY1NHY2jBNXOnhmDH5uv0q4jr94N8p5x1rMsoGSKR3IcAgDcefyrR0+CS6ldBJDEVjaXdI2AQozjPqawvroacqtcu28q7yG2g5xU0xChZMgEdz1x6VmtNE8zeSrCIk7Vc5IHYE1Z3h1COCVzyaLmbp2dzQIWSEhgMdeD3rkvFfh2z8R6LLZ6hCWjfJVx95COjKexFdFHIUchOmOQe5pt1D5kJIYr6Y7GrjKzujCVNbPqee/FbTo9T8C/BmKUEqmgtJt9cRWYwfzrmbS3aAAbflHp2ruPHIz4O+D3/YuP8A+i7KsKFVKncOlejiZPmsc2XQXsua2oxLVLiFmDJlYvMxn3wR9ay5YeeG4q5LlHbYDiq/LNgISfWudHpRh3K5gIxlvpUoRgDtOB6CpGjK47CnlBgE/Ip607spxVjOnErKepFZk6sGAcFRnkgZwK3pEAGSePaqFxsOQzA1abMZJJaHM6oIhbhl/wBYhIbvkHnOegxwMVk7+1dTParv3wybWHII5wa5vUreWG4ZpWLbySX9TXXTknoeLiaUovmWwwNitDTIGupwiD5R94+1Y28jvXReFZ0VHMhC/N+dXPRXMaPvyUTpDbBIwUwigYVB2qzqV0t5ctIFEakBVXAGAAAM474HWpLfVUhtL2KIMWuIljDjHy4YEjkE4PtjoKzSSwINcMndnv0qbitUUlkkt55dhwsi7GyAcjPv9BzSjnoOferLLkZDHdjB47VBtKnFO4nDW5g+JrGKfTp5GXEkUbMrDrwM4+le5/H/AE6G8+MFtPMgZ7fRbbZnoCZ7nn68V47rgzo1+SM/uHx7fKa97+MrH/hZ88e2Mq2jWZJZcsMT3fQ9uv48VrzP2UjhlTj9ahpucJBCVXOOKlx68VcMLKNpUrxkbhioZYyCQK4D2kV8EjIPGOlIYVePLinbtud3OOlIzxbCScD3oQpIzpYFVmwCAO1UpJRjauSfSrF1McLgNt7g8VRYgkkYA9q1SGk7FS7lmitJnj3AbcEqe3/6xXJ8GQMwyvX61112qGymHlhnZeGJPy/TtXDlyCVPbiuyjqjxsw91olmmZwqliVQbVBOcDNS6eQ9wFzgkgCqTNhc5q3p8ZCFmB55/CtnsebT+JHpdmS0LsRC0jcMCo3L9B2qG4t9zYC49MVU8O6nBM6Wl5I0c3ALhd+9R6DI59s10RihvoWlt45o71N0sscYCQpGO4GTj8/bFefODiz6GlVjKOhkMjAZQtIB1OMbfY1MwQBMSq+5QTxgqe6kGpgiPGTsYMvXvmoJFLNuJB4xkn0qLmtiCeLOTtA9hXMa9o8WoxHHyXCfdbHT6+orsPvLtPPvVC4g+fPc/rVQm4u6JlTjUi4yWh9XfCf8A5JZ4N/7Atl/6ISij4T/8ks8G/wDYFsv/AEQlFesfJGb8U0D3fgtTjH9tN/6Q3dOjwqcUz4rv5dx4Nb01l/8A0gu6owXvQPwDzWNSVmdNKEpQ0Llw+FwvWvOPiTOIpbRAedrOR+g/rXZ32oJEjNnJHfsK8n8SXx1vXRsJETERqT/dHU/zNYVJpJnq4CjKMud7IzI0RVE9wokkYfuYz0x/eb+gqNi8n3icdh2/KpL6QT3bFBhM7VHoo4A/KpYkwBuPTn6VklbQ6pzcndld7X7TEFmk8tQQQQu41UNlbwqWO+bHTdxn8BWhKS7nHToKRYsJg4596ZKk0tzm7sYb5Que+BgCoyMKCxBP1qzNGwnkCZAUkVA8Mm5Q6HnpnvUnT0Kzy45UH8DSxagAQJMrUskflD5tv4dqoXcyRqxfp6k00kxNuKubtvMjHIJx9aub8BSCcfnXGWuqLFIGjjbyejHdnn1x2FdPav5yoVOUIBFTODjuXRrRqbMvhjj5SPz61ajkEaANw56j2qjASTgde/FXETeFUdjx7VmzoubmmM4tgyH5c8ZFW9VbHwM+IjDtr9kefpp9ZulTqWFu2eOV57+lX9WH/FiPiN/2H7P+Wn10YbdnkZr8K9V+p4okvmTcjnPfvT76UjbGhJY81FpwEt05Awq8c0l6SLqTAOeAKPtC5rRGRI2fmP41cgRc8j86gihPdjk9atqNoAHT3qZMmLJCy7cYGadFIqkbcAdAKaEY9wMe1NeNyw24U9qnQ0TsXEuTAS23K+9RwA3sxY/dHUf0qvM7xxlZNrDHBByK0PCYDBiw3Def6VMnyxujWilOdmbdhYFPmQHp1rpdP3w5ZuRmmWqIR8o5xjitCCEyEAY3eh71ySdzt2LEMrPncKtIWYfKeSO4qEW5j3AH5gORjjr69u1Eayu+xFO4DPpUM0TT2NXUW04or6ct3FLuGYpdrJjHJDdevY0jM3lb0bG4ZAPQ1EtpMImdwoxzjOas28DSpjG4HlSRjOOuKG+y/P8AUyfKlvcs6dDLcMu0HByxz6VoXdjKYlBXcOOnUVq6dYrbwK/VpFBAz0FXBHtKMCQeuRWsYNrU8yriPevE8k8YAN4S+D+en/CNv/6LsaxtmYyF7DJrd8VAHwn8IQcAf8I0/X/rnY1jsQqdefX2rtxP8QjL3+5XqUHjBz8rfU1Eyqkh3AjjBHcVZkdV3Y5+p6VUMgJLMcn371ij0kxJ5Qcfu8j1J5qpPc+WuPvE1LJIFUtuKgUlram4YtIMVWwkuZ2KSxT3X3iFHtT5dFcICzkZ75z+ldBbQCJ1ODwOCRWrdPFdxJ5yASqMbguN1LnsW6S6I8zvNOuIVLI4fnpjmsqWFroiGbC7uMntXqE2lg2rys0QCnAUn5jXL6jYIwJVQrjuK0jVtuZ1MLGafKca/hy7acR2xWQH14Iq/Y6e9gxjdW3E5yR1rqdF5fBOGWtXVYWuoFHO6PJUD9fzrec3KJ5tChGlU1RzKoQi7gvOcc8/jUgVc5PT+dTbB071HKn7vqevaue561uxEpwcEYBP5USJ3PFRp88uOSPWrQA2nnNIiSMjW1/4k2oZH/LvJ/6Ca93+MYH/AAtWYt0Gi2f/AKPu68P19f8AiSagR/z7Sf8AoJr3P4wf8lSuP+wLZ/8Ao+7rV/wZfI4Jf73T+f5M5xflTLEDA/KmsoYHOMMRxilVuNrYAxyc02TleMEgZ4riPQehTuV2L0TAqnIu8ZUArnjip5WDMvmqDHnGAf51WEhDMoP3ehA7VaQczKl3E7RMxXagB5Pes7yDK6rHlm6KqjOTW7fBGtnRTlQmR/PNYqIxO5M7l+fOeR+NaWHGVyG5UC0kiaP96DguW5GOuBXD39kyM0iDJzlhXf3TSXCybl3FVySFA2rwO34Vz9zCC5BOM1tSnys5cXQVWJxwO9wO1aUZ/dqrNhRV2605JTuX5ZB3XvVJrW4HQqR7V086keSqE6TelzTD7bf93kDPyseufXNdDo1y80X704kB5IrkMXBYebI3H5flXQ+H5X+0sGDAOBgHvWNVJo7cE5QqW6M6i5REjRQ8/wBp3YlR1GBwOQQfXPFRRP5mQQDzgt600xsRhG2gdMDpUdsHeV1JbaAMZ4rlaPU6allcZ4IFNuAHYcnOakMag8Z460qRhnPfngZ6VJOid0fTfwn/AOSWeDf+wLZf+iEoo+E//JLPBv8A2BbL/wBEJRXsnx5k/FvHm+Ds/wDQZb/0hu6wJnG7HYcVvfF04fwefTWW/wDSG7rmpSRn0PpXLX3PUwCvF+pn6yzpYXRPTy2wa820+RF1KN5CcZOcduDXpet86ZdcZxGRXlvllJPNJ4APHvniuaeqR7NL+G0Wbcb7gg9A1T3LZJC9KhtpAJHYDGelAYZzVGFru42NWJJP0p7R7FBGOf0qeBQdpJ/Si6GzZxjg9KEJvWxkz2r+d5kQUrnO01ZnhW4jVuMg52+lLLLkbcde9W7YxpGpUnI54GefSlYrmbscxdQsrP5iAL0Geork9dmLSiEHEagZxXo2vRuYBI/znHb07V5vq0ySXjqmduACO3H/AOurpL3iMVL91ozPKPHg4IyMqfUe1dR4Yut0DRMcsnI56g1zoJMYU52r0B7Vf0gy2tzHIwARiQR7GtKi5onJhW4VE0dtbsC5IOPetSzUcorcsM59aybDOwcZxzgVv2aooDPww7CuI91vQQRtBKrr1U5rW1tj/wAKG+JDd/7dsz/47p9ULmUTRB5FxJypZe/oat6wc/s//EY+ut2X/oOn10Yb42vI83NYv2UG+/8AmeJ6I33jzmnud0rk/wB6q2kthmz0o8wGRxn+I0Nasxi/dRfVgRxwe9Tx/NyckVnRyED2q4knl2+T1PapaKTLQcc5PQU4k49cVVhkLKMc4q1G/GOtQ1YtO4qxl0bI/OrPhhxFdzQ9MkH/AD+VVvNbBC1FYKYNTjeUFo5AUcZpS1i0XT92aZ6lpiF4gyI2ASpyuMEHBHNacfBIk2jJ4OMkEVQ0q7ja2AVmfe29nPUngZP5VfkkVmCgDA56Vy2OpTbeoyZwjnDtz3NNhkZn+V8sO/pTJHOworHYxGQTxxnB/U1rxCEWsK+ZHsRDlxEFPPJBPfB6Glq9jZy5UX7SXdaqWIQsMAkcZpunXEnksrMpETbFTt+B9MVnz3kaFY5opCo+ZGQ8MB6+9W7WR7plLIoQnPuKtI5Xs7nW6fdmVAOh9avBsA464rFim+zoAm3Dcc9KuRzMwz0Hr61sjz5x6o8w8cMV8G/CDB6+G3H/AJDsq5d7l0Iwcr3z2rs/Etk194V+EMaMF2+GZGJIzx5diP61g3OgXEZG2RNp74Nb4lpVNTXLYt0FZdWY7XPmDnHvTGkRuASG96vzaDcR7mwGrOubd7ZgJEwcZHcYrFNPY7nCS6EWGmuUTO5RXWaLFb+UUmhw+AFYHqfWsTQ4lmkZv4jxXRRwrtAUAfU0nLUuMdLF6HR3uUaSFmyD0b29Kq3cFxFuE6tgnJ9Ca0tJvnju4IbuYQx/dZn5VR+FbapbXJP72N8fdOfvD6GloyZVJ0n72qOIuNhi2eWxk67i3A+grFvEGCCBmu28R6Wttb+bbgFB1A9K4m8bCtgDpSas7HTSmqkeaJkwSCC8BPCscZrcE4JA9a52ZCZVz6GpBLPtC7z+FbqVlY5KtHmndFrU41juOBwwyfaqkjDbnnHpSSTEjMhJY8ZNSQLllRzz1qWaRTitRkNuY0aRl4PIzQ230PP6VoNF8pUEjvg9KrvGcjpkVNyd9TE18EaHqP8A17Sf+gmvdfi0AfincAgH/iTWXb/pvd14h4iTGg6kcf8ALtJ/6Ca9y+KsLS/FO62sBjRbL/0fd1t/y5l8jz6mmLp/P8mcnMuDt4/xqpch9vykA9SM96uTQsj45+o9aq3Nu2CSSGx1xXIj0mUZhuU4wSOfT9arzxM2ULFX9GOMH61OI50DdGA9uah372xKWB/2sEGtEStNiGYTLBs3Nt5HTOaobZHlBVUTChTgdfetdPlBwvHQ4PFVvMZHwAuCe9NMepSaMkMARk9eKqXlqduQuTityM7lI2Lv5xtqveNIzHdySeTVoxlK+hy8X3mDD7vrSyxoTuGBW7Y6DcavNP8AZGjj8lQzNJkAnsM+tUINPmnuDGxCsh+YHtVkXSbTKsFgshjaQkjOSO1aVnYSTyNLCFAiPAJxnHYep9quNafZoGAIZiOCBXovhnQLV/DlqFzIJV3Oyt91jySf8BTtdWMZVvZtTODjzIjbVOUGWIH3RnHNRwqjTyH5ixGMKMkk1r+I7NtMuJIVlBY8K8bf6xDzz+VVP7SSe0trNIIcR/MJjGqS5PVSynlc8gnmsuWx2qpzx5kRGP7O3lyI6OvBVlwfxBpURycpkVME2sQVznnJ5NTDaEjAQBl6vk8+gx04rMD6N+E//JLPBv8A2BbL/wBEJRR8J/8Aklng3/sC2X/ohKK9k+QMj4vfe8H/APYZb/0hu65q5KoSM5Gefaul+Lv3/B2f+gy3/pDd1gzCNXBIOcYPvXLX3PUwDtF+pmakpnsJkj6tGQPevN75NqAj7rqcH1x/kV6e5AYADGO1cJqMUf2i9szxhy8BPG1vT6EcVzvoetD4WjBiYlCw6jn61PEySMCc8qRgetVFJTIIxg5pkjsigx8A8imjNroaMEhAYN94dKkmcyRLggkVnxz5CnkHHNTiQFGVuD7c5pkMqzylSMngcEU+CUgAk8Hmo5FQ5DevfvUQLjiM8np7UPUaVixqc37rYp3PjjGcDNefavZSQ3TSxqWVuWA6g12tzhp3dIgu4/dB3fXFZ0sDmTLLlM8qe9KEmnoa1KUZ07M42Ml3VVVic8jGMVtg5MSE/KGBx/OrV1DvlYQqAufvMMcUyyiEkoVB8iHLOe9aTkmjmo03B23Om0wbTvxwBWrHKPJZmHPXBFZdrIdg4+UdAK0U+YFSCe/A6Vys9eCu9Sfzi0aq3A+natLUmMn7PnxEPrrdmP8Ax3T6zoEDpg4I9a0r5M/s/fENFPXXbNc/hp9a4X436f5HFnNvYxt/MvyZ4PprFdyk8gkVCZMTPyMbjTY3aOYqTg9CD6iq+/MpycHdW6jqzy3OySNO3fdIqmrMkoabGAQvas2GUR7mJ5ApguCiknJJOfrS5Lsr2iSNuCYRHI6GpReop3BhXPCaR+rFR6CkwuepP41Ps11Gq3Y6KHUIt+S4z9asG7ilyu9Q3UHPSuYVE/u1KIVGMdfak6aK9tLseieG9aVsRO21xwef1FdbFfKNmDwR1PUivDi8sRVkc5HIOeQa39K8Wz25WO7XzUHGe4/xrGeHe8Tto4uEtKmjPVd7SN8ucY71atLny9iyDKZGfT61zWj+IILuPMLLz+lbSSCQckYrkcWtzsdRPQ6a4t/tdoZi8aRKT5LY3+dICAUAHI69TxUNhOygDaR1yp6is7SNSuNJuy9nKI5GxyQCDgjgj09avoRdTy3JDI0jFmy24lj1OcDqcn8atO5zuPLvsbNtM3J4wVI2/wB2tK0kOFXOcKO/P1rAW4kxkx9B1Xv71etbzA2FgCcZPT5fStEzKcNCrDGsui/CZW6f8IpL/wCg2FW7m0UIMqMZ6elRWGP7J+ExPbwnKf8Ax3T6vzksW3df6Vvil75w5fNqFkZNxCFtSMDYeK5PU7e3ZX2jLg5I7FT7V2V0y+Sdw4BPA71yt3G5upMgqrjjA7VzPRnv4Zc17lO30xImHl/IGGQetbdrEZI3EjIrrj5Gzl8+nrSww5t1I5wvepV2ltv8Q/lSuKa10LTWn9n3yx6hbtIo+9EJMZyOORmsyQNC7PGSvOQuTlfxNXWLIcZ46gntVe7YSJgsRx9Kb1Ihdb/18jOutSn8iWNpSyuMc9a5u6IEeM8ntitm5QKc7ssPTpWJKu6csrcA/dHemtdza6irRRU8olgSO2BSSxnjYOa1IoSz8gEgYHWnSWx8z5hj2q72MFqzCa2ZkOQfUe9T2kJUZkIJzjGecVrPEh4B46k+9ReQY37YPIoTFKXQd5YCjPK9KSWJSoIAB9u9WGQCEE8j1HUUxfXBIFQStjC8TQkeHdU6cWsp/wDHDXtHxPUt8UrvaP8AmDWXP/be8ryDxUCfDWqs5Ofskv8A6AeK9q+IChvinfgjg6NY5/7/AN5XRHWjL5Hn1XbFU36/kzk5kct8g57VSmjkZySAT71sTK0c4Qj6GopFBUZTPuexrkPRuYLhkIDJle+Kyp2RZXaNQCeMkYArrLiNXRlQDOBzmufmth8wZPn67ie9XFhoUEMkwVok2kdCBjNI+QNrfKSe/OauMFjJYMTjqPSs+7uJJpNw3A9hj+Qq0DTexNY2d1eXbQ2TRhgu4s7cAfhSTWbwTG2ul23CH5m3ZB9MUmkXBtrtZHkZU4BKDJAzzxU3iW5gnv2lspDIpA+fG0k1as0c8uZT5ehmtI9nNIYWfa33gGwOKpXWpTT3/wBsMUcZIAJQcN7mrEcLTsA2dhOceta9ro8T2xmkwyk7SOM/40c3Q1VJW5pGUmp+dgSRtu7FRx9K3dC8T3GlxyxRQjym52PkfiPSs2SzRDhVIUcKCOgqsYyTz24pKoxyw0LW6E+s6pdapdG6uivmAbURegX0qva2zQjzQjbehO3IFWIoC/BHPauz0OaM6EbZpI4o0DiYNj5s9G/z6Ur3FUl7KHurQ5q1JkhIwd3b6VJgqV3Lz/SktxgsijIHQirkUBfDDjPOO5rNhsfQXwn/AOSWeDf+wLZf+iEoo+E//JLPBv8A2BbL/wBEJRXtHyJk/FwZk8HD/qMt/wCkN3WLLGCdpOc9CTW58V13XHg0D/oMt/6QXdY1xASMN1A4Nc9ZanoYOVo28zOkHGOhNcN4kgIv5mHDKcj3Fd/ImwbsBvUEdK5nxBaud06rvB6+3vXNJaHt4WS5rdzzeYvBKxK5J6huhFKjiSTZGC2eQrYBB9K2byzV+YwD361jvAFbLAqQeoqFI2qUbjwyRsBJujf3HFTRSIGwQpHpUM+HhXzOQeAScg/4VW2yxAMvIHQg9Ku9zlcGtzVkbeRtCDj86hMJcZIPPdarw3GBlCD6gjNTQytIcDaD9adzO1h/y2xRyEYnjBXNUr2/hckBA2Ou3jmlvb63MbRMRMT1CDC/maypjCR+6j2e2c1LfY2hC+siCZ3nwuAATgAVcs4QibAAFzkn1NRIgCgkHmtCzQrx1B65FS5HRGmlsaWnxZGF5Pc1eWM7/lHOMdKq20g2fu8Fc4rQt8twSuT+g9KybOmMeXUfDGRIMkYHU1evCP8AhQ/xDO4MP+Egs+R/3D6gt4ZbiTbAm5Ohbt+dT65F5HwE+JEatkrrtng++3T63wvxv0PNzhr2UV15l+TPANch8txPH0GM1jpJumLdRWyLkTQPFNjdjBFc842Oy+hxXXS2szxsS7NSWzLUtxn5V6DnNCy85IyfeqoNL9OlacqOf2jvcuh2PXge1TR5bhBmqULDq5yB2q2k5IwoIHtUSRtCd9y5GNp+ZhUysOPSqsbZHIOasx4OFLqmSACw45OMk9gOv4Vk0dSasKxzwarTR8Eg4NXVt5ZPPMKGVLdd8rx/MqrkLuz6ZIH41Wc5FC0JlZkukXDx3EboxWQNhgD1FemadqLm3Cv09TXlWnsFvkGeCa9H02RX2uAoB5AGa5sQtbndgptxsdjZfOo6sVba+CCV+lbkJ8qFUU/NjOKy9ER1sowFjO75ztH861xA0hJ6OR2HFYxity6k23qxz3DrE23HTPHaqsz7XXDYJ7jrVqZdsJUEDIwcfrULkJMiKxOGBGPTnH60MdOdjWtW26P8Jz2/4ROXP/fOn1clbIYqOtUIcjRvhLj/AKFSX/0GwrSO0EY4Poa6cT8ZxYDSncpmPzYZM5B7H0qmkMfm4nBAPQ+hrbgg8yGUh9rAgbcH5vx6fnVWWI7nAU5HTHpXM11PShW1aMhht+VMgDj8KWWMqAwB471d2A4yCD702cHGFI9qmxvz6mbLKyLyARmqs8qmM88/TrV+ePcuMZ781ELUgMxzjqMCmim1YwJkeeNtvH9ah+yYIJBY+w7VtiAhmDDJPQn+VRtF0wvA7AYouVfsUIogobk5x0NOMSA7iScjgVbCZySDuPrUcoGenHai5D3M+WACQEMQG9+nvTRbncSwyfrVlxmUZXJP+eamWEhyR07j1p3Mno9SlJEWHXn0qsyFQVI/EVqtGvIG78u9VZYV2kZyffvSGjn/ABUP+Kc1Yg4BtJf/AEA17L8RbgQfFe7DHG7RbLGen+vu68f8WIU8N6tx/wAukw/8cNep/FnP/C07kdv7Gss/9/7uuiH8GXyOCsr4qmvJ/kV53WRjnJOMjH8qhxkFT6d+DWb9paBlySQO5rREqToHiIJA7dxXMd2xUuNm0hv51mXSB2IcYJ79K25FXgqoz6VVlRpRgqPYHtQtBnPGI72BUZHQDvXT+ELOCCCe6jdPtuDn5ctGOgYDv+FZU8DckqoYeveoCrBF4yR1FaRZFWHPHlvYl8Zxl9bPlRIsgiBkZcAM3rj1rlbgu7lSMbeCa6L7B94s2Cem0/zqM2oJIPUdRVc1xQiopR7GdZxjCKq9DjcOtb+m2ZdGbMZWMHjIyue9UFtY8jD89xirSW4ZsEnnhiGxn6moOlu6tc0NS8PJDbyTXl5JGrL5kTEc4PPQ9ec1yEiMIyVPQ4zXaeKbhdS1CSSTOFURxjer7QOMbhwfrXMXCrny9p298VTtfQzpOTh771ZDZkY3N17jvV0BWHzAe3FJFbA4C8jpxxmtvU9Ck02zjnaVJQxw8YHKnHFS7sblGLSfUw0O04Xr6VbhMqJujLDdlGxjkd6gx8xIGCaepKEZ+6Km4TR9CfCf/klng3/sC2X/AKISij4T/wDJLPBv/YFsv/RCUV7Z8aYfxnv7XTI/CN5qFzDa2setHfNNIERc2V2BljwOSB+NczceN/CbruXxPoeccj+0Iv8A4qvQvGX/ACMfgT/sNSf+m68rxvxh8ZtT0v41fZbfVbGPwlpt7b6XfWbGLzZXkV/MmGRv2xtgHBABVeDk1Mo8xrTquC0Oj0/WtL1fzv7J1KyvxFjf9lnSUpnOM7ScZwfyNPmiE6shB5GK2fEMDTfFHVyoyV0XT/8A0fe1HJa7h8wwe5HNc04WZ6dDEpq/U89ksgrurpsIOP8AdrKvrEKxypzngjpXfaraJjeZAJBwHGfmHoayPsofopZRk+pFcc4uLPchWVRczPPLmExMRsJ9ieKqIXiYmMqQeqMM13GracsibgM9s9K5u6sQHYEMjA8HtRcvkUkZe+0d/wDSYpIz/eh5/Q4P61SvnjJxbzvJERk702sPY+tX57Qx8MRk9M96hNowbOKtSMnRje6MyKPe3Hr2q5FbE8BSW9v8anjtWEhA5PqOeKuLblehJz2pcwcuo21jQx7QmD3NTBBycLinQxSFw2xRnjmtS2smunWCJQXPvwB6mobNYrl1ZmoyBML94dMV02i+HL262tebreFuQvV2/D+GtDRdAtrOeOSdVuJgchivC/QV08kwUFhyR6VUad9WYVsU17tP7yhcRrDGIYwAijGBXNeJyq/A74l7iFUa7Z5J4AG3T6PHPi2y8M6e1xdkvcSZEMCn5pG/oPU074Oapc618J9U1C9KmefxpppbaMAAXGngAfQAD8K7KENb9DxsfUSioX1vc+Z7uaBZAVnhbPGVcH+tZzOrSMFcMc9Qc19c/Ejxt40svG3jy00G/wBRW00OxtbuBLeCzaGAMgaRp/NXzWTG44jyR9K5j9qu8XW9G+HOoRSR3Ed1ZXVx5kakK4ZbU7gDyBz0PNbpcqPOlN1XY+bc4p6AuflGT7VcjiVOQKnEUbc4w3qO9JzLjQbKsVsf+WkZP48VejiXHCY/3Wp0Sjp0IqbYOvQ+orKU7nTCkojArDADA98MMcU9ZCofch5XAIbGDkc+/ekZeOQD70wg4+VsipLHmQlSOx5I9ahkl7U2R8cd6gJJ61SRDZLbFvtMRQkNvGCOvWvVvCdgty2HJCKoJAPJrhvCuli6kE7A4HOfavTNHgNvIksZ2sPu/wD1648RNN27Ho4Sk4wb6s6y0skjAWPKoBjAPY1oqGjjBzlVqlp94sksaOu3eQuQcAHPv0+tXZGXJXcoUgkE1nFp7CnGS+Iq3EuH6ZViM47c1G821lcYGCa0YY7SJ90snmcgEoAQAev1IHavPPir4z0/wzbpBpT+fqc0ZCo8e0R8keYRk9scHqc9q0UHJ2RjOtGK1O7vdUsNJ8P/AAjn1O8trOFvC8iCS4lWNS2ywOMkgZwDx7U+Txh4XKceI9G/8Dov/iq6/wCHH/NLP+xMm/8AcbUfwi1XxL450GLxPc+IprRX1GZRpa2sDQLAkhXy2+TzQ+P4t/oSDznuqUFUd2zzqOLdKPKkVNA1rTdS0S4Omajb3imUIfs7rIqkAcbl4zgg4+lNkJZ92cEcGoNQbHj3xsF5I1GE4/7cbWk3n5hnPrXFVVny9j1cOuePtO4y4IEmT175qALnJGcZ7VI+0odwx6d800khSMcViztjorEOzLbm69CKdPgIpHajkye56+9NmHBBOSPSkN6sznUtI23v0+tMIKPyPu++aslG3bgSCO2OKhuTucnHOPpUmq10Kzbc8Akg8moJ1wWJJB+lWD8o+QZNMm/eDHBP1oHsVI13cAEk881YDfIMkDNEcZ3dQMU0LuK4Ofp3p3IkkySONCWRQxLHgjqapXyqH2KMDPOOKsyO0MimF2R1OQykgj6EVUlckfPyR61RmtHcwvGRT/hGNU+cMfscuRgjb8p/OvRvjFqdhpvxSn/tG+tLQSaNZhftEyx7sT3ecZIzjI/MV4B8QfF4mtp9M02QOpVkmlHIxjlV9fc19ZeNNRu9H1P4jalp0vk3tn4UtbiCTaG2Or6iynBBBwQOCMV3UaLdNxlpc8fE4uMa8Zw15bnjsvifQCu061pTD1F3H/jU+malBtW4spo7i1kJw8TB1ODg4I4PINdt4Y8Y+JtPn+Gdxqesya1beLoNtzb3FvDG1vL5YfzImiRPl5wQwbjvzxy7Whe71yXhgdZ1LjuP9NmrGtQVKN0zrweNeIm4NW0NSORLiMPGwKd+9V5xhcp82ehrGIkt5NyEj6VehvlYDP3u+a5T0eWwueT5qEg+lRSIjN+7BHoKsmYK2R834VHI4YFuVI9aAbuVpPkB3KGB6hhWde6ksYISMA9Oa3dFs0v9R8u5jMybSQpbaCfc5Bx+NdDqHhuxk0me4tdMgR4ujRE9upOSc1rGDauYTrRhJRkeYfbRJwTlvY1dtrranUZ9+K0JbVGAQxhR32gChbQRxkK+Ce7dazcjt5U0QTTNKpGAg6cVqaV4flnsJbvKgAfKueT7mq0URkRlkQHHIZeDXT6Vr0FtZ+TcWXmMI9gYHGT7iri09zlr+0jH92jmEi8qX0q9qOp3N3ZrbTlGQMG3bfm4FVn+eU9FB9Kc6EJwQPXFQ3bYuydm+hQdflBXAxVK4cIDkAEfpV+7ASNmJCqvJJ4AHqTXj3jjxadRd7LTXItAcSSg/wCt9h/s/wA60pU3UdkYYjExoR5pH298J/8Aklng3/sC2X/ohKKPhP8A8ks8G/8AYFsv/RCUV658sHjqHUPtfhi/03S7nU/7O1NrieC2kiSTy2tLmLI810U4aVON2cVyP9g6X/wjWqaAfhd4ibStTuDd3kLX1mxmlLKxcubzcDlV6EdKzP2stY1TRPh5pdxoupX2nXD6tHG0tncPC7J5ExKllIOMgHHsK+VI/HfjSR1SPxd4lZ2OABqtxz/4/QB9ff8AE+j8V3eoW/gjX1sn0yzsYka7sWkBhkuGJJN0cjEyYOSSQc+9ua41uU5PgbXw3qLjT/8A5Kr5h0vXfFfkj7Z4t8SSSHk41e5AHtw9ai63r5A/4qbxL/4Obr/45WEq0Nmd0MDWa5k7HvtxHrU6MkngXXWRuv8ApFgP/bmsF9G8UiQ+V4O1ox5+XddWOQP/AAJryA634gH/ADM3iT/wc3X/AMcpv9v68B83ibxID/2Gbr/45WLdKXRnZSp4ql8Ml/XyPXH0XxbghPBmqjPrdWP/AMkVTuPC3imVTt8F6orf9fVjg/UfaK8nk8Sa+DhfE/iT/wAHN1/8cqu3ijxGM48T+JP/AAcXP/xyhQpdma+1xkeqPTm8F+MicDwdqHlk8qbuyx/6PqCTwJ4xwoi8IaljuGu7Lj8fPryq68W+KI1yvirxKM/9Re5/+Lqi3jXxZnjxZ4kx/wBha4/+Lq1Qps56mY4mDs2vuPYE8CeNlbI8I6gMHteWX/x+ph4K8bbcHwhfkjoTd2X/AMfrxkeNfFh/5mzxJ/4Nrj/4ur2n+KvFNxMFbxb4iHBJ3avcgcD/AH6boU1uKGY4mbsrfceuxeDvGqbR/wAIfqOB3F3Zf/H63NM8O+JLJc/8IZrLSHqwubEfp9orxxte8RNbM8fizxGssa5dJNauRvycfJ8/YYyDVRPE3iiU7Y/E3iUvjPGsXPH/AJErP2dJa2Z0zqYySs2j3/7D4oDbh4K1kH/r6sf/AJIqrf2PjQwyNZ+CtTeYKdiS3diqlvcickD8K8BPizxQP+Zq8Sf+De5/+Lp58VeJpEKjxZ4mRiOGGr3Jx/4/VfuzLlxS1uv6+Ro678H/AIsa7qct9qXh15Z5D/z/ANrtQdlUebwBXsHwp8C+KfDHwhvtO1PRJRqo8R2epx2UdxAzywxTWjsVbzNgOIZMBmHT3FfN95408bWkxjl8XeJPYjVbjDD/AL7r17wv4p8Qzfss+M9Vm17V5NUt9XiihvHvZTPGha0yqyFtwHztwD/EfWupWtoePPm5nzbnrOt+HtO1vVtQ1LUfht4te71BEivDFq9vClwiABVdEvgrAAdCMVyXxm8L+JvGR8NReH/A+pWdppMFxB5U1zYxhVfydgQLcEYAiI7dvw+c7Lxp46vbuK1s/FXiea4lYKkaapcEsf8AvuvevB+h67BpCnxB4n8S3185y7LrV0iRf7K7ZBn3J/CoqSilZmtCE5S5odDgZfgp44fJHhS7Vj6Xtn/8eqq/wR+IY/1Xhm4P+9e2g/8Aa1evXKwW4Cpq/iWaXv8A8T++Cj/yNzVNVlZsnVvEYB7f29ff/Hq5/a049z0FhsTUV9DywfBT4kA/8itL/wCB1p/8dqZfg18RsAHwrLn1+32n/wAdr1QxqBn+2fEh/wC49e//AB2oztHXWPEo/wC49e//AB6j21PzD6riV1X9fI8vb4MfEY9PC03/AIHWn/x2om+C3xIPTwtL/wCB1p/8dr1ZChYZ1bxLtPf+3r7/AOPVaEMWMnWfEWPfxBfD/wBrU1Vpkyw+IW7R42fgl8SD18Ly/wDgdaf/AB2nw/BH4ieavneFpvL/AIgt9aZP/kavW7jykGE1nxEW7AeIL7/49VfDgA/2x4jPt/b17/8AHqHWp+YRwmIeuhzunfDbxnZxKg8IX/Hpd2X/AMfrah8HeMkjKf8ACH6lg+l3ZdP+/wDWzZfZZwFm1LxHG394eIL8j/0dWmujQuAV1fxGQehHiC+/+PVmqdGXcudbF03aVjmX8KeMGjKjwZqeSRk/bLLn/wAj1sw6R4oNpbC48EaqlxBGYx5F1ZKDjG1i32nO7qScdgPerx0WNGy2qeJCv/YwX3/x6orjRAqb4tZ8SEf9h6+/+PU40qUXomZzrYiorNo5/XdC8f3Uby2Hgi6S6EQVRJf2YR3wBuIE3HrgD/GvGNR+BXxX1K9mu73w801xK253bULXn/yJ0r2jxNoWqXukypoPijxLp2op8yOdbu3Vj/dYNIeD6jkV8/6p4u8eaXfzWWoeKfE8F1C210bVbjj/AMf5Hoa6KSgvhOTEe00U9j6+0XTdc8OWvw+lbw/fajJpvhyTTLyGzmtg8MzCzIBMkqKw/cSDKk9B61HBpFlb6q+oW/w18Uwyvc/bHii1K1S3efOfMaAXvlFs4OSucgHqBXj/AMc/FPiHT/h18JbnT9e1e0uL3SDLdS297LG9w/k2p3SMrAscsxyc/ePrXmvhDWfiD4p1VbLT/FviRVHM07apcbIV9T8/X0Hetm7HOk27I+jL3TvFU3inxBqcfgvWBDqF1HPEDdWIYKttDEQw+0YzuiY8E8EfQJ/Z3ivp/wAIXq4HtdWP/wAkUzS9CaKyiF7r/iaYxqA88uvXitIe5IWUAfQCoryKA5jstQ8SEjrI/iC//Qed/OuKapSd3c9SnLEwShG2hO2meKm6+C9Yz/19WP8A8kUHTPFRH/Il6xn/AK+rH/5IrEuoZLdNz674kB9Brt6f/atYF9qlxG5SLXPEQPq2u3v/AMdqVCi+jNXUxSW6O4Ol+KxjHgvVyfe6sf8A5IpjaR4rJ/5ErVsHr/pVj/8AJFeef2vfs2F8QeIvQ/8AE8vMf+jasS3WqLEWHiLxCGH8J1u85/8AIlV7Kl2ZH1jE90d2dH8VEYPgzWMH/p6sf/kiq7aF4uI2/wDCG6qV97qx/wDkiuAk1LWIwC+veJRnpnWrvn/yJTF1jVR97xB4kP8A3G7v/wCO0vZUuzGsTiV1R33/AAj3i4cjwZqmc/8AP1Y//JFRnw34vO7Hg3VR6f6XY/8AyRXFwa3frKpfW/EMi55VtcvRn8pRXZ6RqGnXwVJ9V8R28p458Q320n6+dR7Gl2YfXMV3Qh8NeMcADwfqmP8Ar6sf/kimx+GfGSHI8H6oDnIxd2XH/kxXQNo8ZHy6t4kH/cwX3/x6oDpYUkPq3iXHYjX77j/yNS9lR7Mf1nFPqjFfwz4ybH/FG6kMDg/arL/5IrmvF/gX4manZ/Y9I8K3NvDIMSySX1oHI/ujExwPeuxvNPmtyCus+JGUj/oPXvP/AJFrlPGum+I5dMFx4X8VeJYLmPJMLazcsJh6ZaQ4b07fzq4wpRknYzqVcTODV18jzp/gN8S2jZR4YbkEf8f9r/8AHa+svE9jdnxTr/2jwxqWuaLrGjWunyfYri3j+5Jd+YjeZNGwys6YK+p5GK+J7nx342g81JPFviaOWPIZW1S4BUjsRvr2f9rDxR4g0X4k2Fro2vavp1s2kxSNFZ3ssKFzNOCxCsAThQM+wrsPKPXfDmj2Ph29trvS/hr4oFzawfZraS51K0uTbxf3IvNvW8sey4rmrXRfE8YvvN8FawWn1C8ulK3Njwk1zJKoP+kdQrgH3zyetfP3hHWfHniO+2R+MPEsNpGf3051S4wvsPn5Y+lenl9TLeVFr3iZ2UAF21y7A+p/edfpXLiKtNe7PX0PVy7BYmrepSaS7s6e68N+KZDmPwbq6/W6sf8A5Iql/wAIt4y3A/8ACG6lx/092X/x+qECagVCnX/Ert3b+27wD/0bVnyLtRl9e8SE/wDYcvP/AI7XMnQ7M9GVLGrTmj+P+RdTw34xUgnwZqZ/7e7L/wCP0knhzxm5/wCRN1ID/r7sv/j9ZE39oByE13xIB/2HLz/47QGvgMHXPEhI6/8AE8vP/jtLnodmH1bG780fx/yNhPDfjBQM+DtU/wDAux/+SKn/ALC8ZeWYz4Q1fyzzs+2WW38vtFYO+825GueJP/B5ef8Ax2gvd/8AQe8SZ/7Dt5/8do5qHZh7HHfzR/H/ACNd/DfjFj/yJup4/wCvuy/+SKX/AIRvxfjH/CG6p/4FWP8A8kVgtcXo/wCY74k/8Hl5/wDHakiuLo/f13xJn/sO3n/x2i9Dsy/ZY9faj+P+RuR+HfF65/4o3VMHj/j6sf8A5IqM+GvGPOPB2qD/ALe7L/5IqnbSsTiXWvEnP/Uevf8A47Wl9ikkTdFrniPPp/b17/8AHapewfRmUljY7uP9fIh/4Rnxfjnwdqme3+l2P/yRTh4a8XkYbwdqp9vtdjj/ANKKcIHSPY+reIy2cljr18G+n+ux+lVru0ugN1vr3iQjrj+3bz/47Rah2ZCWMb+KP9fI5Xx14A+J2vL9l07wrPb2BA3h7+0DyH0OJiAPbPNcR/woj4l/9Cu3/gfa/wDx2ul8df8ACXW0BvvD/irxOEjX99a/2vcsQB/EpLkn3H5V5n/wn3jL/ob/ABJ/4Nbj/wCLrsouHL7h5GMhVjU/fb/h8j74+Hun3WkeAfDWm6hF5N7Z6ZbW88e4NskSJVYZBIOCDyDiiovhlcz3nw28J3V5NLPcz6TaSSyyuWeR2hQlmJ5JJJJJorY5Tyz9sZGl+G+jJGpZ21qIAD/r3nr5s0PSVtUDvhpyOW9PYV9R/tUoH8GaAp6HWk/9JrmvnqKIIODXNXm17p6eAoqX7xjoVCips46GmEhRyKacFOCMmuXc9Vkjtnac4zUbKWzt5x6npUTbk5GDSSXQEYX+PGMYqkhN2Kk3UnIwPSpbzT7m0aNLmB4zKm9DjIdfVSOD+FMjnMMivE4WRDwSR8p/GpL7Vw9qYI/3cKy+bGiucRZGCFBPA71aTMpS7GDq8u6RTtReMYUYFZZPNXbrEpYkgnsT2qgRXVDY8bENubHA45rZ0RNzFjwT0zWRbxmV8AcCtuwKI6q3AbjPoaVTVWKwr5Zps6B7eIQxsQxZlPG4Dac8HjnH1xVC5iEg/cwMNiDzCpLA9tx9MnHtWro6R3k0NtPPFbQyOPMuZAT5S85IA6/T6dKaEaN2e3fjBXJUEMDxyDke/tXFse7e5zskRWowCrCtK5hKKSeao4zVJmijcffWUV1b7JBweVI6g16J4T0+dv2VvHFhCvmXEmv28cag43Mz2O0fqK4SyfaTHIMqeh9K9Y8CID8CPFCHgHxTYj/yJp9b0ZPVHlY+ilZve9in8NPA9t4atTd3JSXUHX97P2Qf3E9vU966i51Bpcw25Kw5yf8AaqpqF8JGFvCcQL1Pr71TMirkIeOma46lVyZ6WGwqgti0zKvOcmoJrnA4IzVC6ucDGeazmuCMk1mtTsasrm6t0Wxgmql/fpGdqsWfv6CsSS+kyVQ4BqjNP3zzW0YHFUrWehpSX75O1iPxoXVJ9u3zmK+hPFZAkHQnA9qBg9avlRzurNvVm7FqRBywz9DzWhDfrIinkD3NcoTgfKaWOWRD8rEUnBPY1hXafvHaxXQwAG5rW0vVJLdlVDvUnlCf5elcBBf4H7w4Na2najmaMZGCcVlZxZ12hVj3PVre5SeIHOc+tIWaNj3U9RXP2N0QoZT25960xOWTg1vGVzyalPkemwt1hfmT72cq39DXE/EPwZZ+MLDeu2DUoVxFPjp/sN6r/KutafJKk8GoC/lPv6p0Ye1VdrVEOKkuVnD/ABT8PXXibwV8FrC0ZYwNCaSWVukaCGzBOO5yQMeprqvCmhad4Y0iO2s49kS/MxP35W/vMe5/lUs+waD8JGkPyr4VkP8A45YUizC7ulWV/LizyfQVdebvYzwdJcvOW57mS6PLbYh0FVri4W3iO2o726iWR/IBSEfdDHJx71zGtaoGQqGwo7+tc52r8BmtaqsauXwZCemc1x9xctM25icmku52uJGYvnnjNVmV92ApJ9K0jGxnKVyUSkHrViK9cDaGLL6GqOIwwEkuBjkDr9KsLbW9xFm3klR+xkIKsf0IqjNtG1Hq8ckYhuFVox0VzwPoe1TtpkV5Fv0+dVYj/VyNwT6A/wCNcU0jIxUjBHBFXLDVJo5BEz5TGFz1+mf8adiNieV3gmeOVSkinDKeoNSw3zA/eyKs3sg1K2ZpcJNH91z1x/dNYSMRz1x1x2oTuNxPQfD3jOXTzHFeFpbM8dctH7j1HtXpNtdw3tuksMiyRONyOp4IrwGD95HLz8yrvH4da6Dwl4gl0icxu2+xY5dO6n+8v9RUtXKSsevSINhR+Yz6dV9xWFfA28m0rz/Fjo47EVsWl2k8SlWDKwyCDkEVDqdqLiAqPvDlD/SpTHbW55F8VvCFtqelXms2hWG9t4WlkYDiZFUk5/2sDg/hXS/tMeHZvEPxi0+MN5drFo0Bmk7gGe4wAPU4P5VD4slMfhTXon+61jPj2PltXafGEqPijPkfN/Y1nj/v/d1rzyjTbXQyVGFTEQUlo9ziLG2tdJsorSyiWONBgAc49z6k1r2MLSIDJkDriooEBO5gOOnFWkmwMGvPtd3Z9G52jyxRa2qoAHSopXDDAqBrgdM5FQNNz16U2ZK5cX5jzjj1pJDGBkY3CsyS7xyeBVaS7DffPHoKkbuzRmywPp1rOnleHdkEr2Oc1VfUEBwgIHfAzVaW6Uj5jtFCjcqNXl3LTX4bA2e2R3pY5wTuycVmtLEfuOAfalZ12ZB61XIaKtE2BOMgg5q7Z6vLayhn+a3PUj7ye/uK5mOfa3Y/Wr1rcqx+bGetTZou8ZLXU9EWW3vrZGjOXI+8KptmCTZJwOxPT/8AVWHplybdgsf3OvB6V0jTC/iVXVRgYBA5rRO5wyi6bt0Mq+RJGLwZDD7ynqK8n+IHgrzTJqejx4lOWmt1H3vVlHr6jvXrN0jwtuH34+v+0tU7hFfEqD5H7ehpwm4O6Jq0YV4ckz3X4T/8ks8G/wDYFsv/AEQlFHwn/wCSWeDf+wLZf+iEor1j5M4f9p0A+FfDoP8A0GV/9JbmvBHiRvu8H2r3v9p4keFPDu0En+2V4H/Xrc14D5d1J0TbXFifiR7WXO1J+v8AkMlUx8nBHvVOZ9zHy1bip7pLmLBeNgPzFRQo8542oo6n1rJI7XIj8iWRGcuFRerM2Bn0HqapCEysRgke/StkW0WeXDkdTmmTSRAYH5U79gjHmepQj0/aA0hXHZQOtSeRbpgMij/ZCg1PFK7sRGoz9M4qxHYEOsiyBmBzhlpc5qqKXxGbcWEL5xbOvuEx/KsLUdJlQNLEGIychutejxQRahGY7uTy5gRhgMHHoKzri3EM0kBO5U4DEdRVRqSi7o56lClUTjJanntuRGMHINWDINpB/CrGqWwtbtsD923IqOKVR8pVduOuOa6lK6ueTKi4PlNfSpXMKuM7sdc1pxyheCOo6VkWbiOBf5VK10WHyAgjua5Z7ntUU3FJly5I+71JrONuQCwBx2qzbgSOpZsg8kZq0QGJUDt0rPY6LcpWjQqqspO4GvTvCGV+AHi3qSPE1l/6HYV575RAPv6V6N4R4+A3iz/sZ7H/ANGafW1F6v0POx+sY/4kRFGWLPc1BKzDGavugCEngVmXBwx3da5D2FIrzOP4sCqj8/eP4U6dzvbGOnp0qteP5cGQfnY961hE5K9X7KIp3DOQhqBbeSZykUbyNjOEUnHufSr+j6bNet8iE5PAPA/E/wBBXV2+kxJEkVw094wUhYIMpHx1Hy/ePPbPvitb9jzpzSODMbxkq5UMDgjOcflUhhkUA5AB6ZB5rrp9QsbNhHDa6fBKPv8A2hl4P0yx/Sov7dhIUN/Zjn0UBf1KD+dF2TzN7I5R/MHbPuKaWwMNw3oa7uCbTNRAV7SMt0PlqD+qlh+YFV7rw3a3cJe1cbyTgZ649P8A9dFxe0WzOJunxCpHUGm2t20eCD07Va1XT5rbMTr8wPHPX6VihirHOR7UWTOmlNx1R6lot4Li2jdT8pGa6G2mwo5ryjQNTktXKKQULA7T39ce9d5Z3u7GW5qdi5x5jZuThgy9DQj7kwe9NgcToVz71ZhgyCuOa0vdHE04sy9ZOPDXwj5xnwvJ/wCgWFVxIFBPap9ZGfDfwhA6nwxIAPU7LGsPXrgQNJb2z7mGQX6DHc0V/jLwKvSsZms6uWdkiPAOPrXMX8sjjlie/wBau3a/uEYevJqhIN3A5PpUxN6q6Iz2dh1qKSZi2QxJ9c1qG0YryvPpitXS/Ca3Lh72Rok/55r978fSr50tzlkmcm8zTcNgOP4jxn6mprexu5E8yJJMZIyilv5V6bZaVp1nuj0zS2u5V4aV+AvuWPSrEV5blSZr3RoQnylTfxkjnnq1R7R9ES2luzzGa3uZjtulkFzgBHcbQQOxyOv41QntLmCby5opEkHO0jBr1CbVLCWcxC+0m6jP/LJJ1JI9MhgD9MVZfTrWe1P+jmKL+EO2U/AHp+BqudrdE3TPMrKRpFAaRs5wwPQirjW0Kl5FWVk4JAI3J7+4rqpfC9sfMlsGhZ8Y2vIQCf6fjx71hXds+nuILrFrdAkx85BHpnoQfUcUua+xtFq2pUtkkCeaF+VFII7lTwTj8ajhYbiAeasWx3t5sPzbQRJEoxx3I9q07Oa1uLUW7xRhxny88Nn/AHutFy2jb8Daw0TfYJm+U8wk9j3X+or0G2nEi4P515FDJbRooaKSG4TlZFk+YEeo6V6DoN+t5ZxTA8sMMPQ96GC10Mj4m2wj8N6xKo+V7KfPsdhrpfjGM/FeQdv7Gs//AEfd1neP1WbwLr+7tYTsPqI2NaXxj/5KpL/2BbP/ANH3dU3+6ZFJf7VD5/kznSQBwM00scelNUetMndQvFch7DYkkoA4qo1wBknr6UyWXPHTFZV9diIHnmiwLXQL29ZpW9F4FZU98+4H5dv161VurlsnDAk8mqKyhpgNrSuTgKoyTTjE0la1rmi2quCQqrj0zUjajIygRoqN/vZzU8Gha5PErxaI8cf9+Zdn/oRFNfSdSt42NxZxY55jAbH1OafMvIwcE31IFvm3jfFGT64/pWj/AGnEE2vEYweCvGKwJI3DDMLLj7xjO7H4U+3UndiNp1I4Cgg4+lXoZyh1RpSyRtMphYKQMnmrNtcAsRnDA/nXM3jGIL5R3ROMq2P0qfTrkvIAWw3bPeq5Lq5nHEOErHdWFyB14rp9Ku8qFB59a4KyuAzcnaRgH2robOdkYB/7oZSO4PQ1g1ZnZdVFc62YrIgI5cfr7VjBPKuGgbiOTBXPar9lIGCsTkEUmswjyVkXqh3D6d6NzKL5XY9l+E//ACSzwb/2BbL/ANEJRR8J/wDklng3/sC2X/ohKK9c+SOT/aFjEui+GEPQ61/7Z3VeWtZbFLKQMD0zivW/jspaw8KBev8AbJ/9IrquASFWTKEEHr71w4n4kelgvgfqc5c2imNV2+Y5IwAOWNcxrFikckhVXiZc7lIKsPwr1BLLyLgStH+92krt9K5PxlA8+o+WvISJVLDkt9T+NZWsrnfSd52PP7a2nmfYisUH4VcXS5z16e1aFvazQS8MQPpWzbywr+7Z1Mq87Seai9z0pNxehh2lhJEy7V/3ie9aiQKADgCtZLdZVJVeSMgg8ZqqYgGPHI6ihIwnUcjLu7cGTIIA96pSoUBO4H1q9c58w7eg4qkY95bI4FUhLVGbd2sdymJOg6d6oHRoyMoSpHQEZFb/ANmIGO5NLFAzEbk+Y9cdBVKdthOkpLVHLzWssAweV/2aSMA9OTXVz2O5MZ/SsS4szDKCF4PBx60c19yox00GwSjCoFw1X1QcFQMmqvkhotyjDCpoWLKATjHvSaDmJsgj5Rk+leh+EAR8CvFYPX/hKLH/ANGafXn0OFPzfhXonhNgPgf4sbt/wlNgf/Imn1rQ3focOO+GPqhtyNpODjNYV3IS7CtvUpQc8AVzt4T823pXKetF3Qy1KSTGNzgt096ux6SlxeRrNISAQNi9Sew9vr2rF3FJQQfmB4x610KSJpOmtcTMd7KXPPOM449yTitYs48TG2q6mprd9ZaJZrbkKzHOyOPgsPb0H1/HPQcRrfiPUNVRlaXyLY4H2e2/doccDcB948dTWXf373tw9zOxMjDBB52jsB7c1XgnTCru+bkYrWMTiUOXfcs20O4ADC49BVtozH1yaS3wE3DvT3mUHn0oZtFFKWJ1YSvgMeQR1H41cstev7ZtryPcRAYBZvnX6N3+hyKrTXAuCAgO0UkQT5Q3U96i9jbkU1aSOnfXYdRtxHfoJY3+VZ0UK6nsD6H2PB7EVmX+hyOSbdhKShkjIH3wOuPcdx1FZE0whcmIKcjayno49DXY6PeW0mmxR7vLG0MJDyVI43fVejDuB9KpanNUg6WsdjkLVSCQeorptLuHRgxJIwMiq2s2DxXrSsgTzCQwHQP3/wAfxqXTxyAcms5HdQacLnYaVdgyKe2a7CzuAUMICRxyEb5CMkCuA06N1JZhjniuoikPlIQeoqoao48VBc10ZHiM48LfCInoPDMn/oFjXH3nz3TA9q63xQ2zwl8Iz/1LEn/oFjXHSvmcZPfrV1/4gZf/ALv95UnT5GTcMDnnpmqKRnflgAPUd60bhPOU7ThfX3qpBHsYZAJJxUGrVzY0yLEZlkLKidXPJX6D1pLnWXtQ4t7bK42gF+VOfvMf4j+X4Vmxu8k4SNiLeL/x5vWoLzeAzMCMnCr3OaEr6mM4WlZmd4jmvNRixf3c80S8rFnEa/RRxXN/2dwCsikdMbea7iDSExGb1maSQ8Qxj7o9WY9K6iHTdP02JDFZwtIR/wAtV3k/99Vaq20QpYXms7HkT2zBQAQfYilt7m4s2BhkkjI4zG5H8q7O/toLid98aBmJJZAEVR646Vh32leUNxI2nlXAODTjWT3LqZfKKvE3fD/xAkQLb69bJdwqMJcRjy54/TOOGH6/Wti41G31OAQTtE1tMMxTHBHJ/iwOmf4l5B6ivNhEqPsuFJQchlANXNMYWk25S8lqWy8anDD/AGl9GH69DTcE9UcV5RdpI6G7ik0q7O9GSaFgGVgDkHoeP5jg0y8ZTcxXFv8Au0kXcAOMMDyK14GTVbcWk8iz3ar/AKJIOBKvUJ+PUZ6Nx3NZGqqYNOshGF2uCXbvnjg/hipsaxnfRi3dwrXIeNyykKf9045H55rpfBF4VuJrZm+VvnX69D/SuJibcK2vD8xg1S1cHgvsP0PFNrQtPW56H4wYP4E8Q+o064/9FNWr8YgP+Fpzk9tFs/8A0fd1ieKzjwP4i99OuP8A0U1bPxl/5KjP/wBgaz/9H3dH/LqRMf8AeofP8jkJJSBkHFV2nwDnrRPkD8azbuUgHBrkPYY+ecZYk5FczqV1ulbHNW724KxtzWJdSC2thcuAZHJESn26kj0rSKu7Ec3s4uTJZZba2ty188jM/MdtFwze7N2FVf7dvVfNiU09MYAtRtb8X+8fzrILPK5klYszHJJ71JGjzNtjH1NdKppbnmTxVSo7R0FnuXlJ81pJmPeRy2T+Jp0KXn3rcOmOf3bYx+VbGlWMURzKitJ1BY9KtzwpDHkBee44oc7bFwwjfxsyYNX1i1wDPJIo/gnUSD9efyNdONUtby2t5ntRBeMB5qBiV9flJOR9D+dYgtJpyNq8deTVxdMkUcld3pWM2nrY7KWG5NHJ2FvbaS/mlaFC4HzEL99fqO/16/Wsh4Hgk7H3B61t27zadPBdMCFbKhicD6N7Z/LrT7+xVQLgEeRMxG3OTG/cfnVQlY5q0GpWGaZcmNUldQ+3hh6r0/SumtZI24jlIjI3KccZx0/HFcQpa1n3AZ4wc+ncV1uhFfIaKUBXByFxg4xU1I31LoVHF2Z1OmXHyAA8Ct9NstsQ54PUVy2nfwbehFdBaMSVB6ZrFHVUSvc9j+E//JLPBv8A2BbL/wBEJRR8J/8Aklng3/sC2X/ohKK9c+QOf+N5xa+Ez/1GT/6RXVefPIY4yVxleMY713/xzOLLwoR/0GT/AOkV1XDiBXjOc4xXBi/iPXy9Lkbff/In03VoIJHNyZLhzGPnVOFP93n+dYOopHcPJIq7C5zx1rUFrhCeM1EYSfugcflXK5tqzPSjTipc0TnDYee23bjHQkZq7DpcaKu+3Qt6rkVr/Zz7H0JqzHAQCdzbfSpUjSc2ZH2PyVJQADPArNu7Yl9sYOWrpmi8xsDqOuKrxReXeo8hVfmwc+/FWmZepylxpNwsYby/kIyxB6VlyQzNceXb4Lhgu36j3r1+fRXuILl7VvLUcByQ2D0yB+RrzmfSWS+E8zMZY8qxVsbj6mqloPDVYzun0M8WjwTmOchZEOGGevvT5YkjIKncT/dHFa9lpn2xggd4nLD5h1rp7fw1ZoWgbezMOXJzQk2FWpGG5wixeYwyBmq1/p/mh8DkelbE9k1vfPEjcK2BT3iCmRmT8j1pEOdtUcOsZjkZW45OKjjT98QRzW1fxDecDHcVmMAt0PeqTNt9SdoNyK34V3Hhk+X8CfGB/u+JrE/+P6fXHBSsfPJPpXZaGCPgT4zH/Uy2P/oWn1rQer9Djxy92H+JGNe3W8ms24fcc98VauFAYlj8oHJqjcEo5BBrnR6zXYLSITXkUY5OQKn8Xy71SOIEIXPH+ynyr+uTUWj/APIThO7gSKTx71X1R2kljQgnapH/AI8a0Tscs1zVEjk7svG4PvzVYzASMQcYORW5dxJyrDisSa0PmYyoU/dLHA+ldEGmcWJhKm+ZE0euiMbGU/WkutVVlDI4yO2axbuIwzFXwD9c0kFpPcMBFE7574wPzrb2cdzgWKqfDY6vSZvOhVwcAjOankZS5CZJ9ap6Zpl3DaiORkUe2TxWzbWEYH7x2IHpxXJOyeh61FycU5LUpxQlmycmrlqzRsYhkFsvH7MOv5gfoKsyJFCvB57YOaoKXlu42UkBWBHtipTN+XnVjqPN+06NbtJwUJhbHPIAKE/8BO3/AIBUehqTfNu6Kvp3zUojIs71F+4ixS8j0Yr/ACek0P8A4+XOewA/Ole7uKEORSXY6yKMEDArVtlH2XcCDg4way4G+WtK1O63P+9WkdzirLQyfEq7vCnwi9vDEh/8h2NcvPHC86tMNiE4YgdK67XRnwt8JP8AsV5P/QLCufmi3NjAOa0rfEZYGVqVipY2gupcHi3TnjjNUNQVbS6uwgUxhRg9cE+ldS1s0dqipgeY+1yF6LjmsDVbMWtvOqDch27Qe3JrK5rF+8ZVorLEGb5ieQMdK1oLJIgs9xjefu5HSqlm6COLeeQwBFaOoS+dGWCkIG9PTt+dTJ2R2U6fPOxkXc3nX5Ee7Yi4+UdT61tSXvnW8Qji3yyfeyxxGOwPv7VD4csZLm9aZ1KwR5OSep/ya6PTpfIg8pN4hDs4iP3Nx/ix+HfpWSuzurShD3Ur2MKx01IPMlnRWmLHDEZKjtipZ7YyxsrKNp7YrUkkyxLKefSsjUdVghl8pmLP2VBmtU0kccuepLRXZy2r6PG3mHAU44bHeuRaN7djgYIODivRpt1yp+XjkEMOMVgNpDLKWnj4b7uRmrU7GNSnGS97cpaPcm6tpoUDfaLcefER12Zw4/AkMP8AgVdPqtl/aNg13GVSWXbKYiMbn5WQj33qGx6NWZp+mvYXlvqVvA4VC6MQMghkZSCPxzWkl217pEkwXynjunRlXnaXi+bGfUpn8avc86S5XoczCnGauwN5bow/hYH9abGqqk6nO4suMdOM5obO3gUGyPSfFjBvBPiEj7p064x/36atz4yf8lSn/wCwNZ/+j7usLxQpHgPXv+wZcf8Aopq3vjH/AMlSn/7Atn/6Pu6T/hSJj/vUPn+RxF4wSPGck8msO6JOa2bsZ5PWse7U5P0rmieu9EYl437wDGe1c1qsxmvGXqkX7tR9Ov610symWXKjofWuXuIOS/cnJrpo2vc4cbzcqiiEEngDrW7p0BVIxtHzdKzdMtPOlDPwgPHvXSWNvIZCyL8mcB8dParqS6GeBhrzSLdraKI97jBzjnuaS6QSTpHxkc4q/DC0jhQDgD17/WkaCFpCJY1k+bA4z9a52z1Y2uSaXFaCYtOWaCNGeQRkbiAMDGSP4iOmTjNSXSIrQLGsqMYlZ/MI5JHJGO1RT2cJVV8lfbAqXUjJcfZzMo8yJPL443Dt9MUrila97mLNEZDMrA+W3GccA1JZzq2nvCSAudmDyd4GAfxqe4gJQOsZQ8dTWZeIUlO0lRMpLAdCRyPx6049jmrrmXMuhDdoy8SffU7WrR0b5I7dyGAYEZ3dWBIqG7hi+wxycCRwejA5Axz14OSeKdpcZ22pLAqzuQAeRhu/p0rR7HJH4lY7fTQMRtxkECujteHXHrXLaduM0XGAW/rXY2sRLjiudHoT0PWvhP8A8ks8G/8AYFsv/RCUUfCf/klng3/sC2X/AKISivXPkDnPjqQLHwoT0/tk/wDpFdVyUYLxgDpj866/44jdaeEx/wBRk/8ApFdVyETfuCBxiuDF/F8j2cvX7p+v6IrozbijA4JPQ1aSAAcrxj1qOKMmbJ+9nitGW3mWBZWRthOM44P0riV2ejNpWRWdE2j5RkdqjGW4VdopQq78FefY1OAq5C7sd91G4mrFd9saZTORWXNmUtkda1ZCGT5cYHaqMyBRx1BzRccVZlNZbuVTA11IltxlUG0sB70y4iyOBxngd6mHIJzzU9r5AZXuY2kiXgqH2nketWtRS0eiKsMco2vBv3R/N0zgVvRX8R06SSVgtwo27QDu/wAMVSjnne0S0jxsUlgFXBOfU96huE8pCAQCeDVptbHPUXNuYV0GlnMh+VjyarTsdu08Ejn0rSlj7FsOepNZ9wC7nAOfakWrN2Ma8j4LE1kzJuZW7g4rYvCBGVxyT1qhtGfqaEbx0Q6MHbtJwo5zXY6CpPwP8Yrnk+JrH/0PT65QJ8oA6V1/h0f8WV8XDGP+KosP/Q9PrbD/ABP0OTH/AARf95fqc7cwswcEdiKzLlDuyAAPQV1t3bFiSF4NZU9nuzlTWKR6ftLmLa5FwhQc/wCcVJq0bC4MkRUKw3qfUHkfzI/CrYtdjcfe7etaY0e91K1SGG2kLKCYyy7epyVyfckj6n2qkmzGU4wmpPY4eaPexDdaYLZWjCSruQnriuq1nwxqVgjTT2TRxZ/gbeF+pqhaWolhYY5709UVJwqxundFK002zjTMdvCG9doJqZ7ZgPkUY9KmitSCcZBWrAgcZOTt+lJyuTCmoaIzVZkONpx7UjuRwFZa00tmAOUB9iKc1ruXJGPb0qbnRyJGCwZz82ST2q9a22AMjPI6CrZtvLJbCt25q7Z2zNKiucqvzH+n60N3NYJR1LTkeTqbY2qYY4wQOpaQH/2Q1BowAlJxjtVnVCsdhBGvW4k84rnnavyrn6nefxqtpqlXUe+aaORK6k/600OmhYbK6DTIQIE3jPeudtUMs0US9XYCu1ihEYwO1bRPPru1kclrOf8AhGfhJj/oV5P/AECwrDuYW35HFdLcx+b4f+Eg/wCpVkP/AI5YUyaw3DkVrW+M5MLO1OxX06ZJoAufnUciub147rmcHG04GD654rZms5IX3JlT61nTafLdSECKWYsNrBELH68VlY2uk7owlIhcMyFhkH2q/c30NzDHFGpMkh5YegqzLpN5HCPtVnLbndgbkIB+mahh0nYgKjDhs4xkGs5X2PRw1SLd2dFoLpa26qoJK5xxxzVS6uo1mMcBEkh6BQSSe4AFSxkRoqGMbSMYI61Ba6b5dyXZdozuBB5ApNPoaQUXJykY9yt/qLeXAGigP8R4zW1pWhxW0JMcYLfedzyT9TXTRWUUcQMrBJMDEe3nBGQSegFLHaxlNzyhU3HeT/CPX39hRGNnqTUxXNHlirI524t0xjaM9OfWqd7pstzEVhCgJzycflXTGxklkVUgPBOw5G5sngFfX6VJcactrapKsjGVzhkIwAauxxyqK5ysSSxQpDI0bDcAyY5aqRskt7C6eNXBe63Kr4JbbHhv/Q66J41hZ3OPlySx7VWvUEYgt3wpRCXz2kfkg/TgfhQr21Mp8rdkcHNbszs20L2CgdKbDaPJPFEBnc6j9a6O6sn+9syPUc1J4fsGn1mDK4VCXOf0/WqUiuVG94tj2+BPEPtptz/6Katb4wjPxSuP+wLZ/wDo+7qt40i2+A/Eh7f2bc/+imq58XBn4p3H/YFs/wD0fd1X/LqRnF/7VD5/kziLhc9Kyr2LKtjvW+8O48VQvbRyh2jrXLex6+5ydqgF0UYrjPJNZFzZSKzoF3KWO1h0rsl0w7gyKB+HWprmxumgVIoQhiJl8pkOZOmQp9cVcZ2ZnWipI5XQrNSoMg+YcYro4YxFAqrHvO7Jz0I9KjW2iTFxabvKcngrgKfQ+9X4gDjc2O1aN8xyr3XoVfOCwEBdrDkCqysDLhMDjL45AzTr2PbLKUPBPGTUtmFQoZCpmJCqG6E54FZM9ClaMbliWBI1iWSKdJWQhjIwIJz/AA46DGOKaT5bKqAkY5JPT+tdve27r4dN1PnzChVFxuV8dznvwSMelcg6r5ZcFsEZ5p2szD2nMijMqtIEd8qzHLtzgEjPHtUNxpMi6+bJisht3ZGZc4OMgn6damPlvIkefJEhxuKZyT7VbgcW8qmG4kE0DNjjK7jg/wD66NtiW21Y4yYICCr7n2fMAuADnoK39A08NdrvIKxqNwH97vUZs0DiWaPnaFXHA47/AK1e0gNbo5UY38fSrctDOnTbdzc0lN2pRIpyN/5AV3dlHhgSOM1x/hC1MmoyzAZVExn3JruY0wAOmTWSNqztod/8J/8Aklng3/sC2X/ohKKPhP8A8ks8G/8AYFsv/RCUV658mc78c222XhQ+msn/ANIrquPtcMQSOSDXffFfSF1648G6bJd3Nms+stme22eYuLG7bjerLzjHIPBP1rzyy0mzvfFms6Do954/v7rRpYobyaIaSkUZkBKkeYqswwD0Unj6Z5K9CVSV0elhMZTo03CSd7mtPAkM3lB2dgoy3HXHOMVq6btuofInn2IASoLADP41iXVjc+GPG17pcerX2oQR6fa3cb3awh0eSS4RgDHGgxiJeoPerQDMrHuRniuWUPZysdil7emn+JPGoSUheCCRlTUNxBu3bRwe/rT4IlcBsnI71NIw5CkZHbNRa43Kz0MSWPYvP3unBqtMB0GMfTmr1yN0hzj8O9Zsp2qfmrNqx1wfMrlcgJnByetRl97sp4BHWmvJtfviolfc5wBnNUimup0WjanJpqv5QQllx86g4rLvpvMdpARzSOSIgD1xjiqMxEabMnGKpzbVjn9mubmK0s24kEg9uapanHJaTeXPhZF5Zc8qfQ+9PuGCnPyn071mXDl2O7k+vr70XNoU7O5XnzIwCjpzQkW447+tKBzgZJPep4C0O148h15UjsaV7FtX2GFWQYxyK6/wrC0/wh8UwJjfJ4r05RngZL6dXH3l/DawTTXu3Yq5MjuQE9/f6V1fwxuf+Eg+D2uywyz2wufGGnRpKm0yRjztPUMAwK5GMgEEeoIrpwsbybPPzOajTiut7ndweEWIH2m4jHsik/zq3F4P0lOZY5Jz/ttgfkKyNckk03xvH4Utdb8eapq72I1DbZxaQqCLeU5aWNOcjp7j3rWW01HRvFujWk+s6te2+oaZd3MltqKWoaGSOS1CjMEajIEzg/Mw9PWu1UYLoeXLF1pfaNCHRbK3H+i2lvEexVBn8+tEmmBud3PqBWoKa7pHGzyMqIoyzMcAD3rTkitjnblJ3buYs+nNIpWVd4YFT7g9c14ne26WWqXUcJ3RJIUyD2zXfeK/HCXPm2Gkl0hYFXuR8rN/u+g964Sax+yAM832i3kGRNEDkHurAjOR6jIrgryUn7p7uApTo61dEyhcIyy74mx6ipbebLDeefSrJstygwus0fZlI5qq9o6y8oyEdiMVyXPa5Ey3JKFUbevrVaSYtkAcZqzbWxkwGBIp1zZiNiVOCBmkOKSdiksbySICpYscKoHJNbNvZGHzIZyY1jG+4cHlVPb/AHj0A+voa17S0tdO0pLqOZ4riRBm6dfuA9QikfM3b5eB3audvrx7rEFsjxWqncFY5Z2/vue7H9O1WlbcwlWdT3Yaf1/X9b1rm4e8vZZwgA+6qjoijgAfQACrNjEwcMw+Y1Ja2xRBx1/nWjY2zyzKqqSxOAPWqSM3JJWRueFrMyXLTsPljGB9T/8AWrrPLzhR1PFN06xFjYpEBl+59WPWqfibWLHw7o0+o6nOILeMY3Hksx7KO57AV0RjoeRVq88myjotpHe6d8J45WZVHhKVvl+mn/411g0WxHVHf6t/hXMeHtLbVtP+FUK6reaUI/B80rT2ohLEAaeNp82N1xznoDwOeuU0K4bXkW60fWviDd6O8/2ePVI7PTDBIQ20sq+T5pQHPz7NvB54rs5YvVo8pTklZM6xdLs1+5axD3K5/nU8cBiJ8raoPYCsvw4Lu31TxLpt7qNzqK6fqCQQz3KRLJsa0t5cHy0RT80rfw9MVu1SjHsS7vdlK7thcRlZVUoRgqRkGvMPEdg1hqU0cOREPmjOM8da9N1fVrXSod9wd0hGViX7zf4CvLNWkvtQ1S51IvHJG2A0AYK6jGBtB+9j25rlxCjay3O7BylCXM9iGNpZokklTaQMHFTWZDSjzCVGecLu4+lQxXMTBSkolQEbkH3l+o6iup8NWVrfW6+bIjy5J2N1XHv3rkV9j2HXjGPMUZpzPM7CMK7HcVVcf/WFNTablWmBEUfOMZBPaujls7Z7xIZpoo0xlth5A/8A11nalPaWZnXyVjWFPKi+bmZieWx0J/lVKPVmHtr6RRl3EzrP56cHdkcmommOcuxye5NVJrvHXO9uFAGSfYCi4kjhP+l7hzlbcH963++R9we3X6daCZaaFjICC5f/AFat+7U/8tHH9B3/AAHrWayGQsz5Z3OST/OpJJZrp98oAAAVVUYCjsAPSpkiIHoaGyVG2rM94CpypKn2NdF4WsnKPPJyWOF4xwKrWlkZ5lRRyT19q7S2tBDAkacDGPoKBynyqxzXxBjA8A+JB/1DLk/lE3/1qd8VRn4rT/8AYGs//R93WR8ZtesNE8D6nb3k22fULWW3t4l5dyyEA49MnJNdt44tkTxp4q1i41bVdPttJ8O2d1KunRWzvKqy3zEYnjcZAU4wV689sdEIc0Gu5xSrezqxnvY4mCxeVjtRn9AFJzW3pvhie8kVZ4ngh6s7rg49AD3q1FdWrz+CoU8W+Mw3iyFp7H/R9NxGqxLIRL+44OGH3d3P51u+Dp7qfR5xf3ct5Pb6hfWnnyqiu6RXcsSFgiqudqLnAFOOFXVmk8ynJe6rF7TNIsNNjCWltGp7uRlj9TV9sMMMAR6EUlFdShFKyR58pOTvJ6mXqXh7TNQjdZ7WNS4wWQYJrirz4eqjgR3ZRATtfy93HbPPX/PFelUjqGGD0rKpQi9YmtPETh1PHb74eyZYR35IPT9zkD9azx4OWJ2aS+SUxjdsReh9TzXqmrxB96szbEXCr2auIvbuxtt489HcZBSEhiPrz+lccqaW7PSo4ytPSJz2qyJDpypljMvCuMsJPQN6HmuYnup4JDCyP5gJyuOh+ld7qNpFJp8eFVhONykHG3HqM5BqrY6OhkiVlI3OFLnkgetY2szvjVTXvI4+0sL69PKJGhbeMoC/APfqB7VpR2PloSwwF6e/+JNdZd2sFoy7MOVBDEHIJ9vUVh3jBizAck8AdBQ2HtebRIyJsJtIJBHP61NCCERACVbkY/iNSGAvt+XPNdl4Y0EKovJ13N1QN296L30NOaNON2WfDWlmxsx5gxLIdzD09BWlqLi3tJHz8xG1fqf/AK1WIwSRkV5t8WvHtv4d2WloUuNSxlIjyqf7b/0HeqhFt2Rx1KqT5pvQ9/8AhP8A8ks8G/8AYFsv/RCUUfCf/klng3/sC2X/AKISivUPng8Zf8jH4E/7DUn/AKbryuIs/hvqNn8TPE/iK60Hwrrltql1bz2r387LPZCNcEqDbuNxJB4YfdHPpqftA+KNL8J+DrG91vwxY+JbeXUEgW0vCgRHMUrCQbkcZAUjp/EefXwD/hc/gv8A6Ix4Y/76h/8AkagD2fx7IE+K18uQC2i2P/o+8/xqNXK4ywKngV5ZafFDwpcxCRfgx4WVT03vCCff/j1qyPiL4XP/ADRvwl/38i/+Ra5alKMpN8x6dGtONNRULnpqsYuir602VjK4ww9xXmo+IvhYnH/CnPCI+skX/wAi1bh8a+HJiBH8HfB5J6DzI/8A5ErP2Mf5i/bVN/Z/idlcME6Y3kflWNdyEk4OQKgg1zRplBT4PeCvxmj/APkSpzqmjqMt8IfA6j3nT/5DqPYQb+IuOMnHT2f4/wDAKcnQZPJ9KW3AYjk1HN4q8NQsVk+E/gYEf9NkP/tnUA8a+FScf8Kp8DD6zIP/AGzqvYQ/mL+tVn/y7f3/APANSZGWIMSM/Ws6ct1wee3rTf8AhMvDOSF+Engpsd1mjP8A7aVOvijw80e8fCPwTt9fOjP/ALZ0nQh/MCxNZf8ALv8AEx5X7+/NUX5YkcA9zXb2Oo6Jexh4PhP4DK+8y8f+SVaCQ6c4yPhN4B/7/r/8hUnQgvtD+vVF/wAu/wAf+AedRKME81DfXsFjaST3MgjiTlmP8vc16Syaapx/wqbwCW9PPXP/AKRVjazrmk6VZy3D/BjwfcCMZKW8kbNjuQDaDNHsIN/GDx1Wz/d/j/wD508T+IJtbuMDdHZof3cWevuff+Ve+/s//wDJEbz/ALHPTf8A0p0+uX/4XN4L/wCiMeGP++of/kavS9C+Ifh66+A/iXxFD8P9HttKs9RS3m0RDH5Fy5a3Akb9yFyPMU8of9WOemO+MVFWR4tSpKpJyk7s7bXfhtHr3xjh8T61Z6RqOhR6N9g+yXkXnP54lZw4RkK4wxGc55PFXPFUUcHxC8LxQoscUej6iqIgwFAlsQAAOgr5y/4XP4L/AOiMeGP++of/AJGrfsvHnhy7hSQfBnwlFuGdskkQI/K1NNzUdWEKc6jtBXPdb69gsLczXT7UHQd2PoBXm3izV7jWlMW5obVTlYlPX3b1rnx4u8PHP/Fn/Box6yx//IlNHjDw7k/8Wf8ABv8A39j/APkSsKlSM9ObQ78PTqUXzezbZltBsdkdRk96tRyTxxoqSM0aknG44B9h2q3/AMJf4d/6I/4M/wC/sf8A8iU0+MvDoOP+FPeDf+/sf/yJXP7KH856LxtZ/wDLr8f+AWLKZNpN1Z27hl+WQSCN/wDvpSCfxBpXn02Ugyi8VhkZEqN/NOar/wDCYeHe/wAIPBg9zLH/APIlULv4i+FraQI/wd8IMT/dki/+RaaoxlopfgYyxc4auk187GrFNpm0mJrtnB6GRFB/8dzVh9TtbOHfb20JuD90uGkce5L/ACj8BmuYPxS8JAkf8Kb8Kcf7cP8A8i0H4peEh/zRvwp/33D/APItV9VXf8DF5lfeD/8AAv8AgGhcS3mqXDSTuWLd2JPH1PNXYLFI1wBufuT2rA/4Wp4Rzj/hTfhT/vuH/wCRatR/Efws8xi/4U54RDDv5sJB/EWpFH1dR3kUsxlP3YQ/H/gHQxWpbA/yK7LwzowhC3My4cj92COg9a82/wCE58NYz/wp3wf/AN/Iv/kSn6f408PahfxWdv8AB3wb50mQoeeFQSATjJtcdqcYQv8AEKtWryjbksepeK9d03wxo02paxOIbaPgY5Z27Ko7sa+Q/iN441DxtrH2i6zBYwki1tFbKxL6n1Y9z/SvVr74n+FbJC0vwX8LMAcHa8Jx/wCStZ3/AAufwX/0Rjwx/wB9Q/8AyNXTBLdHmVXNe7JWPcfAttHeWfwztZs+VP4IuI3wcHDDTgf51k6T8MfGmk2XhrRbDW7e303Rb9ZPt1tqN1DJdWYdnMMlqo8osS2N+7oAPXOf8VPiH4e0Twb8P77Ufh/o+sW+q6cbi1tLkx7NPTy4D5ceYWGMOo4C/cHHp5qvxl8GMQF+DHhkk9AGh/8AkarMj6C0zjxb45JIAGqxEk9v+JfaVn6/4pS3LQaaVeUcNKei/QdzXji/FHwmwH/FmvCgz2Lw8f8AkrVqH4ieF5U3j4O+EFXr80sX/wAi0pXasnY0ptRd5K5001008jPOxkduS5OSaaJAFJXjgjoDx6c1yrfEzwmpx/wp3wkfTDxc/wDkrSj4l+FT0+DfhL/v5F/8i1h7B9zq+tf3fxNe8jVguFUAcDjkfTHSrGlT3MMoVJZAp6bQGx/31z+tZen+PPDF62F+EHg2JefmlliA6Z/59Pwp6+OPDTMwX4PeDiV6/vY//kSs/Yq9uY3decYKbp6Prc6Z0km8sm7u5CMsoWBRsPc53fyqpqMETjfMZZZBwDLJtz/3yM/rWJP438OxD5fg34QlP/TOWI/ztaitPHWh3ty1vZ/A7w5POo3MkflHA9T/AKLiq9gu5ksZJfZ/EtyzXsW4QiO33Dafs4wxHoWOWP51Lp9gQA0nA96xp/iT4Zt55Ibn4K+GIZozteOQxKyn3H2WrLePvDKrlvg54RA/34//AJEo+r+ZX17Syh+J0yQgkbV4/nVmK2PHBJPbFcXL8RfCyLkfBzwi/GTtkiyPztaqn4p+Eh1+DfhT/vuH/wCRaf1e/Uj64/5fxPaNF0v7NHukH71uv+yPSsb4keNtM8EaR597ia8lBFvaKcNKff0Udz+A5rzL/haPhLr/AMKc8J4/34f/AJFqK4+K/hGCMufgz4WZR12vDx/5K1SoJdTCdeUtTxXxb4g1HxPql1qerz+bcSg4A4WNeyqOwFfcfinSJ9f174gaPZvElzf+F7O1iaUkIrO+oKCxAJxk84Br55b40eC1Usfgx4YwBn70H/yNXv8A48W01LxnLYN4H8M6/c2mn2873eryhHVJZJ1WNf8AR5TgGJz1H3unWtzn3MjRvhAdI1j4Z6hp9podpcaBbyJrEtvH5cl5I0CxhgQgMnzBzlyD82epNa/gz/kG6j/2GdV/9L7isX+wLb/olPw8/wDAkf8AyDR/YFv/ANEp+Hn/AIEj/wCQaadgO4pcVw/9gW//AESn4ef+BI/+QaP+Eft/+iUfDz/wJH/yDT5hnbSOkUbSSuqRryWY4ArmdX8X21uhTT0+0S9N7cIP6ms//hH7f/olPw7/APAkf/INH/CP2/8A0Sn4d/8AgSP/AJBrOfNJWi7GlOUYu8lf5nNXWsahc3qTSvHKVO7Y6/J9MVfkvLC8LO+jafFI3Jdc7s+uVxWt/wAI/b/9Ep+Hf/gSP/kGj/hH7f8A6JT8O/8AwJH/AMg1zfVn/MdjxyskoWt5mCwsoxkLl8/wjFQyXZIKxqqj8zXSf8I/b/8ARKfh3/4Ej/5Bo/4R+3/6JT8O/wDwJH/yDS+q+YLH94/j/wAA4u6aSRCATuPeoIrdmOHY++a7v/hH7f8A6JR8PP8AwJH/AMg0h8P2+P8AklHw8P8A28j/AOQaPqv940jmVvsfj/wDntD0oXVwCwHlJyeOp9K7DaVTylGF9q564t7K3k2TfCLwGhJIBM64P0/0KmKmns5X/hUngMADJYzrgf8AklWiwMrXuKpjZT15dPU574rfES38I2jafpxSbXJV+Veq26n+J/f0X8TxXzLeXM95dS3N3K81xKxd5HOSxPc19hLZWDAH/hU/w/5Gf+Phf/kKj7HYYyPhP8PyPa4X/wCQq2p0eRWSOKrOdV6npnwn/wCSWeDf+wLZf+iEorQ8EX0GqeC9A1CzsorC2utPt54rSLGy3Ro1YRrgAYUEAYA6dBRVGB4/+2X/AMkz0j/sMxf+k89fLGi6QZSs9yvydVQ9/c19a/tYxrN4H0FJFDKdajOD7W1wa+dY0UKOaxq1OXRHdhMOqnvy6DIYe/YU9lI+lWkjHl5prYxgdTXJe7PVskiCPg9OKu6fIRchVcp7jtVSQhFrU0OxZ2DOOX4ApvYzT1O6sEkgjDLKGUjoTk1ieIbu5aNijHaOy1vWejTW1qZQXLFdoUdqzbyF1jklkCbShHzZyD7Vk3qFOKTucO3mO5UMXYngE0ttGovkSb5V3YdcdKnYRoOvzZznpTfKYxmVTgKQQ/v2ArQ2cmbraAk8fmwKeOhjY1ThtJg5VS6MOuTg1t+HNWhaFlb5bjHzL/e9xS3MollJX5TnqRUqLT3BVGk0U9N1i/0a5WSDaynh0deGHvXRD4gIceZbPAc/w/MKwrmBTCZHBYD+IVi3KRCfcQfLPUDr9apu+jISjJ3Z6fo3i/TL+Tyrp1DnoTxW3dx2skGYWVlPR1Oa8NjiEj4jfGOQT1rotC1JxJ5JneGXttOVb/69DStohSpJapnPfEnwE0txPqOiQ/vuXmt0H3/VlHr7d61vCQP/AAyL46GDn+3IRjH+3ZV1lp4htJJViuJQk6nbuIwG9qsajDEvwT+IccCKkbeIrI4UYGW/s8k/iSTXVSneJ5eJocsk7WueF+FNA+dLq8XL9UQ/w+59672CIIvIB9Kg0+3EajI5rQRSWA74riq1HN3Z7NCjGjHliajaGosmupb2CODbhGBLF32htmB069T6ViPAw5JGM+tW5JQkbrgbj37/AIU64ljmCOsCQhUVSEzhiByxyTyazNo36lRiiLyRn0NM/duiJ5sMZEhBJVuFIHzEgc9xjrxSXCJgnj15NXINIsjp8lxfamlvcBgBa+WxYdcFj2zjsD1HrVRQ5OK3MCaUksA5AHcd65nUHDXeM7sV1uowxQM4hnjuYgBhlBA5GehwcjOPqK4y6drgrLvTd9zaPlI/xroorU4MdK0bIrbvmzx/SldgVyetQljimFs112PFbHFscmt/QYl8sMep5+lc/H87gY471sWrGNQ0THcP4TWVXVWOzBe7LmOoUfLzVK7jwC4GQOoqzp0nm26ucfNzz2NW57YhBldu9dy+4rhvZnv2UkYd8lpLbweQZzKY/wB8JQuA/wDskdRjHXmuL1jTDA7SQr8nUqO30rsriBoZsMMA9Kq3UB28jNdFOfLscFfDxqLlludn8flL/DP4LqoJJ0QgAf8AXG0ryzS9PEQ3ycvjk+n0r2H4zqX+HvwZAGT/AGC3/omzrzm2iJkSNPxPpXceAh1lbec24jEamprxpHiZoYnNshwXC/Ln61rQQKIwiqMYwB1rdtWS/wBN+ywwLDLDEZMSR48wLgsAR1OMnnsDXPUqSi1yq/6HRTjGV+Z2OEjjI+Z8DB5zXW6J4eR7dZtQiLO4+WMkjYPfHc/pWnYaPa3LrL5CGJGDKcYJYevsK6E25YY6Vc59EQc8mhWVtukggdSByokYg/gTinJoUSRBI5JFx6gH/CtnU4Smk3m3qsLNnHoM/wBKspHlFYDggGsr9RuTty30ObutKnAITypRkH7xU/rx+tW/DGozaHqjFrcpDIjNLvXoERmyD0PQj8a2ZIuelVLlSmxVP322n6Ec/pmnck4jxlfy6jqY1m7hWNyVSOGNsjaBxlu5qnBewTsVjdg/dWxn8OcflXW6p4csL9RvR4JBnDwnH5r0Ncfqfhe/sQzwqLuA8FoVO9R2yvX8s1pFxasDXYn8pHABUq+fx/Os7ULAupdgS3QEdfxFVYL6WIBCxljX5Src4x2BrVtruO4jyrvuP/LMsc/z5qrNE3MVEikiCxnDLxkjBFVpFaM4Yf4UXEjJeyvEcHcfxFTCZZoHY5yo5HpVCOc1ay2QySwj5dpLL6e9fduo/wDJUNa/7A+nf+j76viG9cNp9z6+W2fyr7e1H/kqGtf9gbTv/R99TEX6Wm04UgCisrWtZi0xVURvNcOdqRqQMn39BwT+Fc++oalLIkks20c5jQ8Y/LpW0KMpK+xpGk5K521FckNZuI8FXcjGfm5GK1NP1pLjiQAY4YgEYP09KUqMoq45UpLU2aWmqwdQykEHuKdWRkFBoqJ5olfY0qK3oWANAElFRxTxS7hFKjkdQrA4p9AFDVtMi1GJQztHKmdjr2+o7isOLw/ftJsnmgEQx84GS30HauroFaRrSirI0jUlFWRgRaFcxuxN+Dk5AMf/ANepRp00YOURh6xvj9D/AI1tUmaHVk9w9pJ7ln4T/wDJLPBv/YFsv/RCUUfCf/klng3/ALAtl/6ISioMjgP2qufBegf9hpP/AEmuK+cDu3A19I/tTf8AIneH/wDsNJ/6S3NfO235sY571yV/iPXwH8N+v+Q1pTt7DFQl8Ddk1LsyQCpPfpSuuFC4+8elZI65bE+m2Ut06yMMLngGu60uFLS4glZVIQ96ydIjVLdOOgrUefYgJB21Mncx8jq7+7iksmNucyEHbg9a4uXUGuY2iaBlkUEkE8Z71c03U3uJNka4UNgkjGB9Ky9cFt5siQTATbv4HPX8KixtGHI+Vo5a9dnmBKnb1x/9emec745L44x2H4Voy2XlklnjUdi5OBg+1V47dTIPnDZ7rxn/AAq4nROaYyBZdyPh1w33tp4NdZBCVEM+1wHUlg3HOfQ81zBhuIHlhuImjQkMFb+Y9KuC5uUWNGlmwgwqseAKpHPPXY3b24EMOBuA/SsWTZOCqxgD16U2S4mmBV2yp5xUsKkY2jJz060nqSlyoiaFPL2DKPnqf8agRHhlIYkN1zn+tazort+8ARz1xip7O1t5ZCJeXX34NFjSMzIh2F+eVPDK3eu301APgL43VWZh/wAJHZAEnnGdPrE1XRntmDhWCsMgFa2dGDD4CeNQRhv+Eksh/wCPafWlFp39DlxjUlFrujm7dvLkQgYIOeauTSJJtzhTyWfpnNVoVVhtfBwepq1NGkYDEHYTzXGek9yAEGFV2A5b9KkYiQ7RnJ6AdvrUT7Mgk7WXBDKMZq7bINrHB54yetUhSlyq5VNioc5Jbd2x0qzf2z3x3ylQwVV2xjAOABk+/FP8xd23oRUhlwDmnYwdV3ucxqsTJZSljGixjG1mBJ/rXnO8nOa9G18eceMHvXnd9H5N06jhSciuqh2OHHNtKRGTmmFueKQtTraMzSgdu9dWx5luZ2Rp6VbZXcR8x5/CtIoAB0z7im2YCkfkasSYEvPesJO7PRpx5VZFvSpo1k8t/lVjx7Gumhhi4Z+UxkqGwTx64NcYAAxVmxgjH0rf0m73r5cxxIvB9/euWrC3vI9LC17rkZY1y1Ee9P3bsvUxsHU/Qjg1hR/vIyD245rq3hDLgEHIz1rC1awmsZyzxtHnkqykHn2NZwl0NpxurnWfFhd/gL4Nj/qAN/6Ks64e1gC8gckbRiu7+KTBfA3waG0tu0BlwP8ArlZ1y1lGGkIBAGcfL3FerI+URcsrbMZIPJ4/H2PetmK1k/drGRHICsiscZBHfFJZQgR4VFPByT0THH/1+9bNhbAAysWMj9ST2rJs0uR2CoN8KqqNEeUHYHkGtBU49qrahE0Oy9gQtJAP3iDrJF3H1HUfTFW1lSSNXjcPG4DKw6EHoagNyG8jElpcR/34nT81IqpZThtOtXY43QoefdRU01wgbBcKO5/oKxNOw2nwKS6lE2HPtxUOdtDWFJvU0rq7UHAP51ly3Oby3XPZnP6D+tac+n2c6hre8CyBQXR+mfRc8msBB/pzDCsEXYGU5yc5P9Kltm0aStob8ZDr70kidxTLEgpmrZUEVpF6HNJWZzWuaFaaopaVTFcYwJ4wN34jo34/nXBaxo91pjnz0DwsQqzp93JPf+6frXrcsYx0rNu4gVYEAqRggjIP1rSMnEh6nnGq6YgGYRsfGSoHDfT3rByUYkHBHB4rvJNOe/1mPTbE7ZXHLNkrEpGefy/WsPxN4Zv9Fumhv0QTld48tshhyMj3qlVjzcjeonF2uc1qkTQWtx3Uxtg/hX2j4k1CPT/iXrLOpdm0fTgqg4z+/vu/418eauo/sqcEZPkMfpxX1l44iWX4o6kGyCNFsSrDsfPvK6KSUpJMIJOVmS3Ou3UsqRwIluwOWyQ5I56D8DUDajeajDJbCbZIvzo0fyGQrnKflyP92qNzBJbrBcIscnlIA+47TnpkUiO9vKNrZmUhg4wfmzn0rtVONrxR0qMeiCyh23W6NQyOPNMhOT0xgZ59KjnkWeVdrgxs6tuByp5wQe/XHHvSSNHE6OqiNRk7AehxnaD6darzeSkO0MD5mdiglsYI5J6fT8K1Su7l3uy/cPGVWAMCvyllHULkcfWoYN7EmRs7WwCpx8vXn+lR6etyVDZ5+Xa+MjAPA+vFXIFRSdrfPtGDngYPJ/XHH+NS/d0DZl6yubgGWG3fdcICQFP3hj9DVO4v7mbcsbuhU4f5iGAB5x344zVm9P2KxKxExPdjL92VenTPAOM5rP2KQjOQW4wT37VnFJ62HHX3rFn7RIYVJupmDMVZGYkr68/lj61SluZGYbx/pAYkSh8hsZ5ZSOuPTril3rucgBQTjjqcdfwAqGb5nHnAYPHmNzu/p7+taRikOyJUu5RdNM6+TIDncnGScc/Qmt7TfEqKrrqZVWBHzp8w/Lt0z3rlr4yxzKgkj2EY3Lz+Pt9KhtXUySpIDsjBLP6HjORTnRjON2h+yjNanqoIb7pzRXEWHlxWVxb3Fw1sryI9uHBDBvXb1APHXFaVtr7WlhHHfK898G2lV6sM8HpyT7elcMqDXw6nG6TW2p0lFUNO1a1vyogf52yQp6nHWrMtwqMUX5nHYdvqaxcWnZozs07F/wCE/wDySzwb/wBgWy/9EJRR8J/+SWeDf+wLZf8AohKKCTg/2pf+RO8P/wDYaT/0lua+dg3zNn6V9EftT/8AIneH/wDsNJ/6TXNfOEbElvrXJXXvHr5e/wB2/X/I0473ZbSJF5sTuNjGOYhWj/ule/IB6/hVCeQCdMD5RULy7T+gFJjJk39QOayijrna2h1mmzZjAz2rWgt2u2WINt3cFq5vw463LQRljhmAYj0rtZLJbCD7TZStLCG5D8FaTRldIvTeGZIdNkaC58pY0Ls3l72OBwAAepPevN7mGCKEfMcv/dzu6/z6132n+LftUrWtxFtUnBYsMYrA8ZxGO1jvDaMskcSqk1v8ipIWJPmAk7uOBtx0qHob0efmtI52WORoysmfKHzKemfqagePABj6+v8AhVzSInvbW5jeX5sByT2NSz2wh8pkEhQ4Db1wDVrsXUfYWS9uLmRZ7tlklChAWXqB04pkz7naSaV3Yjkn27VCzMTuz369KeNuQCvXrVnOkh0IWU7kLH6ir9vdGKBomTKnrjj8feqSExuGQ4IpS7liQCO/FSO1y5OUYjEobKj+HGPakiSV+UIUj+LdioAWkcEgD1wKtQIY03MMqT3FIa0Nxbm5eC3jvbvzYdmI2bp1/X0rZtolj+DHjeOJ96/8JNYYb8dPrj/PFwwt/ujtjoDXXaTC0XwV8ZRltzDxNYc/8C0+taW7fqc2LVox9Ucs8LLKTyP1qwWMgCsRu9D3q+YwrkTgbiflPrUE6rgr5gCjjnn9a47M9D2iluUoI2DkSA47cdKsssi4AyAfSoo52DgEg9s+tXw+5QD0FMipcqBUG0FMN3Pc02Y8EAGr2wNgnFRzKAMY/GrRi2c7qMPBcZ6dDXG+ILXcpZVww5r0C7h27jkmuc1CJSGBH1zWkHZ3QpRVSLizz3knHf0rUtIzbSYk59dpqfUdOKOZoB8w6j19xUCTo2WbCn0ANdTlzLQ86NL2UveNZJFJG3P0pZZF8wE9hzzVGF9wGMkk9fSp9vmSAenJqbGzkTty6nqQMmtHf5ckMwxtJ5yM1Qt086by1PJ6n2q/cRbIfLIx2qJa6G1J2fMdPZyjYpA+hzxUmrkXNuhKrwu0EKBnHr6n3rG024Y2ybuewzW4pWW3KBSTjmuPl1PSlJRSZf8Aic4h8BfCCU43x+HXKZ/veVZD+tea20xgk3CV1Ynko2Ca9D+LX/Ig/Bvr/wAgBun/AFys6w/B8FiLC+nuQpfO3LAcKMdc9O/SvZij5GpPkjzF3QLi5vWgtnKSQ8u7Ec7evP44FdvEOK5XwqttaiSH7VFJJK2YT90PGOm0nG7vXXIpA5GDXNN6my2BjsG4HGOc1yeoaj/ZEkkEQzBJ+8iX/nnk8r7DPI+uK6m6OIj+VcNriCeZmYZXOB7D1rCcrHZhaSnL3iH7c8jCSaTKnooqCbWpV3LDGMjjhsY+tQNhRtjGfUnoKS106e7yEIjjXBllIysSkgb29hms0j1OWBLLqDzSKZxggZ4OKnVyqhldvUZ61HfQrCxVgoIO07TkHHGc+/WoLH97IUQkbTj2qmidOhsafqWHIcbW7jsfet6O5jMW93VFHUscCuMu7MQI8kkgAUZ6H5q2NBs1iEbSqJJv77c4+melOMrHJiqMeXnibqyJMCUY7f7208/T/IqO5NssOEtnml7vO+FH0Rcfqxq3jIqtKm51HqQK2PNOG1a8vI9SleC5ktkjfahgUJyO2AMYznqKz9T1S/1O58/UbhZ3VAikKBgfQAVl3N7INUu5gFdXldip6YLdvQ1OJ0uIXkRuApJB4xx3HrWvs46Sa1Juc9fXLGwvI5GyDE+CfoeK+vPGzqnxP1IuWVf7HsPnHY+fe/8A1/yr481ID7DP/wBc2/lX2J40EZ+KGpeZnd/Y9hgA9f397nPt0ropfGh0/iMdYiJFBCyxjPLE4LZ5HvxjmpriBip8oALu+6uPu88H/HmpSyK580fu8Yxghh+PQcYq+1sjsCuDx2PJHX8812ynY6eY52CC4KmJgHZGIIY4AGeAM98VQ1DSJ4rqaWwkUPJkOTJgDA449v8ACutTTpphKgYCAoWY/wDLQN2A9OBnNYY0OSCKddMnXzZF2zPOTI2zJz+P6VMarvoCnqQ6XfyTRqwmL7QVwWBAI4/MHP1xV22kMFqZJ4tzMP3Z3AYT3J96o6dCNPj2tDPKMqWwM4OOMj+tXI5o5NS86WMu0Qyqsu7GPrW8lfoUzo5IUvoI4AjQyRRrtZnDBxjpkehOc1jyxyRSbfL6cblPBxntz39aYbjzpUkRmZcFcEcjGTknnj/DFSGWWWMGcEo/zgKxVyB/jgnHXrXPGDiTG6G/ZDsYxhpE4J6Zxn9e9QzhZNxYBccoynIKnr8x9vbtVhrpbBYzKsk8U2QCi5bPGMf3vfPPtT57mAmWN4n88KdhYBVOfbv/AJ6VScuw+Z7lGe2t0j+0jyyijnjqB0qlmX7X5qSfu5WHlqBjb2BOfTjmnx6kxhVHhjltsA/L8pz1H+ferUEttJGTKHZ8htkjHczDPQ/pW3vR3LTZDdsiO1oFTay5Ls5Jz0x64+tR3rvNIHhZkwuDh8FjgDPHrimtDJHkqjLvPzM7qMehxwD+tSW1o8l0qXdyqSED90HDtnvz2zRZLUfNbVhptvLz9kmkhdiA+GPzDuDjiurs0aGJg3BJz9KpaZZi3d/lIxgAE54x696vyAsrAkrnjNctWfMzKc+ZnTfCf/klng3/ALAtl/6ISij4T/8AJLPBv/YFsv8A0QlFcZxnA/tUnHgzw/8A9hpP/Sa4r5pMmxSc19KftWnb4J0AjtrSf+k1xXzDI+6XaSMFv0rnqq8j08HK1N+v+Rdtj/y2YZP8I9Peh22QPz88hqNpSq8flVd5mLbpD06D0rFK52ykkrGjo16LG6QuCYs8gHkfSvQEujNoslxKWKzL+7Ud/evJ2kOcqMmtrSNelto0tpWP2cHIB/hz/SnKL3MU03Y6ewtXiuEuM5x27Guj1GztvEGlmNmaKaPBA44rnZNTjMCvCw464PapNNvZJrhI1xtkyp3HquOa52mzsUndNaNGVbpJput+Q+yRMhWwchlPqfWr9zdS3jrC0yso+VUUHk0us6Nftf3FxZrEYgBwpwelUtBuXF67SIytGDuwp4pqV9zWUItc0WR3cTwFYhE4KnBBFKWVGCumMHk/0ro51t763ci4QSbQ0ZQZLmuZeORieMkcHHBH4GrjPm0OZ02tyYGJo1wHMucEdqjV1HXcTTzbyRgFwVJ6A96LjbFJHEmGYfeOM9aG9S6cbluDcCpJwG7Y5q8iteYUN5adM1Stgz8M/sMjJFdJpWmyPjBD+46UnKyuEoWFsLOzthMQ/mSRLkHbjce2K1reVv8AhTfjeV8bh4msGOPrp1aq6baQ2cQKl5SAZG9T6CoERJPhl40TaBG3inTVx7Z02roSvJryOHF6wT8zmPt8UgHmD5qp3KJOMBvwFdDqOkCBS8ABX6UDw7I1slwHVQT0A5rK7OmPKtbnLm38gAOAmcYyeOfetAW19AiieByvcx8nHrXc6RaWy6eguUjCnHLHp74rXinsY7RVO1uOp7UNhOtbRI8siuFkBVgevpj86XzlOUZskdK7+7h0q9YtJBDv/vKME/41mNo2myuoWABmJwScfqKOYSmnujiZyuCM9a5/UI8ZD/ma9Hn07RmiaOZtkmM4Jz+PFU5vCunSQSPBPLI6/wAO4sPxFNSW6Y1KK0kmeYjADRyLu4rLubCOUlh8rd8d67rUvCNwhLWzjyxwGc7QT6Anoa5i7tLy1cpdW00eOpZcfrWkZ9gcYz03MVIp4CVjZSPQ1YtLKeZyfOi98HJFaUdhLdvssopJXAycYGB7ntUYsjG4aQ7HU5xxWnOzL2EEXrW1S2QAAlieT1JqK4kbD5XJxkHsKv6fpmqXlr9qs9Ovbm1zgvBGWB9enas6QSTTMChQLwUI5GPWpYRteyLVixjhUEZOOK6a2lW3tFBGZCM4FZWm2LSFW2kY4A7101npRQbpByfXrWMmjWU1syv8Wc/8ID8HMY/5F9uv/XKzrgbW28+RI1BMkkixpg4Gc8E/nXpfxCtUu/BXwdjcPj/hHWIKdQfLsv8AGuZ8PaPPba1E0yh4otziRc43YwAfQ85x7V6nMkjwEjt4bK3azW1khikt1UL5bqCvHsaVNOmth/xLbto0HS3uczRfgc71/Ake1WLf7oq0tcxRh6nfTxW/l3dpJbyMwVZUYSQsT6MMEH2IFZE8YcEvwB+tdfdW8d1bvDKu5HHI/ka5u+jMMn2ZkJGQCe4HqPWueqtbnfhGtupgNaXN5buthFNOituKhBtUkep6cD9KzIpXT+Bjjt/St690e3bAM2xh04HTPORTVsFUskeW29NxGTSUtNT0FKPRmZqMwlHl7CGP61Lo9uIQeCSTkEmpbq0lnj3ptVugDcAD1zWlpsO2JVwCw4yeM+9DdyZWURksMcxCSjcP7vtV20RUmRUOQAKrTKY8uckjtmpdIsSxaecne3QA/d+hohqzmr25NzZ7VTvpRBbzTMcCKNpPyBNX0WNRibzcf3oyCR+B6/mKyPE0Dvo14thNDcTSR7EjZvJckkDGHIB4zwGNdB5jPHHyVJf7zEZPbNJarm6UE8HgjPBHcVJqEFxZz+ReW01tKBykqFTT9KH+kFyjAbMoSCAa676Gdipr1qIrG4aJi8flt16jivrvxeof4p6kMqCdGsACxxz597096+UdbZTpN2R18pxn/gJr6x8Woz/E/VQp4/sbTxjGcnz73Bp037yKjuVID5eXkyzqoUqeOfXPuat2/wA0HmlPLdhjqT06Y70GNGz8hwvBJbt7+9SwDdhVYsq/eLDnOenNbydzW4tgywh1ctvOAcfjQY2M5G4bQvIAHzcdabG6BpC23YpznP3eKlZVkBUMwwAQMEY9D/n0qHvcDndjRahPEEbCyZGWynPTJ6Djt7VBczqkoNrJuwSFeNSc/wAiByeO+K3bi0gukcybkn4BkQ7ScZx9f/r1zMkMskcUTEqoDOQBgIQcYwP612U2pGsXcvWd15Lu9zGDBICN7cHH06nj8fWlmiNtdeUAzWzESR+UMlcjjPtnoaoJaak0AeSNJXKspjJ2lGGSNua2dPuYDDam+fdtjaKSSLjLjGFB449x6U5e7qtRvTYg23lo8UpA3tHtaIAZB3E8HGPqKz7uR5/nlcykjdhgdqg4xjt+tSWdzJcTyN5khZvkODgrjGMYPPByc1WEcqyGJB8ykEK65CHdgZHAz6cd6qMbPXcLWIbqZoYWdk3OxYgMMMfQ9eO5B5zipIr0Qsku/wCUMMl8YGSAPbrjmteXREhhS5nmmE75woCsQclhycdBkVVtdOtLqLy3jLucHy2bKt33H39R+lP2kGg5kPnjkn/fL5e5wWX5ScAHBAHYd9x9aWK1tJJYVl3CUqGKAEbiR3PXoP0rQubbFtDCgbIj2iROVwcAqfUHHSoFRo4lVcblyzIvU46DP4Csee60J5jS+QRtsG5c4JB6HHp+FNkxgc5APykdvTmq9ugkVMkCbkkZ+7n6d+KsAFJiFQMoxubPX0rC1mZN2Ox+E/8AySzwb/2BbL/0QlFHwn/5JZ4N/wCwLZf+iEorlMTzv9rM7fAuhH/qNJ/6TXFfLkbbrkk+9fUH7XJ2+ANDP/Uaj/8ASe4r5agOZ2yayqI7cNLS3mXJG2DJNQR7pmznCioZ2LyFQeKcZfKTA/Ks0tDpc05a7E88oUhExu/lUBDNyTVdXJOepqVXPGadrE86kyxBcSQEAElf7ua7HQLxSY5M8Y5A64ri1+btVi3mktm3RsdvXAPf1qJK5tCTR6NY66Ibm8ikV2jmG4bux9PpUEGZArjy1Mhzvzjb6D8a4w6tNNt3gCQdx3FdT4esb6f95CyMvRkY9R7CuacOVHoUZQnc3Vs2sonMautyxyNy/dIHT3FUre9WWRluIgbgcDaMFvarTX11cTtaXUqJHbqQf7z5HHNV9MtQdWtpCQUSUHnq3tUQu9y5JfaL9/pDCFLiZX3cAknAU+lZ7R29zfDzwFhiXB2cFiBwB+Peus8WyvJAUztiOOA2OT7VhwWn2WdnZklg2Z/2h7YojO97kRh7t3uR2FmqvANyPJJz5YOWHPGa9AsbJLCz3SIDIcAAVy2kA3epiVVEUKcqB646+5ru9Ega7kCTDaqcqW9KqWsdDGt7usuhVS3YPkgBW/hqtq0QtfAHjmNeAnifSz+mmGuy/s2OEbtxfpya47xJIX8A/EBz1/4SfTP5abW+Hio3T3PMxNb2nLy7XKUV2sj+XKcA/rTb/XbfS9PlgkJaU/LEo6nPSq32V5rMtalZcDPl5+YH2rk/Ejg3EdyHwYgvDgkA9wawbPRjCMnaWxavtUvLSwKSTpDIGVQg+8VPJPvVHS7q9muwvmBy4OAUDD/gQJ6Yz05rPvpk85SwV0xv5GOvcGmoY/LGFVSDkOece30pKOh0xdtbFy81e8W/NtJJGq53Rui4DD1HX9TWhZapqkM6B754IUDbZQwO3IODwDkZ6iubkt42kLlFVyc5Xj9KvwqFh5lHA6E9KEjSfK0rGw1/HITK94sl46rkqmArdwp4yPenT3y3Mm57yO0xgKqJuxjuT61jJbhkDB1xjgDIqs+FYsVllOfmyAvP+FOxEoxkzpRcyWrKyaj9qbqY3j3L+WOv51p3HidZLYx39tE6FMeWQDuJHXkdPbFcNAp3mUsYFBwZG5/JR1p6zfvIlkYu543ccCmkkrGE6EZPU71Nas44StrawwgrnbEAo/QYNcvdWNncXr3JstsEnOHk3En1wAKdozRfZ2MwyFLFeecVSub6SCX9wMLnAVuaSbWxn7CLbSOwtp477TLeyl/dWcY/1MZ2g46DjtWFrVlDCV+zGIMeAifwiotBXVtXaRbKznuUiYJIYV+XJ5A54HFX9W0W9VFglEKncS0ULFmH1anzPqQqShPluVdNYQN85Acdq3I7oy9ucetZkHhu4ba2yJFHPAJY/U1fbT2iUBlII7jipbCUY3uN8asF8IfB8k4/4pt//RdlVDTzt6sCcAYBzjmr3jcD/hEPg6cZx4ccjn/pnZVjJcrbw75nwo7n/wCt1r05K7sjw1sdPZLNOStvFJKVxnYucZ4GasrIVbY6lWHVWGDVrwrqNhHoEJkvIkM0zvIc/MuAQvHUnpipbzU0vVMen6XPqKgkLK48mNep4Y8jjPT+6Kzas7MFrsV0kGKyvEckNtFFdzMsZX5DkgFgemPX/wCvWh/YOpzRkveQwNk5gt85A9PMYdeG7D7p5ql/ZsNlIfOs9szDBknG92H+82f0qJRurM1pz5XdGbPNE1l5+G2leNy4bpXNQXsly/zo8UY4JA5btxXYXWn28ybRlPYHI/I1kXWkyrgxEHHpXO4SR6dDEUkrPcyb67ECFwWAVQMO2egHT9TTYtXQRIwPHXPqKt/Yp9QZ18lfLjYpv/vEcHH0PFaFn4egVV+1LvI6DNNQbLnXpJalGyuBqTJ9lIdM4Oe1dPBEI0UDoBiqosorSVJbaFIx9yQIuCw7H8KvZxwK2hDlPNr1vaPTRDJOlcx4xjjn0wW0wzFK+W57L0/UiukmfArj/Ekqy6kFLZEChcA9CeT/AE/KtYrU5zkJbW/t7YR2ly8lvjItpvmTH+6ePyrS1LUoL+ztEghEX2eMCT5duDjkAZOPw4qR053yK2zqBnP+c1x9zKxnkkUgMzE/LVOmpyUn0HGbgml1JtZfdpd67HH7pgOPbpX114iUt8U9V4O3+xbDJH/Xe9r421GR59KulIX5UY59Rg19o60gb4oaz1z/AGNp3T/rvfVqtGQnqIsChSMFl44Jx06c9e1JMFjhYb/KUfebjirZXap/l0NQ3MAvIEDbozkNtOM/Q+tWnrqXcoyrGSoXcUAJJXBHtmkjUtH5mW24O55DyT659KuW9mIdz7mZm5JP8sdKjv8Ai2cRpufgqpbaCeMc9qvmu7Iq5iXM7rEvkxEockSsM59dv0HPPXFQLqUv2eUqUXA81ZIxjzAOvJHBHpjNT6ZPYRFjqUewmQqrpIxPJ6MODjv0qfWLSztrZby1bdHcMFYtgn2O7rnI7mun3U+VotNJ2ZhFEe7MzL12+Y+GjALcEndzx3wO9WVt2S6hYqrfMrnapZo1zkAgHpgdxSCzivruWFoppv3vmGbcwaTngE4Ix1POOlbqaUrQeW5dZcbfNgJQkZ9c5+o9zirnVUdGynKxmaXpU8d3GxVVii+cy/3jggY7HOfyxWjZ6G63ktzeXUkhdg5iThHxjBYeoOf/AK9asFuIUjXAAQYUZzj/ABPvVkAdRyenFck68m9DJzK17BDcQFJ1DIMnJ7cHn9TXOzkQXMU8UhZuMFoyrMO5yRyOw+vetfVbK4u50CTlLYja6qxUg55Pvxx7VJBpFujq7AtIDkbsegHTGMDAx9KcJKC1YKSSI7mGS6sAIkWAsoKqRwvcZ/8ArVRmiazRVdiylADLsP385zgfSrVxqUwnEUFsz/vChZuMY6seOlQXk8sk5t5SkSvwu84BOc9f8inHmWj2GiJGRjh0aIqu4pkEEHuPqRU1rJEP3aK0crLuXJ5cA88/54qpLGHfyfJZ9mVI3btnPYD3zU+nWM0V7K0qLtBO1+PnJHbuPpVStbcHax2vwn/5JZ4N/wCwLZf+iEoo+E//ACSzwb/2BbL/ANEJRXGYHm37Xuf+Fe6LgEn+2Y+B/wBe9xXykkq5Z8kCvrn9qe0ub7wd4ft7C0uby5fWk2w20LSyNi2uCcKoJOACeB0Br5w/4RDxKkhZPCfiMg9R/ZFzz/45Wc99jpopWvzWOVjmy+T371Kk2BKrRBg4ADMudvOcj34/nWxeaXdadcNbX2n31jPsWU295bSQPsJIDAOASMqwyPQ1VaAIAQSEPcf1qOdXOn2Dcd7orRGIYAyPwq1H5WBu3FMgEgZpGgCjLqMHo69KRPNgdXidsDkMjYIqW7mqTiTRozPGlvDK7v8AcCoct9PXp2pJJJJ5mlnYvI53MWOST6mmKysOCfYE9KcCBUlq73L+l6Tc6hc2UMFo/wDpM4iimIIUkfeGenGQTX0To/hC1trGGIuhnReWToCR+teH/D+6a38TW8ys2yJCGGcgKeuPT1r3vT9XgW4WNpVYScg1M2rEvnXwnmvxGsm0LUkMCKbeYjLt1B7j2FQ6FHHNeLdkL5MX+rGc5J9a9D8QW9nrQ23SbwudoI5rNtfC0VrbM0YdF3bwmcge2a5FKydzshNOCU9zL1CZrmNtqjJA6jJH0qhaWU95L9kgUfJy8mcgD611Vp4eDJI8pd3bn5SQB7Vq6fp0dku2KEA9ct3NRFW3OqVenGNo7lHQdBiszl8s+M812WmWWGWRwVAGfr7VV02JpZd8oJVR0AroExtGBxXXRjzu7PFxeIk3YguP9WfU+tcNcoJPC3jKM4IbxfpSnH10yu6mhMylQ20Hjgc158LyzPgzxnc2UpurWLxfpg3WyNMWKNpoYKqgljuVhgAkkcZralFuTb7HC2lHTe5sap4fCnz7ddsi87lHNeaeONC1EzyXqM0lo+DNCo+6R/F7ivW/+Eps8f8AIO8Sf+E9f/8AxmoIdU0zVdQ/s5YNRt7qSF50S80y5td6KVVipljUNgyJnH94VnUw7jrE7aOO6VFc+dJLNfIHlMQoJBjJ4B9h2ptvJJbABJSCD0BxXqHizwJJEz3WnQoG3Z2gda89uraWGZ42DKUPzRsCMfgeRWCd9z2IVIyXu6ojjkLtjAZj+OTUoIX7h3EnkYqrgCQMxcLnPygGpSU35jLlP9pcGmO5cV3OMbM9OnNSLEHVgqj65qmsgHt9acLj2BoIbfQS4jC87s46AdBVV3QYBPzdelTASXLEIM+p7U+DTpZJQZCEj6b8dDRew0+420l27jLL5UZ4ZiMlR7D1rR0qH7bcmPSoJph0knm/gU9/QE+nWul07wdZzRI1zvkBH/LRsD64HSur0S3s7Xy7S3i226nAwOGPqB3+tRzX0RMndN2DS4hpWmJZWaeUp+Zm/iYnqT7mrEVqrnIBLN1Y1sy2ReEoNvmc7cdKr2cJUnzDgg4xV+Rx88Wm0Ri0CpwtULi3UAlhXRFfl6Vga7KsEJZmCqOSTwAKixmpXPPvibetYeCPg1Mqlv8Ain2BAODjyrOudSSO700NFISM7wzAjkHoRXQfFPT7/UvAfwdh0vT76/nXw+zmKztnncL5VkCSqAkDkDPTkVw1roHiu1DmDwx4lUsuGX+x7kq31Gz9a9js1ujyLJqzPY/BGitElxc6nDEGuXWQRRjCDjg44HeusTUkt5BFdRfZ0BARgPl5JAHT26jjkDvWToGow3kMkUaXMUtqywTRXNtJbyRvsVsFJFVh8rKRx0IrdjYFccFT2NY1JucnKQRgoLljsFw0Fy0KxR+Z5q7vOj+6Fzg5PQ8M/wCfvS3FlI0bjekitkneMYznkjpwXZv+Aiqz6ev2lZ7W4ntXyu5Ub5HUdiPoTj61Ibq9twRPb/aY8gboyAcHrntxwOg9akZj3ejW0q74o5IC43IE6c8gYP8AvRrx3JrF1fTrjT7Ke6jlinSIZXGVZiSQmB3zx37j1ru2uZJrBZbNAzuFKLJgAA9yM9vQVk6jAJr7SLOREDGV7yUJ91VjxsA/4Fs/74pDTZxcNnLptvFb3MciNGu1iy4Bbuc9OuaeJV6gjFd7JbOpZY2DIAMeZ/Fx0/QD/gTVk3WlWzvte1iZyCd0fBOOMnb+H5t6UDucyZMcq21hyCOxonZQqTIAElz8o/hYfeX+o9iK0LnRoRny5J4vQOAf8KpNZvb2t2jypLC671wp3I6jggc5yMqfqPSgRmXVysUTyNyEUsR647Vxjs8juXYCWTMmzPJOepPrWzrMGqXVjE2m2oukch2Mc6KQo7YJBzn+Vc3PBqUTYm0jUAM87I9w+vFaRQFXWZ1isiRwW+VQGJPPPOecda5Nz71t6xFf3MgxZ3UcK5Kq0TZ/HjrWZ9gulcb7eXZnnKEfzFax0EyvfIE0i4/vNE5Ptwa+0tXBPxP1rAJP9j6dwP8ArvfV8X60sx0+5/dbB5bdT0GK+wfFGqR6b8U9U8221KcSaNp//Hlp893jE9797ykbb14zjPOM4NDEaZ5JXkN9cVKG+gzWOfE1o2Q2meJPTnw9f/8AxmrukXtpq9kt5YvM0DPJHiWJ4nV0co6lHAZSGVgQR2ouFy03XHP4iq1zB59vLES4R1KkrwQD3q2VZe/FRBJXbHKLnBb2+lNOw0zJm0+SNc2kdqDsMZPllSVIPXHHU56etNstKRLNILlnfbgyKrkIzA9SO9b5t4yc5cHGOGNRtC6f6sKy46dD/hV+1drD5yraWsduNsQIXknk9fWrKDOc9B+tJGHBA8iQZGeq4H5GpI1cNgw4HruBqG7i5hMFtpJ4oHyjag6U5BLkAxBR6780vlMWB3BcDtzSuK40Jkc9fahWOCc5XtTnRyRwMdyppriX+GPP/AgDSC5Tu7X7TEyM7c4+7xwO1ZdrpdyhkjnZZoWyAJDu4J9+nHpW6SxbYVZWYfLkjBx16UrBUj/ebRx1rSNRxVkVcqWtnDbpsUIq5zhRjJ65J71aK4zkfIOuajSeJo1IberDIIpTeRIwD/LkcDqT7ADmpd2wNj4T/wDJLPBv/YFsv/RCUUfCf/klng3/ALAtl/6ISipIDxl/yMfgT/sNSf8ApuvK4vTFnP7SeqWLajqzafDoyX6WjajcGBZml2lvLL7cYJ+XG0dQAa7nxppuq3k/h+80OGxnudM1Brtoby5eBJEa2nhIDrHIQQZgfu9j0rAj0LVotaOsRfD/AMCpqxcyG9XUnE+4jBbzPsO7JBPOe9AHi/7TrlPiva+h0a3z/wB/7mvMEWJJf3rFYnB5C5w3bPtnrXvPxR+F3jfx14qj1nyfDViEso7Pyf7Snlzskkfdu+zL18zGMdutcw3wD8bGPY03hs8dft0//wAYrnqU5OV0ephsTThSUZOzPJmjMWWh5Tun+FJ5Cud0e6Nj+VesxfALxxH1uPDbDv8A6dP/APGKQfAHxwGO248NhfT7dP8A/GKn2czV4mh3/M8hlikRsSxhsfxrxUfOBtYEeh617MPgN454Bn8NEehvZ/8A4xTbj4A+M5Hcxv4bRSeFN/O2B9fs9Pkl2M3XpdJfmeceC7pINejWXCiVCgPv1/xr1jTEV53O4KqLhSefmJ9O/FZI/Z+8cJIkkN14cSRCGU/bZzgj/thXV23wx8fWzB4v+EaEmzaT/aM/X1x9nqJ0pN3SHDFU11LHhtZb3WZFZj5Nt8pPTcx68V2XyyTMgGcdRXNaT4F8d6bt8q28Ns38ROqz/MfX/j2rdsND8bWiEf2V4ckYnJY61Pz/AOSlZ/V52SsTXxNOT5os0/soCHaMZ9KWPT4y5ZgSD1yc/hUIsvG/fRfDX/g7n/8AkSnfZPG//QF8N/8Ag7n/APkStqeGineRwutLozUAAGAMD0pAtZn2Txx/0BfDf/g7n/8AkSuZ+IHhX4l+JtDbS9Lbw3o0U2VuJU1OeWSRP7gP2ZdoPfqT7V1uxlc8u+OPxg3/AGjw54Qufk5jvNQibr2McZHbsW/Aetan7P8Ax8EbvH/Q56b/AOlOn1zQ/Zg8b/8AQR8N/wDgVP8A/Ga9d+HPwv8AEfhL4X3uhzy6Rc6s2u22rQhLiRYGSKW2fYzmLcpPkMMhD1HvSEXv2gprvTv+EOvNJ1HU7TULnXrSxZLa+mjSaFi5ZTErBGyduSVJxxnHFdF4w/5KP4b/AOwTqX/o6xpj6Vrj60NYfwL4JbVxj/Tjqkhn4GB+8+xbugx1qtrGmeN9R8Sabq39j+G4/sdpc2vlf21Od/nPA27P2TjHkYxjnd2xyAaskaupVlBB7GsTVPD1je7lmgUq4weP69RVz7H43/6Avhv/AMHc/wD8iU02Pjg9NG8Nf+Dqf/5ErGpRUjWnVlDZnn+q/D5Y1L2XlzLnlWAD/n3rnLnwVdwwSSrBMx/ucDA/M16xdaJ42nUg6T4cDHoRrU/H/kpTLHQvG9vDsk0nw1L7/wBszj/21Nc7w8uh3wxqUbt6ng/9iX8szRwW00xXr5cbH+la+h+C9Yv7pAto6orZLTsI1XHqDz+GK9kbQ/GZYkaL4ZUnuNZn/wDkSqVz4X8byh9mm+HEY9D/AGzOcf8AkrU+xqLobfX4S0vYxP8AhBLOCMHUdXUS9o4EAGfxotPD1nYyEx7pXPIdwCfw9Ku2ngbxrBJ5klj4ckfsTq84x/5K1pJ4a8bKc/2Z4cPt/bM//wAiU/YN/Z/EX1qnDRVOb5WMr7PcSOqJGWHfPNaNjYSW86zFFCquNv8AhVyLQ/GsZz/Y/hv/AMHU/wD8iVYGmeNsc6N4bP8A3Gp//kSmsPJdDOpj01yx2J1YOnCFD7iqlvYlJZZGOd75Ax0FTrp/jZemi+Gv/B3P/wDIlDWHjc/8wbw1/wCDqf8A+RKp0H2ORV+W6XUhvZEt4JJJXVERSzMxwFA6knsK+XPi58Rj4huZdM0WRl0pDteYcG5Pt6J/OvbviV8OPiT4ztEsYLjw3pmnnmaJNQnkaY9tzfZx8vtj65rzb/hmDxv/ANBHw3/4FT//ABmrpULe9Imda65YnuXw9JEXwvI6/wDCFz/+46vKvgN4t1vxFq/hHTPF+u6va2Sw3FzYyNeSZ1icTMCkku7JEY4EZ6454IB9n07wz4i0K08EnTbfSL+50bQn0i6juL2S3RmYWvzowhcsM27cFV+8PpSpoerR2llax+APAq21lL51rCupOEt5M53ov2HCtnnIwa6TnOP1WfyviJ4zGf8AmIQn/wAkbWtGG5DIQG2kjg9ce9VtS8D+ObzxNrOrC08NRjUZ45/J/tWc+Xtgiixu+y858rPQdcds1NH4N8cpj/QvDR/7i0//AMi1nKLbKTL0EhEah33sAAWwBuPrgdKf9rhS4SFp41ndSyRlwGYDqQOpAqnB4T8eRb91n4cfLEjOrT8D0/49an/4RnxuWVm0vwwzL91jq02Vz1wfsnFTyMLot7yfc1nWoeTWNQunGFASCLPZFG4n8Sc1Hq3hb4j3Fqsemx+GLKXdlpG1KeXI9APswxUGn+DfiImlzWeqx+Gr1pQVaaPUp4GKkYI4tj9M0cjC6NCDUbW7G6zuYJwMH924br06VEscdvvMakF2LMxJJY+5p9z4T8ZG2lisdI8L2RdNm6HV5xt4xkD7LwcVm2XgDxlZPM1tYeHF3AKgOrzkIo6DH2Xn6nmjkYXJ55Bu3HqBjPtWRK0myQu0ckpDbflwo64H8qvxeA/HkcMi+VoDyOOHfWJ22+4BtaZ/wgHj4x7Xi8Nl+MsNTmHb0+y0+Vhc8307Tbw6xHdSxyxldxneV872OegH4da177YFOxQW7Ak4rqX+HPj9jGAvhraBh86jNlvfP2YY/Kq1z8LvHkzqQvhtFHOBqU/J9T/o/I9qIwaVjWtWdaXM1b0OEvioHH45rl9TuoUDksNo5yOgH1r0+b4LeOJVUO3htyBjc+oTkk5z/wA+471g6v8As8ePdRCKdQ8NxxKMbRdznJ9T+4q0jK54V4g1Vr1ZEiysAB+rf/Wr7Z+IFzPZXHxMurOeW3uYfCNtJFNE5R42DaiQysOQQecivB3/AGX/ABuyMv8AaXhsZGP+Pmf/AOM19K69o+tnxTql7p+laHqum6lpltYT2+o3rwf6uS5ZgVEEodWE4HOOh4qiSz8Jbu4vvhh4Vur64lubqbTYHlmmcu8jFASzMeST6muX8H/8eGpf9hrVf/S+etDRND1bQbiS40PwB4F02eRPLeSz1J4WZcg7SVsQSMgHHtWfo/h/xvp1vcxf2X4bk869urzP9szjHnXEk23/AI9O3mbc98ZwM4oA29oznHNPrP8A7P8AHH/QH8N/+Dqf/wCRKP7P8cf9Afw3/wCDqf8A+RKANAUtZ/8AZ/jj/oDeG/8Awdz/APyJR9g8b/8AQG8N/wDg7n/+RKQGiKKzvsHjj/oDeG//AAdz/wDyJR9g8cf9Abw3/wCDuf8A+RKANKis77D44/6A3hv/AMHc/wD8iUfYfHH/AEBvDX/g7n/+RKANCis77B44/wCgN4b/APB3P/8AIlH2Dxx/0BvDf/g7n/8AkSgC9LEsoXeD8p3Ag4waYbeNn3Pl+hAbkAjvVT7B43/6A3hv/wAHc/8A8iUfYPHH/QG8N/8Ag7n/APkSnqBbktoXGGjGBzgcURQwod0caK3qBz+dVPsHjj/oDeG//B3P/wDIlH2Dxv8A9Abw3/4O5/8A5Eo1A2/hP/ySzwb/ANgWy/8ARCUVoeCNKn0HwXoGkXjxPc6fp9vaStESUZ441UlSQDjIOMgUUAbVFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQB//2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) A 4-cm long segment of Barrett's esophagus with a large island of squamous mucosa in its center.",
"    <br/>",
"    (B) A detailed view of a lesion at the 3 o'clock position.",
"    <br/>",
"    (C) Same lesion shown in the retroflexed position.",
"    <br/>",
"    (D) The lesion has been delineated by placing coagulation markers at its outer surface.",
"    <br/>",
"    (E) The lesion has been elevated by injection of diluted epinephrine solution through a standard sclerotherapy needle.",
"    <br/>",
"    (F) A transparent cap has been attached to the distal tip of the endoscope and a crescent shaped snare is positioned into the distal ridge of the cap.",
"    <br/>",
"    (G) Using the coagulation markers for orientation, the lesion is identified and subsequently sucked into the cap.",
"    <br/>",
"    (H) After closure of the snare, the resulting pseudo-polyp, including the lesion, is pushed outside the cap and removed using electrocoagulation.",
"    <br/>",
"    (I) The created EMR wound shown in the antegrade position; there is still some mucosal swelling due the submucosal lifting.",
"    <br/>",
"    (J) EMR wound shown in the retroflexed position, no markers can be identified indicating an endoscopically complete resection; note the mucosal whitening due to the vasoconstrictive effect of the epinephrine solution used for submucosal lifting.",
"    <br/>",
"    (K) The EMR specimen is subsequently removed from the stomach using retrieval net and pinned down on paraffin to prevent shrinking and curling.",
"    <br/>",
"    (L) Microscopic view of the specimen showing a well differentiated cancer infiltrating into the deeper layers of the muscularis mucosae, there is no infiltration into the submucosa.",
"    <div class=\"footnotes\">",
"     EMR: endoscopic mucosal resection.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.Barrett.nl. Copyright &copy; Amsterdam Esophageal Research Foundation.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_60_7111=[""].join("\n");
var outline_f6_60_7111=null;
var title_f6_60_7112="Pyogenic granuloma 2";
var content_f6_60_7112=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F52128%7EDERM%2F52429&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F52128%7EDERM%2F52429&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pyogenic granuloma on the finger",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 420px; height: 273px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A rapidly growing, red, dome-shaped, friable papule with a collarette of scale is consistent with a pyogenic granuloma.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Fleisher, GR, Ludwig, S, Baskin, MN. Atlas of Pediatric Emergency Medicine, Lippincott Williams &amp; Wilkins, Philadelphia 2004. Copyright &copy; 2004 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Pyogenic granuloma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 379px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAF7AfgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDr7SzthHnHmS52Jv53H1HtV90RGBh/eJD8igcbn9fwqO25WRkDD5jFAc/d9TUwEbuvlvgbgse4cbQfmP41wJWPYeo6eMrBKiksYowGOOC7H/CuE8RM32SQKcqRsAxkjH+Nd2lyoMqmMFHZpSc8t2GK5HXIS8TjcUJyAD7daUtSqS11L3gGY3WjpGZYZZgquIiSfLA4OR+tW9etGhupHacnaPMAK8t6D6V594b1ttG1dklAMZfJ7ZDcHp1x1rvry9kntmWKCLy36Mx+YgHrWl00ZOLhOxm3F0bXWYym0zzKpZ2+4hxg8Hj0qLxjcRSWllM0jSyKxjZgmVIYYIVf61DeWyXiJIim4ni+bLnAx710n9oyPozwWdskjNbszyBVHl4xkKTz2og7aE1Fsef+GJJGt1ictsjcgA9eDXewtIXlJcZdgCV4U8DiuK0SeNru/wDNRGDSF/l6HPv69q6qG5W3kRCwIypV88EY4/GsnudHSxpSW0bmYSys/wC8CAKcce1RyWUTMTDGdu8oHY8YxUNvLK6RtGiou9ny5wMe571MHj8pVurzOFJCRrwCaWg1cmklebaWuAoYfdXjOO1QpbRoW8yJnYYI3fL19e9JbXjJD5Nraljn5pNuGIHpnoKinnvpFJ3rFu+Y4bk+lSUl2L228RVSGGFI3GPwHf8AOqd8SJQ15eKzDlgvXPYVUa2TaTPfSOT975uh96oSXFrAu3YztnOSc0czNYx7FtpEZlWKGSUgZPPU1FIHhUtKFjH9z1P1qul3vchC3UE4GAPxqleXsZl+f942cbQ2cms2VZlu4vCckHPPKr0496r2gmvZQIcAjLSSMM4HfNQRWsrRK965iiJJRM/MfwrQeSX7L5cAWCFiqhf4j7mmlfcG0tEV7KEQzsHIO45ANR+d9lmkSbJVumBjAqS+KQ3MZiB24wSx64rD8U3RNupjYh89fX0piSu9epBJtfVVfA2kkEmurs8XBUqNqLwOe1cHDdGe1UpxJkKxz93mu707BgTYuD0/+vSe4T8jTVtqkgAHPA6VYTeCVB6Doagt4mc5LD2z3q9sCkt/F2Pp70CuOSNl4yMnGc81ZiDiPHysox1qKJWA+YE+v/66uQspO4nIHAOOPwFJBqS26GQnCoQnzH1+tWJgSZg3zHIfJPWiHJgdiWYiMg57ZPyj8+anMQd3HTOyMfhy1UIcsX72VmDbVkXHHt6VGkJeLIOAUcjPfB60sjNu3pwGYykt2H8Ip54twytlhHt2+7UydhUg5UdiXPPcEDNJ5YVDuOHRY2U+2cf1qVnVZBlsNHAQQf5UkhP73nKpCiliOhJpoH3I/s+6YtggrOV3AcgNUBaSMR5J+WQRyD+8Qcg1oOA7XCxMdxmjXPvSSxZ3goCr3IHX0qiblSFts8YY/L57qCOBgjIpkW6Q2yYLDa68dDzTljzNtLZBuDjjPT3psbBfLUtjCyOBjGOaTdgepSnKpZxlgM+SceuScYpt4G/01Ax+VY1I9RUmGeNiqAYhRCGGRy3UVKIU86cgEhpmxzxtVe/41IFO6hMiPPCArZ3oezBBz+tUJ23XcVypAidPnYDOMnn9a14zvSFBkRJaEEH1J5rMaPMN3aEcwzgqfRSAf50yehxk9nt8Waln/XyRgxYHO7P8jXoejStqGiWs8pYmMeW4DfMT2X14ORXBaxcQx+J4rqRd6YYDB+bOOP1FdDo929jfTRSfu4ZyJ0PbY3J2++cj8aqL3Jqxvr5G7AVe+EbhCANmN3XuRn1zVm8uGhgRj/ECFG7rk55+lZ9ncKXWfAQLulJJ7+n8qt2G+6nO8BVYKvLcjPb+tUQT2MJ+zErlt7r948N3Jz2qV1IUAkrB5rsyhuTtHX8+9SRowlhLgCL7RluM8AdqRY2uRB5rusLyuBt4Lj/Din0C+pmXe57Ysg2iKIKSDySTk1X1GJ7O6Webbh08x0Q5EfQKTWndBZoyVABlnCKqnsPb8Kp3YaR5Y2G5Z5BFn1CnqalouLIUl8hTIy8wxEr6F2PWiQeVHMuSXit1iXsAz1XiCiYxSmTaz5GOhQHtVqHdLOPPO4Evctt56DCg0l5g0VCvliZEyWQJarnryPmNWAVaYSEMUlcLtPAKJwP1piwyAQjP71SbiTI9qsW9qot0QBi0zbUz02jkn2yaEDMp4imqHBBdozuAHqefyFatvGonniSNt52vuUdV6YIrNdpBqzxMA5MbITnGTkZ/Kp7e8WO5aIMxZ0KyqByFHTBpx0FK5burqU+WwO/aSkEfYj1Oaz70xRymPzGGOZmJxlj/AA0l3cTyWryR2+yMgrGztkxj1x6msu6eFGhSZyVQfPzn5v8AGhshRE1G5RbaR2QPNImIogM+X2JPviuYgjl1W/sbdVcxKfNnyMqwXgYH+NaOqakYxNJbROLpRlnXGAMYxiofDG5dPlnkmaKW8I4GQ2ztg9Kndmq92N+psXeqxzqUYnykYNIpb73HCjvn1ptxPM7oERxM+ArONqxL6e5qeG0hhxiNXjhfK4Pzuzdi3rmp5yzNKrqxZMM2Ow7BT6+tU7sUbLYyZ7aXf5NzLiFTwkfO5j/F75orQaKS2VRIqR3Eh4D5PkoR1x70VNi7mlb3BDDBQuARGvX5m5P5etStPFC8igqGI8pMt2HU1m2pIcFiY1jUknvzS27C4uIVtYTPOFZjuIIz6mq5hOOpZa4JuoZYA4iIEZGOGx7ms+/jZxIzYLEOPrz61blDrHas8is27JVT9361QuGIWXj5UkJ/CpbKjG5xOt2gsriO5kQ+VjD5Pr/hXT6NeW81gkk0pnu9uwYBCADpx9Kh1WMS2bLPhhnGCO1crotzLY38sUkhUPx/vf4cVUZWQ5xc9Ttbqby3WQFOm3aBwfwqTzZDGEhjLwOPmLEKoHqfYVlzP5kDLwO4x1rP0y+M0U0G/Hl54z2pc9ieS8Svp8iQ6zcp54lUH7yDapx6Z611drMWJACsm7IyOnFcXbW5l1sO5wMZCjoR7111tHtICep+nNK92XJW0LYkZhjcXwdpx2H8qnjvUijkRBGjkgdMnj3qlF9njJN07SndyiHAqSPUItzG1tACpPbOPalqSidbmWV3KJNKzHbnoKe8c2C8ssUSlgMA8jFRyS3kS+ZcI8MO4AlCoP4VTae1UxtMJHPOdx4NJmiRJJcWduC0m+VsE4J4zVUzyysRZ2h/vdOAB7mpDMRGskcASIDduZev50wyz3qZiV5hGvJPyoPYmp8ilpqQG3lkYi6u8JnJ8vofapYrVEcm0i5Q/NK/b3FOkkjiLNcv50y4wi8Rgf1plzO0gUyOBGM7Yx707ESm3uLFPDbzGYuJn3febnH4VQlvXaQSHnJJJqjPKm8jOGzzioXbapYkE56VLNVHS5Zvrxim5vvZziub8SXrNb4VueMe1SajfMAyN8vriuT1y4JI2tkfWtacOYipUVONzpvD7fbLq0CRhUYYf/aI5zXqFuqogAALYFebfDyJ52MzAbQMcV6fap8ucYPAPelU0djKErrmLNr8rxggHPOM/wCeKtqoLfKSVzyfWohEARgcDA+tTRBj2yoqDTRliJcqNowv8WT29KtCFkXfDkDOWJGBj2FRwkFgRtJHc9BV2AKU6bs9SxoQ2yKBnIBj5UvwDj5m7Z9hV1giwl1Ztv8AFzzj+JvqTxVdokeQmI7TwrNjAx6Ad6likk3jKjzAc7T6ep9sUxPUJMbT5hGzO5h6L/CKcuOFmy4T97Jt7t0VaVYIx88YLLJ91XPLOeM49BUcTLtlWWT5YDl27SN/CBVITJEJkhIcA+Y4yT1znOfoBQhaRowvPnzbhkcbV71DFI5STzQRcsSoUcCNe7UsMbsFaP5Ny7UDH7sY6t7ZpAy/AwBjeRsbnaZh32jpSF3LWQZRy/mt6c9BToVadAxGDNhFXHSId/xpJ3DRtIwypJMa92xwuPpVNme5UeSIW0Rk4yZSDnGT0GPxqnc4UNEzElYliUdgxOTVp4RFPbq6pttYjK+Ou7+tVlBVbdSwBIe5YHv6ZqS0NJLyqePLeYKuDgFUH+NIxItjgksImf05Y4qOPP2U7TkRwFhx3Y9vzqQAlxGNxZnEe32XkigGPCOly6OMwyFYmOMYCjJFZs7bdTPD4uItx/2iDkfpVuWVnt2dTkPu/Ascc/hVHWSEuEZG/wCPdznHIwAB1ouQkcJ4/It7m3mBKqhVicfdHeuosrXzI9PjaWH90rhH3ZDKOdp9uc/WsrxpaQTWvmg5bB46qKk0Xz7qysllX5ABKM9XA4yT6Uouza7lyXuxkdNpyt9t3H/UkjqOMdia6pILdIYsLu+Vpj/tfWse3jBtFZNu9sZwOpA5/wAKu2ztHHPHtJCoBu/ixn7prZaHPIdCkheJWiZ0ilb5c8HjNTwskbWxGcpAzn5sgZp88K77iSJj+7TdhflwW61Bc7QLgKhZSAn0RRk4/GqJRCwVPsyuD8itOSy8k4PIqiqGGOAhcbIWmJ64LGp57nETvMzNKI1jQZ3BST2/A1HcRCOG4++Q7pAB7Dk8etZtlooyqZEzEwUwoELdN2TyDUiNvWX7MxHmkRKDx8oNQSSJF5qhS7Id7KvIDnhV/AdacYDHHIWXBWDbGobPPc/WkW/MmuHCxTK7ErIMZzyFU85/HpVe7vZGMUjb0YrtQP8AwjPLcfSlSFWiAhLoCPnJXk4GcE1FOi+RaMAxllOQB1Pq3sKYtLmOjM2uiQuh2RuwUEhTketa0cgs7grGih2AYsp5UD1rKhiabWLdUBQyB9xIxhQOOPbFa0dssF1L5+Z5Xjx83Xce35UovQJkDtc3ckssER2EFUZug5647ms9rRYJXE5d5UOFjUYLvW6808kbFUQpbrtBBxl+mc9yPSsPVJ1gt5XMgEisU3dz/fOf0ptWIT6HMajaz6nqUGn2ilJbmQRbd2MD1J/OuqFosMn2jassFsRHFGR8pbGD+HFY3gmN59VutUdcR2yeVEMZySOSPfFdPp85jt/JuI0aC2JK5PzSO3I+pHSnHa/cc2727DVspEc+T800cZYHaAiMTnP5dKaFjRM3DMy8GMN1kb+99BTmbbZvEXU26DzHGPvPn7pPpTSGRYSf3t9cnEcfaOI96GMhuI0m3+bNuQKJLhyeS39xTRTX2JEIt+VhPQfdJ7ux/lRU3HdorwW53KLhmWNiflzjI9aZNdtBGojKqEG0bRg7T/Oqf2iWWaN1SSX3HQD61M0NvHGktzd75Cx/cwnlR2ye1JLTQv1JHLyJIedpxgn1qvJON+5264RwOxqpJcpvAyQHOAvoajnil2u0iiJSRlXOGJ9cUkWmkOuZ/OOMY/hY/wBa5XV4hHOs0ICuh5NbUkqxTbZWLdiOxHrVHUyrwMRtIHHFVYtSSehJFdMVQ5bBXrWFcXLWGo+amQW6j1q1DJmwBUj5PWoL5RdWYZhtYdx1qlC5k522NVWD3sMqkEvgHtgV0QmBXOdx4BHavO9I1AiQwO4byzkE9a6+3u02buMEDIzS5bE8yZorKzDoFPPfFOa9YAq0pUBMYQAcVlzXChiOxNV5Jo3TAcKF4JB5pWLTNmTUIkJUKNxIIcjc34Ugum3xSxwSqS3Esi7j+A6VjR6s0CFI55F2/wAMYGTVCS8nk2iWd/LZs4zlqfKwuuh1lxqMCZe5hnmdF4+0vjB9gKWXVpryE+a8VrZsoGyPAz9FHJrkhqkMErlEd8gjLjJ/Gq7auCAxUK/JA20OLFdWOmubmzRitqHkYqCZZTyPoBWa9+pZtrcgZrCl1FSPmYn+IDGAPWqz6quDtCoB04xRyD9okbj3ILksQSfmGD/OoZr3glcc8ZrAfVFB+U9etQfbV3lmclewpqkwdaNjXkMe1mkJLVzmpQxHzHOAcZ47GrMmpA5x90frWRfXZdJeQd38NbU4tM461VNNHp/wytTFokTkYMhLZ74r0ixULCoPIHJFcp4Mthb6RaoeGVBnNdWmdpIGDjAGa5ZyvJs6oK0Ui42fswIXALcHuTj9BUscfAweOBk9BSyt/oEAOPmYnA+nrUkROTwP61DLQ+Jdu7pnPGeT+Aq4QQcttUern+gqnEhUZIYD34zV2MYDKSqNkHOOPy6k00NjkjeYb4yVmAwrNxkegFCOrA/J8zHDR/xFv9o9hTwpWdWjyASPnbhvw9KluAk7Y3hJM4LRgsW9iaqwhkhCkESKrg4eUDp/sLTJ1kkeKaFVWZeUgI4Cju1S77iBY/NAgt84DImW/WhlXaxVWETdRuy8v19BQIrWmxvMXcZEZwzD+KR/7v0q822Qu0nEf/LV/wC96Rr6iqcsLKouY/kG3DYOMr6L3/GrFvIJGjaJVLKMRQfwxj+8aFvYGXQ5XfG5CyMoMzDpEnYVGZUeaJzE29/9Uo/hUdAfTNQpIAmM+bCHwx6GZ/XPZRQjS3DukbBVlBM03YKOy+3vVMjl6kCxM6bZADJcuS5DcFR1596iZRLHcyorEzEQR8dBn+VTXLgLvLbVmxFbgjBSMdWqvPcbiqwhkhiXy02nkknG78fepvYtXtoNvHH21oY+VVlTOMD5RyPzpsbGNVnkyZdjzAeueBmrdnakwQ20khZTIeQfugZ3c980yfZHFKzZJuI8Kq9gDhadtBX6FFtruogw+CGYZwpCjJNZcxaSB0C8+UWJHA+Y8fjitNkZg8SfugsZijBHPJGf61Du2ibyipRfmO3qQox/OpHscvdW63GnOJE3nBiLHoxFX/AU0Z05ra5HmMkTQszDO1Vbr7cGi6gFreXMUgALrujH3gWx2+uaq+C4TYXsiXiuI3l/1O7GFYcE/iKUNwqfCzrNGG25VpgVjAMoyMkAf44rTePdIXYvueRG7DhucH8KzVcocx8tuILY6g4BrXZHKySzssUbMSAzYwAMDHtWyOdjV3TSB/MHl7w7KD2BwPrTLsefMpdtkJlk3MT1XuPTHFQxzyMwFjEZOeJDwMKO341HLaqVWS8leUGIkgEAAn0FVcEhqXCZ2WsCPljKSeBgDCjP61DPBJO0LSTBn3HMYyPmPJNTTSwQrGWXdtXCRN1+pFQRi6Lu6xMzKhUyE4Adup+uKzZaIorZEZHdcRkNIyp0IHA/M1PdEpbIFCvIXA2gcZPY/SlRNhKSv5gVQvy9AF9/rTvIJM5jAUpH5jbzgbm6CmkKW5nX0MkaOVV1WMeWSp5IPVsVMFghkhmjIaKOI/MR2PQj39qvGMSSeVuMca/fOMfKOWP1ziqcEZaUW8bhUkzPzkqqj1+vWqehL1Mf5jrenoi4ZCYxkYO4gnrWtOttb6ikxLOLYZmB4+cngYrOZo08Q6YZ3OSGlkcnA3HP/wBap7q4t9zRMmcTfaZHPzfKBwKiL3KlrYWS6ncrBFDztM0m4bVBPQn6deK4PxVdMFRIXd2ZjHExH3lz2HufWuj1W9d43bbjefNlG/A2nhVrnvDds2ueJ2uHj/cWn7xhjjd/CoHqKTfN7pUVyrmZ22m6adI0aysoY1kaNg7MR9+Vh/QVb2hViii2fuSQHwTu/vOaeH82eWS3YuEyEDN827GWb8BxVa53x24km+WJ02nBxtUZwufU1q9EZLXUito1QhCjTCRzJBEOS4z1b0Hes4M1tuO9WvLl9iE8hFzz+FSTzuE8xz5cjr+/cH5kjI4X8axZTLqrP5X7mA/uwwP3V9vc1k5GsY9ehMzrd3Jt7XcbWI4d1/5atnrRWraRpGFiCrFFFH/Cc8f4mikkluNt/ZOZu9RurxWVVdlACARLhc9hnpUJt0iZGv7gJtO0wwfM359Kzpr+J4DHaRS+UG4LOcD+lUp51ES+bMAd5DIgxt/HvWlrkc1lZG3PrFrDAkVlbRW+V5dvndj65NZUt/LPLxlmx8xZuvvmqC6lFbo6W9rCZD0kYbmx7ZrPk1FI2V3YSP0x6iq5Rc9jVuyu0jzi7jp5Y+Ue2e9NUsyc45GMelZQ1BZWIZliUZKnOSfbFVJ9V2qCvHGMng1SgS6pqeckKSxtx6isKLWGj82A425yM9apXV+7sGY8nqBWRdbjKrgkZPSto0jlq17LQtQ3h/tHzEwFY4rqrfUgsYyRtX1rj9OjUyyRzjcr8gjqK0lUAku6g45JPUdj9auVHS5lTxPLozqhfRuMsScDp7VTnuFyCoAX69aw/tEYQKsh3Y7DrVRr1IzgzDcOmRUqgbfWrG/NOGYMoVRjGVOKz573B4m4z03cg1iy6hAQQ7sxP908Vnyajb/MpRuvpVKj3IeK7G1LqrCTictIeOvWoG1h0bYZCu3qeCc1hPqUeMeRnHTNQyahkcRID2zzVeySMnXkzfOsF8fJwD1Peqdxqshb5I0z6nnFYb3spOMgfhUTTO33mquWKM3Um+psPrE5IyyKB6L1pG1m7ySkuB6Y6ViBueaeJKViW29zTfUbqUYeY4HOBxUunCS71G1iaRm8yVVxn3rLRs10HgtA/iWy3AkKxbgegok7JhH3pJH0jpUapBEAARt4/Ctq3jLAYIyKytLDeUmM9OhrctFaNcAMwryWe+tizJuKxxMDtGSOOOasxoACMtkdAOBVdnG8NkAYHOcmnSTfMNx4J4JWpuapXLcQyS2OPY8mrC8NnhW9VG4mqURJA+RTgcFjj9KtQtnAJTb3AO2qTBomAG9GdFX1MrZJ/Cp3uNsIDSEJu+TYmA3071XLKAdn5Rrk/nTQjjlVEbHq8rc49vSqJaLHmiKPczLCnG0uNzmkXcWLWym2ZuskpA3D2FRiVIpnRSoIOQV+djQ5YZaLCO4wC3zOfw7UEj15UnASTGDJMecf7K1DKgtBmPeY5cb1J+aT/CpTE7bWYeXLz+9dsvj0AFQxlUyH+WU/eeT5m+qrQMWbzbpo0YAK42pbxdcD1PYVKfO8tolCJtAWZxghQOig1Daq0ZlWFzGj8Ox++w+vb6VaRCIlWKNt2cQQdTnu7UIlvuVpIds25TtkdckyciNO5I7Z7UkKI8sMEcRBZtyqBjgDhj+pqwLQFSJH3tnM0oOdx7KPU1Fdzx7nEhCSFcMephT+7/vGq2BPoiY5MINuHEcv7lXLfNsH3jjtk1WlMcJdrgq2WDqehCL90Ae9RPeGZVjtk8sdgOTsHQY7e5p8VlMrebI7M8rBTkZwT6ntx6Um77AlbcoeZNI8ckn7tPmlYhvmI7fgKdgQwKCECJtVsdSD8xJ9fSrF5LFFA6ylj5knlrtOSI164+prMxJfyyPKQsQV2KE4P41LK3MvVnaSW2uImZUhkXc7D+8ecD0xVi3ikh1oGY5EqEnIzna3Wk1xoxYTRrxJt6AcKDzj8qrwq7waTdXDhlkAVQRxyCP5rSWjFLY6Z7xpEEUUYfaxAYDnJ7mrSW/mMx1RvM2EL0+Vcc9KgVCZYjbkRQRrvwf4z3qytvB5ILySMxjJMa5+cnjmt7XOe9yKa5VFMdpGz4Xkr0DHpz2qIwXE7hrshY1YKY4j2A6Zq5K6QQsWOxSygpt6ADk1Cd0qrPOyxQujSBB19F/E0ml1LIYhCyyNZxn944RS4ySfY+1TzuVeOK3d/JEwXc5yWfuai3/ZpWlw+y2TaoA4Lngn9amjQwxpGODHF35+dv5VKVguNhhVirDezzSlST0VAcnj6itDy98UQdkQ3TmWViOdo6A+2KqyxBVeOMKWRViBBzkk9fyqzPLHJFeOpYn/AFEW3uB1/wD11aIkZt4hkcP8pN5IRvLY2qOn4YqnI8kd0TbFIpnfYqqP+WYGG4q9cGJ1uTIUEcUIjgwcbmPf61RmtW8mVYQxe2CxGTd1Y8kj60mwRmBdviOxdgH/AHxAO3qqrinXYQ31+mzZHcKqKCvIxyf51GXik1nSHLgKBjGSBu5o1yc22pQGNlDnKbuo+bqR7is47Mt7o5rxBqDPaNEBzLISExxgYCj3rq9E0xvD2hWkESq17OBLO5GWEj8BQfYVz2mWD654mZpQPsOnYdm2/KpH3Qfr1rtUl/eSTSBhIi74hjKgk45z69qqmt5CqS2iiGYRxghExsxHukHAPViPXJqtdyeXL5t2GJgGX3kH94fuqB3xVi7eK13GZ93lL+7UdPM6n8KypI3uts02EtF5APWU/wB6nKXQUUZUsVxqMbJI5js926WQ9ZD6D2HSrUFqqCNcZYABCBxx0wPbqfWraossqxzAhIxukCg/UL7cVdtj5yNLICZG56DCLnjp3qUurNJSdiKC3jaNpeTGjbjuH337fgKKuWuAmZ0JtyAxQZDccZPpmiqM+Y+exqR8rYz4CDp1IqjLqY8xucnO7PWsY3IErY3MG+8FGfzp8yoF+YKpPIyef8K7o0GcEsQXJtQZ8dkA5J7VWa5BO0fNjqPT6Yqr50IjKz3ESjpgnr+VQyX9kpKpOQD1CIeK0VJIwddl9GmOQw27Rxzt3Co1QySHYyN3zuwD9apHWLKJ1Mdu8gHdzmkn8QRyMMREKOirgYq1CJm6jZfCMX+ZkC9xGOlKbRWQ7WyT09ay/wDhIAoISEknuW60xvEDKf3UAUd8v3qtCXJs2PsixBZHY4A4PcU6WWIRlghZT69q5qbWrliCmxfoM1SmvriX/WSsfai6J16mzdTbCxTZgHg+ntWVNd7iTxnPHFUi7FiSxJ96QtUuRauTNMxXHTNRFvXmmk5pmTUjH5J600seaM/jSUAJupM5p4XP/wCql8pyeFP5UWC5HmlBqZbaVuiN+VTw6bPI2Ah/KiwnJFeMjOO9ei/DHTo5mnupATITsjx6d65iz8OTyDLnaB3Ner+BtLFrZQxqANvXjk1hiJcsbHVhIKc+bsd9ok7wRlZu2BjNdFbyOcbQNp5HNZFrbxzRBXQ+vpmtK0PkAIEwvTOO1ebbU9roWvLYgsrY56URtt+SbMgPqcVPE5KDZzj0GKHBLdR+NHLYpO5G2bUqrlDG33WBzV+KYNGACuP9lc5quIYfKIkAbI+8R0rOeaSylw0xktz0CjkUtmXo9Df88hGUGXHHyqNtPCu671t1UA8GQ7jWbHceYisodiOOSTmrcUpACPHsZuQxYg1aZD7EwjkCtGGw3UhExn8aRPNj/wBWhRu+WH8+tOQQbdplJJ4OXJqWB8AhEZVJ+9gLj2yadiSKS2l8v55Dg8lFJVSPrT7WCN/mTdI+cbIVOTj1J6VOU3BjIVKfxfxdPVjVaSY27t5bIRjMirwH+vfNGwWvoi8lusumyhgA6khlC7tnv9arWVykWVYMGYENjlnA9T2FQLO9xF5YQpH/AAqgxu/Dv+NPMaWxDfLhsA55Cn1/+tRfsTyW0ZaWWWSPhfLRfuhTt2j1yep96zoYUJd2YiJG7E/Mf6n3NSzvJdEKDiN2yWPU44z9P0qJmAmSNULRIfnIbOfQE0XBKxYtZLaKVSvlmNPmYKOC2OEHr71Fe6hNKWS1XBAJDEc5PU4/QUsWnXEk3mT7UUOM7OWYnooxwKnmgj0wu6kb4seYpOd8h6AH2pq7XkTeN/Mx1tvKheaXJkUhMbskk9qc8Ab7VluIwiAqOOec1NdzQR5CurOqAhgM7nbqazbmd4YiwjbvkjuPuiptYrVle6dHspmcr50pdmB4wo4B/GsPR5jJ4cuonlAazulljQqSRg5xn05rdvLV4kKCWOSTCwDaM/LjJP4VxulXnlT6xZwxTTXE/wA6xIpYg4wT7Din1Qmm4ux6MjmS52ABw+189Ai1oJeGRtlopdj8mSPlUDvmub8NwyXVlFd6jIGRE2iJCcg/7R9eK6m2+QHy1CxiPeUB49h7GtFqY6IjisCjJdXDm4uPmZAwyo98VKsBKRMxU5ImcHjAz8o/E1oLCyRFUdfMZFXcAcgn0qveIYnaQswjAIUdMgcL+OarlQ73KrBrmdAWVRPMzHA42J0/lTUcpHCrSbpjJ5jFh94AnBH4U59w3L0lVVt4+cYLZyf50soEkUhVAq4EcWBnK5wT+JqQGiaRTHKxVnYGYbuBycAGp9hRHjQhiqLEGxj5m5Yj3xUcW2a4ESjcu/8AeDoNqj/GlL7IkJkKkqzBQcnc3A/SmiWV2SKdowNzK8hZWI5EcYwP1rP82WOdEmH791LFeg3NwD+VabmKQxR2zGWNsRxqh7Dlie/JrJ1lt4aVQSysZmBPQdFBpSVhrc5yctaeIbNIyCTNkDnHpTfGMwtrZ9/y3Hms2xDuCDjFS644XULKSSRFlV4+F42AnGKbqcNrceJLXSY41MfmmeaYsSxUDIP0zWUVujRtXi/U0tEtJNO0aK1YFbm9bzJto5wecn8O1Xpr6OxtF87JcOXZSvLY4Vagvrtpr+5EQdpwiq4Xnb75+mB7U+2sWa6ErkSTAbVVl4Ud9vv71r5IyXdlP7LNPIsl2VQxncEPzBcjJY/pxVtoJEObg48pPNZS33snj6fStCGyWYwIudjv5hHbC+v1NRShrgg45uZuo7Kv86nlSKvdmfCnljMpfen72Q45JJ4B9auvHtQGRVWSQiSTaeijovtmllWFrh/LG6MPxj70rCiUn7J5SLk3DZYquSAOfwweKB3Fy8kwllBHmDc+TnGOg9qKjiwjqA6yzOdhIPGT1yD6CimTY+NJb64fJ37fXaMVWd2f7zE+mTmoy3bNML8V6jbZ4diXdz0prOCagaT3qMvmkOxMW5NJ5lQFgPU0YNIZLv5ppc5poVj0BNTR2k0n3UJoC6I8k80mT6Vq22iXMvRSBWzZ+FZGILdKZLmkckAT2NKI3PRT+VeiW3hZVHKE/hV1PDgHAizQQ6qPMFtpWPEZNSrYTsOExXqA8PAD/V81Zh0BR1TFAvbI8wh0adwMqf5VoWugOxIZenevSo9HXuABViHTo4255FBDqnn8Hh0cZWtCHQBn7ort/sseRgYqZYEXooouR7RnHxaFx9ytWw0DfIqhOtdDHFu4Azj0FZXiLXBp8L2lkwN2ykM4/wCWY/xpOVhwUqklGJU1BIjerYWu0rGQZWB/i9K7fw9biBCQBjAri/DFgzhHLbi3Un+p716VpMSpEoA3DoAa4K0+Zn0WGo+yikatsqOpLjacZ5PWrUbKjlWB3dMKc0yKIxBA3zOeQOuPf6VdigCSKSgyRjcp61hc7kgSKQ4579DVwQZAOwccYzU0adsjJ6q1WFOFOwZOcYPUD2NKwrmcbVgAEbGc8ZpyQqEO9A57g4q6gaVzhs4PA3f402aHBDNgd/uDFFkPzM8ReS4khZtx5K4IwKuLF9rO9tzMOxOafuReGIPsE7U9SFcPEshYnGxQQDRYbY21hktnxHGXUDJJyOParhuUJDKm5+o+Umo1WSeNcom09N7En8qe8DxliwaTAwFXC4P9ataGW+41klclmAjL4PzH5m+gHNNaySPcZhuBGMt1J+n+NW8DZvIKDHJj+UfiaRU8zBtY+OnmP3PsOposmHMzPmzEBlmAA6j7309/wpsRebY6ZJBAHy559PatJLXyG3EM8xz97qfc+lIbYojSxShCPyc+gH9aOUfMQxwxxMTejK/7HQH09zVuP5ZNqxxq20MAGwI09f8AepkUq3XyEBJ0/wCWR6IP73vUSeSreXLDtDnMZJwJD2J9BVLQykWZldCksTNGIxny87gSeAcjuaq3AlR4wGjlRSY1Zhj94eSffAp8iSW+PIZpUzlF/wCekp/iHsKRhhxbLyGzEGJ6H/lo1DZBTcJKqOEQBiZAI/QfKin6mqLBQVWVOA3zZPGFGT+pq/evCCzkDJC4KcFRnK/ko6e9ZXmhTsLFg3DAc8feNS2aRKNwrtbyxKOYwQq+jOetc5ogj0vxVIqpJJLcRFMKcAMD1J9OtdI9x9lvRLMRiZd20dNx+7XNXFhLd+INPRC0Qlk8reOue4H1zUXs0zS2jR1Xhxo/tEsM0mIFlMgYn5cE5wf1rsbVDPgiPYJHwox1X3NYFvYwWEsC2qOVJZDvG4O+eozXRxgyNGUO0xIzHkHJ6c+9bxVtzlb6ocp2ICqkvuLhTx04FQMAquACylh83svJ/WrwQLH1fcgC7sE8gZ/nVa7iZoejFyBGoGO/LGqYJlCcbwu1W3bA7N1JduBn6UkwiW4kRiXEWWO3I2hRgD86sRIkkqAZPmOX56lUGAfzqGCCKSGOAkncxllf+/zwGP8ASoLuRYKyERHcY4wCg6Bj1yanjitoI2YIZJYU5c5PzHgYqfd5zxR28QRZHOCBxtHU/Ws+RVi8ryVPlSuxcs3UA8Z9u1PYTEu45IRKgZSqgJnOCWbr09BWVdyJNJ5MUa7JXESYHG1BnPvVy6MVuIncKxRGdwGzvY8YzVG+Y2ksahVLQRkouM5Zx0/z6VMnccVc5LXXM0NhJMqnMqq+xstgNgZ98Ve0x5L691O8iUST7/s8ZcZCIvOT9e1ZOpRm4hliULmOSOdmb720sAQD3Fd7rMdraX/n2aLFDIqwtGpwGIPy4HsaVNbsqq0kkZ+j2qWrkedkSkebI4+ZieufT6V0FoqxoTt4SN5Dj0bgKKgaGTBlaMR3MS7QVAbJzjkd8/pT0mdHMLx7XVgdoOd2PX2rRKysZN3J2j/dykk744VVFxjk4yP1qG5Rh5vlxfMoW3XgHDdyD61c89JIYnn2iRnMsjbhwB0BNZ4kk8oOqlYBnauect39TSbBFTJFwkcQXacxxu2BsI+82amW2SUnyfMxENinP32PQYp0gNs7oVXdAoAA5yx5x+GamiZ4juBKSJhIVA+8x5LGkkU2ILVbVJSVXEKfZ1JGSzn7xH54oq+0HkMhcM6wEKuRkNKep/8Ar0VViec/P0tk03JPGK2IdHlcfdOfetO08PszYZcfh1r0DxPaI5VYnY9CatW+nTynhTXeWnh1FHKZ/Cty10NVAIUAfSgzdY86t/DsrsCwIzWraeFwM7wT+Feiw6ZEgBOD+FWFtkU8KMfSkZuqzirXwzGoBEfP0rWttAjUD5B+VdIYwOVApw6YNBDm2ZcGlxR/w8/Sr8drGqjao/GrIGQMCnBSRxQTch2YI+UYp20dcU5him5oADSDpzQSM0m0twOaAGnnpSbT+PpRK8UClp5EjUd2OKyLzxLZxkLaRvcv69FpXSLjTlP4UbSRsSOKrX2pWNgp+0zrv/uIdxrlbrVNWvpNjn7NA3RY+OPrVjTvD7Sncw3ZOcmsnVSOyngJPWRFqXiO91Fjb6ajWsXeTHzN/hVSzs3jjkacF5WP3m6t6mu6sPDcYhJZQfQ4wK1rfSLRrVmmRnmHAQcY+tc86t9D1cPh401oij4ctVSzjlc4XOAPU129om0qRgknABHQVx1k0n9pqJQMDCCMDhfT/wDXXcWDBUkLMrPkgDt+dc7d2dvLyouwIFYndyTgH1q/DEzOTtH+56/SqtuVbaeNoGf/AK1aUQzjHzDqCOoFIu5Lg7DkEoOcHqpqSNNwO7bj0PRvx7Gp1ACmTAHOQe5Hr9KekfUBFVzzhhw30piKsn+sUfMgXtIMj8DSBBhSmzOez/0qzGCV3bnRD2bkZpThUGwxs2DjamaB3sLBAdxyW3DLHBB+lTgHesao7YXGC/J96rl3MKgkuWO4jIVVA9amjmCwlgMjOMJwCfTNUQ7seF8hz5W1HI4QDcfrSSlIQdzsbhxnaxyfxx0pg88oyq4jY/wxD+bGrFrHHaIArKkrcEqC7t+NNambdtSmbcsiPNnIPyq+Tn/gI/rVkMVVFYiDjq2Cx+npU8imE7hiLd97PzSEf0qJ8RkKvBb0BLuP6U7WHzXJjFggEbj1ALZZvdj2FNZFyGklAboZCPlT2FMETx58vIY/M8Oc5HuaeJYmRmDokg5Cy8Kn09TTIKeoWu9VEbbHX/V4PJ+p9PaoxcLNAy38JUx5W4KqGHsAe1XWkw5bcEdxlZCPzPsPeqN7sWVZQAIDwAe47ufWltqUrvRkOySCQtFKqDZuBB3CJT2HufWpIsXDLbzxlCEWEHqqk8sT+FUBI9pvQlnsZG8yRCOR6Z/DnFTrK8CMXPmpOCAw6qW4BP4Urj5Ss+9GAdlaNGM6l/8AloAcKPxrLvC0DNFtKMityMYZyece3Na7Mu5H3lhGTLz2jQYXH1NUCVJ3zZYDaoOO55aoepUTMvofJQSy7ZJYpAzKp4wMcCqniyVrbVrG9tg0ZMiTpGDgqCfug1fv8CymkcgLKvUjpk54rK11ZZtJ0vUbvqxTZuPKqpqbWvYpa2bOzhtlt766e+kVZ3IliiiJaNM9R+HGa6Jyu4u8cZinwIyvGAOv1rDv47lUs3uIZCobbuZgdwP8RA5Ax/Kr+nyebYv5pUJGfKUHn5j3X8K6Yu2hx7q5fd23LHGQ6lAFYdApPOfyqO8dtjGJCSq5AAxtZjgUWx2IY0kckBuF5yo+XNVJJP3rW6ssblwXJJbAXhfqT6U2NIUqZZpLa3YAxRiJpcfcHcD1NSPlIHjjUYXCKMYO4jkk9zinWsCQsrq0i7syl2Oeg5J+ppUU5ilk+ZI1MxxkfM3TNTYq4g8seeZNwnjQRIufXvUcqhkubdUii8qMIGYdQRzx3qyIyGt4lGXTMsh6E55wfck1BN++hjkKbXmmJHP3QO5qiWzHv7YQO0Er+YSF8vttJ4x9awL9tyyZk2AEy+aQfmA4C/zrbvke6SQMR5ryquHzuPv9Kx9emSSKWQKYkZhHFEB3WspG8LmNJILfxlCZLYvFJAQsQO44xxXU2enZa1lvXZbxizED5hAD0H1rnPDIjttS0PVJlJMk0kEhPbggD88V3Nu3/E1cDaFjJ8od8k5P4Z6UU1oyKzXMkie2gSGM7GJzOWVzydqjNVbpDIN9z8oEbOrp1Lk9qtCMgIEkFy5ypQ8CMseuarywC2a4W7VFQOkSDOCoHO761qzKJSG9i8U5ClOFQgBee+e9Pncv/qlXfbqctj7zfT0FRTT/AGu7WQKoVTmNHB+bjqfb2rVt4FdoS0DLKzL5gH93/CoRbZRgaN7YQ5k2NzIrH5lbr1/rVmHcIUZgxMasygL36DJPrRqUDSZvY49jSyEBc/fQDkY/lS2twtwiGMbpZHUjrjAHSqRLdy0u5QuRjYSAM/8ALQ8n64FFTK8abyvzrFx04dz/ACoqiT5Yg0tdpygHpV2GwRACQCa0eEwMU7YBjFdx83crxwhOG/SrC4A4JpCDxxx9aAvvSEOJBowfwpPwpRQIXHFOVQKAOKWgBymgtz1pqgY6802VkgRnuJFjQc5Y4oHYc+DTMeuAPUnArEvvEcKfLp8bTv8A3m4Wsq4/tK+dftchjQ8hBwPyFQ5pHRTw05avQ377WrC0JUyedKP4I+f1rFm1rULxitjCIU9QMt+dWLDQ1Vv9WJM9GfgD8P8AGt+DQ3c7MFtgH3elZSqs7qWDind6nIDSZJnDXc7SynnjLE1s2ejBELrEkaNjO45Jx/KuwtdHhhfEhC46iMZK++a3dM02QYNrZqZAMMzjJwe/pXO5s9CFKxxD6C6225UY4G5SwxxW14etkuYVO0+YvynjgV09xp6QsRctvyMBVbOw+n0qpbQy6dfmNQAkgyoYfrWTk7nTGC5S1Z6eAGeQgKPvf7P4UC1VLjKLuD9vUVuWdkZAGZsjPzD0rT/swuflUI2Dj/6x96drhe2h5vfaatlqIlVSokHBY8cnr+FW9Knz58a8qrDaevPetjxLaRT2jhiYwvLHGTjoa5fwwWlEjwNmKElF9XA6nFJ6KxcHc7Ow8wgKTg5zx/Oty0hO0E/Kxzg+jDt+NZGngbUA6sCpBPoMit9F2ruGcYWT8fWkkJvUmySiGNcH76KfyIpVjLFgc4wT15VgeQKdtClgv3cyLngHHWmpIxZWA+VkycnoO5/GgZMUCRuSMtnbx/Ee1VHMnyh2YqeipwHPf8BUhl3gYGAw9fug9vqabI5w3O0AbWYd/wDZFDAWGMTP5kxBjjH3QMIPp6mp7c+eTK2NicoDwif4mqcEbSnEi4VekQOOPVq0FIaJcHuPmPCj2A71SZMiQDeUZSDgYBI/9BWrITYzn5hIepHL49z2FRwLznBGefc/59KtTYKhSpYZzgcLj3q0Yy3sU3cKTt64IxHyT9TUQVoY1Cjk/fVTk/nVmUxs22MYA5IXhBj3ppyVIIG36YT8O5NDGnoMZcIuwLgc7AflH+8e9V7jEmN671bqM/MR7DsvvVkrhhGMf3ljOAF92qtNjBLOdpOC+PmkPoPQUFLyI92GUlmlUnH/AF0YdFHsPWqtwBKxDjewIDBTjc3YD2FWJNyZBcIwXLEdIl9APU1GUVEbeuwKnA7on+JqWaJWILchoWEu7K53AnogPPJ65NVZYZYfMliH7v77RE8KzdMepArRjEaHNwNu1BJKDzj+6g9u9V7qYgpAuBJgyPjtnrn8KTQrmRNNG1k6YJyqqCf4QGJxVd7gu0jvuDnLAAYG9un6U7UYmeUPGpO7MzR8ACMHABpufOiUkYBUyvj1PCis7l2I4bc3Aa5n5QERwx9Fcgc8+mKydV3Hw7CZF8xIZ2VDjPHWt0LIFKhsLDHwOnzN6Vh39sz6Lqal2SWOTGOwGBmkxJ3ep1drcPcCBpjIRMoEcedz9MAnHT/69atogtLuIlCIfL8txjjeFyCfesPSzBY6dCqMnIUySZOXHHQ9etWp7rzEMKbipb5UXOcAcD/65roTsc3LdmnNetbRbUeMSAbcjpj+pyaksYZRExcDzNwKof7zep9cZNQaLAZ4i88au+QigcYJ9K1/MWJt0eZDFvY7v4mbgVSV9RSdtEJLGCxj3BYZH2Ko/hVeT+eKA3mzKGRcSybmX0RelI9oqo0XnYaKMIrd/MPPHrQ9wzwTO5KyxKYSpAyW9R7GqZC12GBky0jrkgNMT3GTgYqndO0cTRhdxhh+77tzzT3Uy3E0ReTEKqCR02gZP61Sa5WWD7ZPMFWU5kjzyUXPB9/apbLUSLUPLs47a5klBuY08xs85Y4AGPSsE2RijgnmKZILQrnhWY9/fnpWln7S8t7e8eY+6OMjovY/gKWYAxv5jBiYWuNmMYJ4T8e+Kz3NdjA0q0e70LWEt8GewuxcDPfGD/MV2Fk6zsbjAZpVXZ8wBG4ZyK5bwnOdN1DUorkjyLlhGkgXILqPmB/A/jWlpjyQ/bIoFXfbMY49x6Rnoc+3PFOD0uRUV5M6m7u1tYkESiSVyrAAfMxUen1rBVjNJ51wzFVGQWHygnqAO57Zq9YWaXToJ95VgQSeGcD+QzzitOG2YxoGT/WsD0BCKPaq1kyVaKM+SzRYgpyssUYmOD82ewPrU8c0qyTzFAsiKqMOxz7djzS3StI4aNg3nzAkeijtn0p8m0RyyyNyZCyKOSG6CmhXuV4nQBvmIaJfLClejE96oyv/AGZO8SgNau2FbHCuRyBWnNYmUfKTDOqEu4IOXPTPYj2qBo0ntEilUBo+JFbu59KbQkRNcKrgKVKwJu2E8O57gdzRVe3Vra/a2mAdoR8rZ+8cEUVNx2PEdowM0pp2OKaa9A+YEpQOKQdadnjmgBppVGacqMxAUVBd39pYnE8gaT/nmnJ/GkxpOWiLKqewzVe7u7azBa5mAb+4OW/KsW51e+vC0dun2eE91+9+dLaaG7DzJ8/N3PLGs5VUjsp4KUtZ6C3GvzTZXT4dg/56Pyfw9Kz10+71F2knZ5T1yx4Fdfpnh4Oobyxhe7cL/wDXro7HSEjAAXcVIYMy8D6CsZVWzvp4WMPhRxOl+H5VUMgVVbhmI6/1rptP8ORwBWkjJkHzAy5UN9BXUxWIwZIx8x6sw6VpwWw7kuWHysQQP8axczqVFnPWunqQ3lwrIjdVC8qfXFWhZE7RMT6gIOmPUV0D2u5BkbSODGo5/SnJb5PlgFNycKgBLexb0qG2zeMEjDW2iRsRRpv7hvmLe49K04YJpdo/eeSRjJO0Yq9DBGMeRGEjbpzuKN6n8amkjhEqfbJS8oOGjB4x6jFIsoJZx+WYwC27j5RgKfc1l7wbsWF3hZScwSep7jNdWgJV0MYSN/lcv/Cf4WxXMeJbWSZTIDtuomI/Edx9aUlbUE7nYWcKW/kxyxFBKhRhjJ3DpVqRvtEewFVLAY9Aw96z9MvV1Lw/aXUQkIg2hwezdCKuhfLG12JX+Mf7JrZGSXcwtcijltTIOoOJEK+nc15/phks/Fksc0YRJE3qN3Ujqce9epQQK63UUoRsHGcctXnPjOYQ3trcCJVuoJD8w6YHBB+tRNW1NKbbdjo9Nj8uYop3J5gIGc4FbqTfudrvn5VwPxrmtIkMQjeQfJKcgjscdK1Gl2xhhhhnt6Cs1K6L5W2aM8vmMfdiDz1Hc017hfLYkEAnJ9gOgrOSZs/MCe5Aq3EAWHmkMAd2OxNF77DtYsW8jSt/dDdT/dH+NaCxD5GJxsHyjr5Y9fqapI6qR5fJ7A9PqauIW2fNgAruyT/48f6CmhPyJWTA+78pOdpPJ/2mNSIcsG5OBjdjv7CmA4iGe5B+Y9fr6n2pVUu7hc5bnj73/wBar0J6aliMFThvlPUAncx/CpJv3hwDtzyfMPI/CkRcIQjAcZxHyfxNTlQoCBFXP/LNep/3jVrYwlLW5DgD5sh+fvtwo+g7mmOx3BWJDZ4bGXP0HapJZQ8u1cuR/EBwPZR/WoG3Fdpxx97ngf7x7n2pDjruNcZ+Ty+CdwQHge7t/So5FYOpU/eOPMPBx32D0p+/KAKnzdQpOP8AgTe1RTOWBZ9xBIGQMF/9lR2FI0irECoGcbUB3EmNW53f7be1G8MdwxIofJXH+uk/wFKJFZZmfgA4cqeo/uL/AFqKR9is6AGdQFRQOIs9v96lcvcSUqQwmIKR/vJmz95z0WsxyVT99kSSfvpz6J2X6mr0/kRuUOTDbcsOvmSHtVVomuD+8bcFO6Yn+JuyfhUyKiVLveyFnG0zENIAPuRjop9Kqkxs7yr8scj5MfTCrwAfrWjI0jbyRud2AIHTPQD8BVW5ttrswyV64XuB3BqGU9CD7QEx55DqWLFl53Beg+lYzTyS2OrImQXYMylc565+lak0caqwYYbgDntjJ/wrEhnV7q/3sv8Aqw4Q8Bj02+9G7SJWzsaGjQXVzHEtup+6AZH9cZAGeldZZqPJjS3mBmZwp+XBBx87MfYVweg3LPbww3EjKI8r0wEGecnufSu50qM+U8caGFJMKjMeQhGWbP4VtBNmEtHY19MSUOBK7KvM20Djjhee2anR/sijzNpVF818NnLHoPeoLaVLlZihbdMRGDs4CDrg/Srs9taXMSTtKRDI5lw3VlQcAe1aK62MG9dSRHWO5VGZSsaByWXkSHsazr5nklimRFM0OZJQDkcdqkSZpbWPeu4zyl+RnCD1/Sq9wVeOMPhIbyTnsRGKbeg0rasYWS8RZ/uM8iuQDjYnbI/pWcIBcTfbGQPbBysaZHOO5qzctGLo/ZifscsxUoPulsYBBqNbcK8kZIeMBEUHjDNyf0FZbmyQ26U3EbDBxGqLwOjMf8KpaheC1d5JAXHmbgmOflGFx7Zq/cXTPNvhUiN/3gJH3tvCj6Vk38DG1jKEmWSPeSRknng+1J+Q0lszIs7ae78NapJCXc294syFOu5V5HtwcV0GnW9vcW9pcwMFWb94gI5wOuD396Z8PGtoNI1+J5lEjTKxcnnkYzUWko1le3NpggKPtNpng7Dw+AfzxSjsmTN3lJdjrLSJWilaB0LgBFz2Hfn61auOZJGG5CuIlx71VslK2tohRVZssxJwCAc81YGZI0UuAJHLkHnFbIxIPLS2nZpCgjhi4HOdxzzSxJtjgSVAYWHmvtOTn1zURTzohGrEm4fLAjoo7/Spxlt5C7Zbj5AT0VV7imMfHh7cs2HEsvCE43DPH+NVr5PKuftUSZMPyvu4EjHt+FLDcDequVCxR5QMD948U+SAh44ZZo0jRfMmGeA/bPv/AIUW0E3YwNckES288hBkjfdOACDlv4T+FFXdSjIiMd46maQHzmHJwB8v4YorOUZX0Li9DwrtSYPoalSI85yAO54rI1fWorBxFABNMRn2Feg3Y+YjFydkaqIxzx+dVrvUbOz4klWST+4hzXNvc3+osQ0pCH+FOBWnp+hl2ywJrOVVLY7qWCcvjILrUr2+BSBfs8Ldl+9j3NT6Z4flmk3OjE4yzGuo07QlQJuUEk8KD1rptM0oM+HIjjU5PHH0Hqa5pVHJ6no0sOorRHPaXoJ8xY7eMyS9AcZx9B/Wugt9BigdTOVluOpQHKr9TXQC38qJYY41hQ8H+85Pqf6VchslhKGbKA/L5f8AGw9T/dFZtnTGnYyLewEhVkUSY5bjCgVZWGGI7cLMeoPQKf61o+U7fIihfL42DgY9zTrW2LynyVDeu/7q/T3qNWbxikVPLZG3zhQ4Hy7xyfoKsosa2x3y/uj97Jyyn+lSTosQUSkAZ64/eA+/oPpTowwffsjtwF6yfxj1FBdhoYQoGCkHoHDfKfr602EGU7Y4uc7imMKcdxVqLyhl44XmiH3mlOMH2qKaaa4YRrukXPyhBhR9TSESiFZUM8suY3+9HCMbcVAbiGMLFBEssw+UMozvB/rVj7A4LG5chhy8CnGR6iq80ltErJbD5f4Sv3lb3qrE3Q9IJJVAmcrHnYwHB9s0+9to0tXIQHjy5uNxHo4qCSd3cF0KM+FkC9c9j7VM8wMP73LMMpJH0zjuaaSsS0yl4UnXTTqmmToTHMhmVe4PfHt0NacVzvihYH5jEcknt/kVzstx9j1+ykYCRuYvmPy7SMc1Q+3/AGK7e3kJPOEfPb0qVKysLlu7rqdTLefZZpcyACQenrzkVwmvwRz22prIT9p2LNHzljg5INXNZ1F3jBjbc4G0dzWHNdk2rywojyOoD5HQ03JPQtRa940fDmpK9tEBtJA3A9c+1bUUo8tRGDk9QO3rXnPhwGyuri3LZkWTKqD69h7V6Bp6+Wg7s3X2rM2n7pqwAod8jAsfmx/IVKAoJ6lfpyarIxYsHAyB1PrVtCcDPJPI9aaMx8BO4OQpcn7vv/hVy3kwu0kMPvZJ4z2+pqpEBhzjOTj5f5CrcIAK4XDEdR/T0oQydcs567jnJzyPr6VchO3YEAyDleM4H0/qarRqU+4AeCSSflH1Pc1Kkny7QCR7cJ9c1aE1dWLu54ZMhxHEfmB6sfah3HlKojwerKT29WP9KqIxwGLcYyJeuPZRUq4IKsvBG7y84P1Y1dzJwJjL8gYklG4AUYLn0HoKhMgH3iuB1P8ACn+Jpd2SCWJyMA9CR6KOw96gk284AG0cEHKp7k9zQEYgTgH5MFjkA+n95j/SoJW6kyEs68Oeqr3fHb2oEoCIMkqW+VP4pG9W9BVe4bDPk7kBxIV6yN2RfapepqkSoUESFeFUnyFbnPq59qZG2I94G9ycQ443E9XNMfPlN5hwpOZdnYdkHr70odo0keUbHIAPfyk9B7mpsNrQrShxLEtvtJJO0k/fbu34c09ovJgCx7m2ttXPO9z3P0p6qxkRsqsrjChuka/409irAeVz/DEPRv71NIGyEpHG5EZBEQ2A+sh7mqcy8+X5ilR+6z2OOSc1ZmZI4yVkbahxGO7uerY9BWXJJGGUFht2kZbqV7n8adidypL+/L4IVWBbI7L/AImubtQi+JpY2QNIISxBOAMY7etdDLIHj+6fOfkL6L0Uf1rltPMUnjOGMl9vkSRl2HLZH+P8qSVmP7L9DU0pA17dRJGWSGbexLYAQ9QPfNdvp/mTO2MIWIVYycj5iCBz9K5RYWN8BI4CFBA2FwDnoT+NdHph+RpJFL+USWwecn5Vx+WataMxk76nUJ+7Sdg5D7WiQhcqAPvHHueKqXbq0TCHh1iS3jXbg7mOTikt3EvlxszKF2owU9hyxHtnrUEtykcySqgkm8w3DgHAHZR7etW3oZKOpdl2ASTlgyogtowvG098+tZlzcNegxRIVWIBFBGCVz/F6ZoiXfJDNM+1xvdiB8q89eep7Zq5Ahie3EiPtciV+5Y9gPb3qd9C+VRRC0CJHJHyJIG3sSPugfdA+pqmsgKRzzxlkct5gUcBjxmtGRDIj/ZvMDXE23k5yemSfzpDFFLc3W0/6GgAcDqSOi/nScbDUivKrW8ckKD94AsSY5Dbuv6cVXvpEtpbi4hUtA8awLnjYehH6VpWP+qjt5QDKjm4hcnnaM4Q/Sse7m8uyfewENzIrOGH+qYknj8BSFe7MjweUNx4ntXAkiaGKRjnACh+efWt3xCrXSC/tYXEsJWON8Y3KO/0INcb4YluI/Eeu2cMTSxz2u6VV+8EDZyPzr0ixNvMtvZQ7THGsfmJnhj0xjrkYopq8LCqu07/ANbEdvKqxzElyki4jVuuCccfQ1e8s/PGFA8pVjXd3Prms2W2WC7dEwsclwRHu/gcgHH0P86vQSfuVRmYOpaRwy56dOfStF5k+g9nSAs4XIRAgI4w3fjv25obdHG2BuaJNoBbPzHt9aS2H2gwEuOSZm49eg+lTJgKnmMr75DIMDHHrTJIJ43fZGoCnAeQgf6sAcAe9TzJFe2ymZJ1Mv7yQxLkMB7+9VpzL5i/umeS4JOFboOwPrxVy5iuZZZ3jmCo6CONRJgIQOfxqkRN7GRqDPJeSt5QhFzEFWN+qqo5NFOaDywr3ThpzEFZt+4L75oqdGUnofJ2panqdzCd8pCHsOBil0WyN1IWfLEg8musTRdqSNImVDYxisxYpNLvEG0rbMeCR0qJVmOng4rZG1p2lKrjI5x+Vddp2nBMfKSex9KpaT5JfJOdygge9dPZsQi4+7jPSsue5uqdh1pZxpy+N3U+tX4ByemUUjJHAPt71Jbxx8vxgMDmp4hLjIT5IWOWI4UHvT1KSBC8Lq0YzOV3gkbiPf609tsYIkJLygHjkk+9KmQwVXAIGfMI++PapgnkgNGPnXOW25LqeuPpTWpRJIryKDMPLdQDGo4DY9algYBQ64AJ4PRYW9vWq4C/KkK+cMfLkng9cZ7055URd1wd4f8A5ZIcBT3B/GhspK42VpGuGaNFaYffZsBceozQsaOx2brtyQEc52oatQ6fPdMr3OIti/KvTcvpT1vbeFXitYt0b8MuPun1zSs3qyeboiRNOllJkuXUzryU6DFMe6ht5DFagzbvvQoOAfc0kgkkVRqVwYlHCqnU+gp9u7NtS0gWAk4ErdTT9CG31KktvcT7DdzCGBvugckexqOFI/8AVW0S+Ymd8jdCKt3Qhgysk0ZlP3x94n/drKN3PvMVmojAGVd/vMKHoNaokuZFCsXKhZPkLfxMw9v0rOeSTzczKURMB1/iYe9K8kdu7OMzXLcFWOT+ArNv5pI/mnZS/GF64HualsqMbkGt3DSRw7UG6Ekrj0z396x9e/0mD7RC2yTbv/H0q1ez7oG2jGcg+prFurwvZFHJVoziovc1jG1jK0vUvOYJK53BsHJouNTW0u54xtEbcgA9K5qVni85Uyr7ty+pqxZzi6t3juCFmcbiO4xWkY2Q5rU2dMVbTWI55DveUdM9PSvQNNcmPB//AF15Xo9y08gEgIlhbj2FemaZMNqE9ccVDViJO5uDkrggADOPerCNkAk9RkVVtwGAeTO3NWU/esMHb/P8PSkhXLUMhKbOP6LWhbsHT5hlR15/mfSs+JFUEcEjkHtVuNhvG3Oegzz+lNF7mgvzLklSo6E8KB7ChlBwiiScEdMYAqBXABLOVI4GfmJpWlfldxC56bufxPpVp9ybPoIfllAaVWZRhAvb2A9anjf5QXBU9SGPH4+ppFnLosJKgE8MBg/RR/WolKhTsXYhOA0nLn6CmLfRliSQMApErE5+VfvN/gKZJIBGFyvH8A4RPcnvVdNgbYhkRm4MYOXb6nsKcyvKNiiNwh5U/wCqj92Pc0ybJEThVBmEpKSfKZAPmkPog/rTZFaKUEBY5EHC5+WFff1Jp4by080yhiTsEpGW+ka/1pjo7TbWTYR8/lE5x/tOfXvSZSdnqIf9ZDjCnrFGe3q7fWopJMruzuRGyPWR/X6USmMsTGXkU43s/WQ/0qFz5jtnLAHaMD/x0UrXHcGkOxyxJJPPqf8AZFNacqpO9FLjlsY8tfao2ZQAxBbLYAXJ59M/5zUDSpCykwb0jxuVj95z6+1UlYzciSaZAm7yygCcLn7iev1NZF5cAIz+WeFBcMO/8K/1q695ul/fJlQ2+ZlH3j2X2ArNv50wrOxMjElVJ6Z7YoaEpWKd3c/unCNIZXOTIR0GOT7c9q5G2vE/4Sq0mAkMYBEhHbjsK2tam8u1aPeMtzIxPt0rB0aQNqVnIsYZhwDuzj8/5UuporcrZ6Q8iXav5UBhxgspPTjjnvWvpMm8pLwc8SgjA3KOPz/pXPWT/MEJyDnc7cZA5Y/nx+FTR3gtLrzJWYwyf6wYx16U27MwirrQ6cyKpZPnMoUQq6fxM3J/wp37lGnV41jXd5ahT8qt3JPc1FbSNLAFRBI6AAAPgbmJwfdjU1rCXW3W72ySG4KeWfu4HU/WqYkyYKC0gfcyhAqMV+VQemB9e9aRiSAvFnNxgQxtnO5iMsfpWfPM620tyuxkNyoUjngHH5Voh0RyqOwiijZ1fjiRjwPxqkKdwhdYI7IEMIPKBlPo3Y/QVWkhFlMoDM9v9o5BH3h/UZrSeEzwXkIkJaCFUXdxlyMkfyrM3q6RWTI4mtfmweT09e/NEtCIO7KupboWFxGSXtsCRSc53n5vyFYXip0itWUS5VjuUkY3AAYrajwwtlYE7y80gPUgdAa5XxAfNsY0Kj9wjEHGT8x71lN6M2gtUQ6POml6v4a11tqwX4azumJ67jjJ/HFdjBHHa+J75pcxxmNpHbPJ6Yx+XFcVa2YvPAkNowVRJIwiPQiXfwa3bu4u9W0a0EasbqZBHI4HMfl/fJPrwPrTi+VETV3+Bt24+3PAXAa3LmWSTnnIO0Z9fpSxF2hzONqt+6UnJ5BGSR2zV9IUZbBLWUyQInb7rEDIIplwnnww4I35LIRkliR3H6Vo09yU+hZafZDcSFlC8RJ329PzpjzLudoyqsqiBM9yaztOuHBignb5lctyQDn0JrStGlmWJ5DF5akuQozuwetCdxNWHiWKK4dntnYRJsBJ4z7U5nhjBM8CoUQt98kBjUcbRpFumdmDsZmyRtVc8fjWXPI15MskqN80mRH2J9x3x6VdyeW5i6rqixXLpCki/aF2QwKd29168HoM96Kbr1sulaxpV6zxzTyymF2/iwRlRjt0xxRUWfULpbHKzWaJBOxXkHNUrzTI57NDNjcVzkDOPoK6K6QEMhxu3kFew+vqax7l4/sqyu/KNjHf/wCtXK0d8TiYZZ9LnmchiiN0Lc7T3ruNIvRNFE24/MMAg1zuu2jTgzW55dCu4D7oo0jfpf8Aodw6liVaKTn94h7iqUdLlSafqenaao2gttOeDz+v4VckGDv+/tO1+6/l3rG0li+DGCUIwwB5NbqhpHQIQ8owS2eCD0x7irWqMW7E0MQjVIzkvgvEcDBHoallXKko4RcfOjfePrj/AA70JEoBiORI2Nu49DnjmpYrcsQbgh5kGGjxj8R601oTzIpjzZUKW0ZhtQ2d7DGw+3oKms4oLZh5Kme6b73dX/wqxcKJEy7P5SjI55x6Goxch08vT18rBDDd0FJod2yW8jJiDXk3lwDlQpyVqmLgmJvsUSwrjBmb+IU1gZ5yHYvcdzkbPx/wq1ZTRpIu6NWvPujHMZ/HpRux25UVoI0jw1urXb8HzXHyrUs0dyUzd3YitznBU4UH0NLPqKQsyoA92DgwxH92P8aop5lxIZJFNzIpJNsvCr7n2o0BXerHq8e1vs0caQBcmSbG4+61XmlWSPNiPLg3c3MvUeoFVruVJvmnH2l0HyLuwkX19cVRnu5JAJJGDKvRgML+VRJpFqLLNxdJbqxtgRL3lYct9PSucupFLkE4Qncc+tW7mfYhkblTyCT29hWbcr5bF524YblRe3u1Zu72NIaEN0XdWII/qaw9RP7iQL1Ybqv3dySrAtkj8M1i3k+1XyQQP6047l2OV1C5xqCM2Rxjp1qQFPKcLnzWbcH9PaoNRwCjfKSGpssvmRF8lWAxx2NdUVcyqS1I7LUzFrqq4O+X93tHRjXrukOY7ePfhnOATXhDyva61bTvICokBJA6Z4r2PRLsyRR4Jqa8bWZzUZOba7HbQlWADH8O1XoiqoQcZAyAOKwrWb1OQD17D6eprUQk8E8HueKxRvY0YyrkbOQPyFWFkwvAbHcLxWTbzeUOSSvv1qy0pfBHfkb/APChlpF4MuBsGf7wTr+dWocxpyFU+ijcxqhGzMmCPlB5wcLVkMiqcsBxj5TtH4mqQMnxh9hbyznnHzOf8KjmO2dXJkRWGFZuXP0UdKZFKjOVhaRxnJWFcD8WNStwNsaqpJwwjO5se79qohvUktolJCvFt/i8uNss3+83arEsqvhUMZQH7p4ij+v94+1U4XHzxIhc5OY4z8v1Zu9SRuA6hhHJKFztPEcfv7mqRnJX1AgpiRfun/lqww7D/ZXsKqXcgiyjeYsf3nXqzn+EMf6VfWZTOfLYlsZE0gz9SPpWVqE6TFYoQRFuz/tP/tZ96RSZC5dYg+3CscZH8XstRO+yLywQZOmAefp/jT9RmKmPypCQiAFwOFPcL/jVBBulLMpwO2cE+w9/WnsS2aVvkwFosF2yBkEbcdX9PYVRnuEiTEaggKVTIwTnq1PmuR5DxFv3andKynG89kX6Vk390rsm3DMM5weDnsB6U2zPqNluR5e1VbryfQ1XnkXO9z80akk96r3ey2UrNMuTjgd//r1Epae3BV8IRzuHesnMdtLnP69exi3kYqWkbpkcisDRJ5RdIeAVYA7T0zW5rFgZ4nO1gzdCO9Yem28kVz8nVMHfjv70o1NdTWyaPTYX3iPIYg4RFGD8o5J/Gr9yiXELkFcDg+rMe/4Vkaa22ONslAwCptAA9zmtkKxRGB4Tkg9Sa0epEPIm8H6n9jvY9OvHXKtmOQ8DHUqf6Gus8tIJbV4pGMAidy5XoSeo9a8+1G1E8CH7sv3yVGDxXoHhPVf+Eg0B7WRo47uBRDICOWH94exFFN391jrLltUW3UWyRJ7K0tFBPmN50mfQVLpyqY7e3nACzymdZs424PQ/pVQsLdbwq535FtC478gFf1NXbqOPyb5toUWkYgRXOMt3+vWtFqjGfZlzLGC1jZifPnMjMcbtq5/TisPVS0kbXcfEouGyynB2Acj6VeM5gkUSMWhsrU5cjJDMMYrPYtFbwxHlhaM7+xY5z+tTN32HTjZ6lW/nWSNbq2barwFVQHOwZAArD1khILxhhSCiexxV5dtqZLZgSkyRsufvbuuM1l64zNbSnHzb3Y5/LFZS2NktbIzdMmuLvQILe3iZpDJJIj9gFOSf0r0DTkt0+xx2Y/d3LfaDLu6gryPz7Vw/ha7L+HtI063kUSy3UyuFGSqbgS3txXb6G8aJ5MBZlsGeOJ+wjP3Sf1rSGyZjUupP1L+k7LeKxRSSfJdl9Mjg8/lSsqS224uso8rPcYOeBUVlIfsts+zDLA7KzdySeQO/FS/KqQvGyllQMFYEA/8A16shENzYgqbiErK6oqbccHnp9RTtOmkm3Q8tOcRjHAVR1NIWYfZ/tTMgy0rqepPXIx+VMa2ZYFl3GIEM6qh+Zuf88UJWZTelmWlkhhnckq0pyEBHyR47D1PepLkW9s89zcRySLbqEG7/AJaOe4FZd1cExCFlbzkAWGEDvnqfXg1PewyzRr9r1GRrm2njWRAMJAP6n3q0Yz6GD44Plq8sRxOHilt0xk+ZjgHPpz+VFYvxNvLi3gmjLq7PMghYAZfIzuz1HFFZ1XaRtSjeN2JKzyRK8I+TPr3+lUdP0qa9upIrgNGpbhmXgKTwxra05I7WW7tU2ieCTCgnJPcH8q0r2/trqHzfPWMhCrA8s2e2OgqFBdTWVSW0SDR7ZfDmoz2F15TSQFZYmdMiRD90gd/SuU8fNbjVoHtYHRbdispODsD8hTjjg5/A4rp9Ymk1DQ7e7yBd2DBR/faE9z7VlatFDfWk0cKOv20eUo/vyKN2T6+mKvdcqM4rlam9yPRJmRcRuwAG9c8Y9RXWaesc7MqnHRo9x4IPVc+ted+G7p7iG3ZVYTR8Op5Jx1r0PSIw4D26F43GRHnHzfxbT6+1ZRNp2RpxYLFSpcYJaM8EH1qSV3ZF8lSwXlZP4lHvVWSVd6OxZlGVEmMMD/tCpZbnYqlmVDjCzRjI+hHerMktSOVNxXzyzzMPlKchj71YhRjEwRDgfegJA/Ws25ubiUKqQrHzuSYkrj8KrvLNKyG6vCNvA2Dg/Wp2NUmzVmu4IcLJtuQw2+VGvT61XlmuLqL7OxMMGOIUXkr7kd6hinRE22kflTdeDuJpHabo00m9v+WCncxHuegFDdwsOMBhjCLbzRhhhcYyfcntUUjBAsUkquOvlWxAwf8AaNUZ5DC2ZHETKduxZcv9fpVDz48gXOdu7/VRf6w/j71JVmWpXt9+1FeeU8DYMBfbHeqt9MsM7i5CyXYxtjXHljjvjr9KqXN/IVaBIxEmcleh+jHqay7meLy22YznBJ+6Pp71NzRRLF5eLCXuJtsl0/RsZRPwrGnnaUO5LHPJfPWmXLIobcxV+gPbFZUsjMMYCoO4OM0NXLih0s65ZAwbjpWZdSbcLuGOuT0PsabPNtfIbd/MVn3k+eD989fpVRiVJpIy9VcOzMCFx8233qJ5/NQZ4bHzDtSXj4hlGAwPes6SXCjqCOK6oROGrUKeq5YE/wB05r0XwXqIk06LnJwAfrXml4+4fMcmum8ASsY3jBHyN3GetVVjeBy4Wp+/a7ns2n3HyKcg54VscZ9hW5b3K+XhmCn361yNllFRdxDHnPWt6zQfedG45y1cNj1GkaKSF+QGxjORxVyGUnqRkjqB/WqWAVyGHQDpk1ZitvlG/jP944/SjUbaLPmOw2qwz3x8xNW7ePbtZ4xkHOZm4P4VXtl8vlQ3p8owPzq4JCuFXYp6Er8zVaWhm2yVSs7E7XmYcnny0A9vWpFeJYTvAkQnkZ2xqf5mqs74UM65BHJmbg89lpBMsgjC5A7MPmY/7o7CqEX9+8Qhs4YcQp8u7/AfWmXqm2aNZdrZOUhj5H0JqABt7JDhGA+bDZyPV2/pUTTDezCQuAdhkxjP+yop3JHTt5N2RcbJT/DGjceuD7Cqb3ReZ5JQBuXHyj8gPSjUZ0MoAKiQkI7JwAB2H9feqpfeWkf5Rj5RjOTnp9fWkMfGTc3KZTEajCqp/M4ou5NsgjQkEEiNM8ID/Fnua0LdI4LNpfNzLxlgc+X2x7k/pWPfyKsTqgUHgk9x6D8arZXMb3ZTvZzIyxx8gEqgx1PrUKWy2YPmnfJJgsegGOlPknW3UyHhgMLnt65rktV1m4uboW1nuMj8E5yfwFckp3ep3YbCupqbV1b2csTGZCADnr0qO2uILIBEYnrkdV9q57XLHWbKxilu7e7QNIVDgfxAdMD0HNZ8etx26x5V5g2D0wSe4xUttPU6/qSqwvB3Oq1ESCMs6eWrc5rmvKCzMTkInzt0FdRqF2mp2YmtwViIBIY52jpz+Nc1d4RH3JnnPXNEdzy46aHW6KjPDG6rlX+VV6jjqa2kQAFlH3OFHq1U9KjYabCzAZMeVH90ep+tbKhFlVowNkCcnHVjXUCEEKkOo3EKFUsOg5qtZXU2haxDqNsNwHySLt4Kk4P+NaDFo4QMcg7zGVyNx6UlzaeZCY9pUoihvxNJp7rctWa5Xszptbliksraex2OisLknPy9eAQO5Jpl7umklcZMrXisQTwRtHFc7ok/+jvplx95RtDsP+WYbJ/EVrWzfZntF+byt0lwQeSRzj+lXzc2pl7Pl07Ekl19tgnKDZ58yKwPU1DqkhzfzAbllZYUwensP0qM7tkLxbFkRXmwP4gTwDVRneRfL3RookLn5funHQj8KlscYpalG6kMxkEa4kVk8onrxn+tZmpXDSWBlk5cI5ZSO+etaMmXdQFAkUIMjrknNZGp5WxlbIVH3Bu5ABrNmsUVPCfm20NskCxpLcXD+ZKfvYxwoHQV22kygajM0nlEvaZAJwMg8Z98V5boF2UtLOcu3/HxnAOeCSM49a7/AESN1klkdZWYqCXdeevHFXDRJGNWOr+Z0dhKzwwMV+QW5GGbGDnOa0xcIoQQJ58/khVQ546dPSsrTY5roJFAAkMaFWnfkIT6VcgdbaF2sx+9CZaTqxHrk9BWy11MGk9i80Zt8tL+8nSDlQRtXPv3rMluXjkmFoxkGACm3IQY6Z9aW8uUfzEe4giUogyWJJHU4WmC5e82x2MWUVz8wwi9MUr3egJPqNG1cNC5luiciQH+HHIx6dhRqMzRwXkh0bUpXdVeb7OMeaB0A9z3FZt8z6dHi03SSON8irgn3I9sVZvftc0zX+n30L2LopiLXAQRLjuD0NXEyqbnB+MYr+51GymvrSS3FxIHCFSFUKoAQH2H9aK6i9nBvtWea9insxFCsMRfO6deWdV7CisqiXNc2pStFIxbcCW/jXMUXnoUZ3PRlPGD24NXLe0Ml4sVuiyOh6/wD/GsayE95pUGqvH5qROGZVGEK+2OvFdugAsYpEAEEzKhn67O4+gp/EXflGaXYKmoy20wMrXSGKQFto56Z9vam6Efsws7eVYy9hPJ5uQcrtPH1zVpm+zFXtHSVIHDCTbnOe9JcvbWHiy4F0jNBdRpdBkb5ge4HtkCrSsZSbdziNa01tG8dahDArrDNi8hHTYr8/zzXWabcxyIjghVkO2TB+5J2cYrjPGGvJN4qtWhlG6NTCF29EJyBn+L61sae6oWlg/eRN8skXdT/WstFJpGyu4ps6m4mLOWmKLOPlbBwJB/jVSO4Ctm3IUjqjcn8KzJZy6jbKWRuhPVfamKEA3O5K9Dt6j3pNlJGyZGZHdW2sBhkYk7qoGZOVj+ZTx5YXcVPtVaW9gg58sykdHduPyobVrqbBh8uALzvVQqj61NzSKZZKzmHOzy4u0krbcf1qNZ4MBbq5eWMdRD8v61k3kuXkV7vcw53IpKn8TVJ7gsR5hHIwWTnH4VNyuW/U05bqFXlSCOMRk4yfmk/AmqdxqawrItuNityzNy+f8AerOuLhI3BRTIR3bis6/mkJ3GTaD0BGfyo1ZSii5d3JYbi6sTyQclqzby+IJQMCcj5COKqz3DS5LkKBxk8E1nTXSopCZDevUmhRNC7cTqMsSfXGcisy6vOpUc57cGqV5dlizMQMDjjms6W6Y8sWJxnA71tGmZydi9cXIWPJcEk8jpzWRc3C4+98zetV7i8JB255NUZZCqgtgenetowsctSvYdMx2dQQxqncOcEA9KZLcAdetUJ5tz7UyznsOTWsYnm1a13YSeXJ6k/hXW/DgM80qkMQTuUDjPrzWZofha81OVWuVMNv1I/iNd/omnxpqEawoFWOPC4GO9Z1Zq1kbYKhPn9q9EdxYER4bbn0UHnPvWtCfNGArEFueckCsq3hZEIXnPBAFa0ChckhgoAziuM9V9zTtflc4z7gYq1EDu+U84IP8AERWdA2ScsMg7cYq8g2gcsCeTtHWmiWWEGQSy7v8AadsY/CpfOJxHGzuF5xCNoP41SeTa2AEDerHOKckrODgtKOcMPl2/SncLF8MIsuIoYsjGZG3HBqxIyhlUSNKNuQkUez8zWZGQw+Uorn+FAXapopWVcMfL3fKzZ+d/b2FMRYRBllkUKQSVgiP8z6VBjfMXyMryzL92MD096SeZXd1jVYY+A7Kck+2e9MjbymT5winOAR91epJ96YileP5uoIFQBUQBVX1/xNTsFiwN+wAfvGXsPQe9VopDcX1xIjOCTgEDovrz3p7EZGFPlhv3aH+I/wB404ky7Gjc7iltErBQI/3ScZUE9W96wdQOGIX5l3bQegJ71pggbt7ZJGZGAzj/AGRWbq/EajgNjhc8IP8AGqmtDC9mcl4huHEm3JBx8ozxU/hLT9JS/iu/ECzyRIc4hGc+zD0rG1uQ5Xdz3x7Zq8LiNLBVQ75HTLjGMH0964k+WV2e7G88PGMXa+mht+LfG9tfpd3IuRYfYh5elWsXyuzEYJdjxjaK8Um1JrrUklY7RkHaOinvWh4kaUAZH7tmOeM81zsQO/cFwAc1uve95nqYTDU8LC8WekeGbppbe/VwWhgG8tj7o/p1q1YA6hfmG0zvuMxoGwcL/nvWckLaPokVixDX14RPcKpz5a/wIT69yPpXS+ENMdpInfCqrq80uM4APQUlG2h83VtKTmtjtoLJ7CHyOZFhVRIw5y3YfSpoFxI7g4MfzEf33/u0szxNdT/ZwTCCRGoz857NT7JJIpnIVX8peDnox6t+FatW2MoEuIwWErAuhLPnj5vTFSW0hXbHnDMd7kjOFpgizh5fuEgjIwW/2jSg7nIGQsmW3Zx8opF2KdzCwaK+hGGMjYGeqjrWrLIJrSa5HDSBYYlwc8kZqO1w9xGZMkYeRwV4UYwKNPX7PdxR3BPlOBIpZujdqnYb1Wg98wyyoGJxshUqPQ9Kp3SyGRp4h8xL5XqT9fWryh4pbcsSqyTNI2euRnA/KqLOXjHXnzDx6UPsJamTnzNjMdqiQIQTz0rI1qICyUyOwG1856cH0rbulJlcHiM8n3OBVLXIB9mmTbgKDu79ah7FX1Rxuh3jy6WqLIgFvuIAXk4bPWvQ9PMlx9rcOywEKxI459BnqTXmtgzNbtAm0L5zptOc4I7e1ejaHM32fT84VQvyjrk461cSKsdWdTK3lWkVuwVo44srsY459fU1E72YWRJIpZZCq5xIcfTFVYm2j9yWYklQo/hNPeaAl1ijaS5DqoIJJX8O9Wc/LYtOLZXYWdpBvLqFZlLAce9RTTpbmEtiS4bcqLDjAPbjFVry5NqfLWOWS9aXcqk8kkdDjpS7HspFRzHLeyqN0xOBFzyv/wBei4WFgiaCdCTtuOTkHAHsKr67DpmnHUHk0a1ngtXjdwxbeylsFj2HPI7VFqQeGONUaQOQVKnk5J5x7e9WLucaeXNzrKfaYIhDODa+aCnUKQfvYNawZhUvc5fVIv8AitL92jjjtpoozEqDACFARkf3uefeio7Ym8v7vUbe8fUV3K8jtFsJA4+Ve2OmKKyluzXZJGppj/2XqLadqNvJbabc7ljQtgxnoyD8efoa29MC2wudHvGZY1VtpPRkP3WHuKpeNDZ6ravM144ljw5Pl7VEoHBA9McE/SsWx8QJewQrcTSJewDyxI65Dg9QT1A9K0dosSvKN/vNAaiLaefT7x08+2J8uROC3oc1U1DWZNREJkdvPtgYzhe3uR1FcX4pnuor5JEUblPzOpzkVXjv5EZJ4pCwI+bac5+tZufQ6I0Lq47xLbPLfw3DbBHux8vGea6fSpzaBVRsIR8rHr9DXM6xMLnTw0YJB5BPA471e0mRpdPQM4yOeTnJqGzRx91XOrE2754yVPcDsfWkMmTuYbW7HPWsWC4lU4LYfHI7Gke6Kkgtx6E5pEcpflmTJzIsZ656g1nyXMYOJGdnP8Kc1Vkuotp3H7nYrk/hUC6jNsP2UyLn5QRGF3D0zTSNE2ty9JLMkSuVMMZyMzt/TrVa41ONVZVk8wEAfJ8gz9Ky78SRANPIqk8hS+8/jis+4uowwIcMQOirsAoUR6M1JLonb5shKjn5vl/DPas6a8Af93hAB/Adxz9TWXNqClSApZQef4qz7nUJSMgBR6kYNWoD5kjRluQWZ2dmb3GBWfPfqgZY9u/ue/51mzXZPDOT7daqTSjJIPzelaKnYzlVSW5ZnunLMTkEe+aovOOSx5NV5bj7xOfc1WVprqURWkTyuegUZrVROGpieiLL3QHYLjpWfcXbM2Ey0nYAcmuo03wPqN3H5t6/kKDjygcuf8K63QvDljp/C24jnH8cvLfnSlUjAzVCrW1eiPO9O8M6nqG15VNvFnq3U/hXT6doEemzKttCJJHH325I9/avQRZDcF3K3GW9FFWrTTjCjEgbmzknv6c1jOu5bHZRwdOnruzH01I0gVY02sgO7I6mi0UxlLgEEBiCB2Ga6D+zR5u6JAJGGNrHNZOn6dcyre27FgFYklRjGfU1hq2dT5baG6sqlon+UKwwaesux+GBBPQiuTN5eQJJBcptkgbc2TgFf6iuh0+ZbhEfBJPIGM4FGvUaib1izFBuzgnOFbpWnGBIDuMmP97B/KsC1d9oGPlDduM1sQzHYu8YXPAfn9aZLjYstmJhhWI6cx8//XqOFCVDMFUZIwI85z+maeXBwrM8RIwpzkZ9aWOQ4YOXO0cgthd3tjrQJD5DskKhpGYDbjAXj3xTN/l+Z82GHyySEYx7AGgK6BVzukzx7k9c1JOhKKXAY54B5Ln1NFwsQxI7KZEHyIMqnf6mlkzJceTuygYF2xjdz0p/CxnJ3FzgZ/jP+FKihJEKZLdFB7t3P0FNCa6kbHdfXImAJDZfaeMDsKJZGLAsAHcYUdNo9arO6iefvCjZLdMn0/Oo2ctuEhJY4MjdceiitEZyi9yZpgNvlqSoOEA58xu5+lVL0b4iZGBj6vJjhj6CpjnzMsQkjDGenlLVW/kHkRkcwLlUToSfXFVuc8kcN4rhkQ+dGpyRnyz0UVycGr+UHjJKMOm7pXoWqrGJGSdDJMV6AkflWBd+GYbtQdp3qvU9SfSolSjI7MLipUVy9DjtXvPPG1pECn+FetVdODvdRG2TJRsgEZyfU+1dMPAz+ZkTYAPK45z9a7Dw94TgslO5cvjMreg9KqMFFWO2rjXOHLfQzPDWgTXRjkmO52O2PI5Lf3q9F0u0ihspoWAS1X5c45cj/OKfYWggCuR5ZIwP+ma+tWoiLe7SRI9zOD5MX91R/E386LJHA5c5NG8ouwxQLO6hY0Yf6pcYGadaom6ZQ5S1wPMIPLY5x+JqGIFpLh3m3qPvzd5W7KK0YIkjkSC7I8uFQ8jDs3YH9KFqO1iOG2fYVMbCaUAjJ+5H7/X1pXiD7CqqqSNsUdxGvU1cTzHaUy7TJMu5znmOOk8sSKxddpdAc9kiHpj1qWguRWyb42XO2S7kC5x/AOpov4FuA3l8iSYJGT/dUcke1LE7CAEAb4Ydi+uWP88U26OyKYKQBboIY2U9WPXik9hdSNJZLs2/nndMxd8HoABiszYyQxlcD90zHjsTWje7QZ2iz+4iWIEdcn0qjd4RrhWGNipHjPcmoZSKrBDuUk5LEAEe1UL077dwSu5go59O1XZQRP8AIchZG4Jz2qlMFeJs8fIuQR3qCmcLo0KJqdwk7AytOQG54Brv9DdYLO2eM8Qh1Jbjp2rhLGHbqd0QQNkykcZ9csa7Tw/H5yA3QCwCZizMeMZ4AHuaqGyJq6u50MCSyIhVvLXIEkmeevAX3q+t1FaJiG1VJQ4UHqz/AEPrUMESyESPi3j8wgAdV7AfWtO2svtB+0zytHEpKIEOWPXJz/DW6uc8mluZ8cX2IM8zRyalKx3OGz5Q/u81TjjiVF3eaS8ZDbunWrkgktGilnV51O/GRkL2yPU0xJI3tchlMgjEaoy5OSe/0oSRNzFuSxlVEdmKDCEnnb3H4CneKr6xW6aObQzeeUgxcGR1aVcfeyOua0brR0a0kgtry3glifcjzcHcaz7+51gW0jx+KtPjwNpLPwp/KqimjOVm1/wTnNG1KBrWaSztFsQ4CC3Vi209+Tzz1ooiE8+qQtd31vfTttEl1E2UfA4wcDp0oqE7GjaRrSTuftASQhnOGHccciuJ8yXTtUZSVCy9QV681um6WM7ydpI4Hf8AOs3WUW6thIjEOPmHHI/GoeqOmEUm13LMyR3CnMYUPkEk8Zri9SgbSmZGLLA5+XHU102mXsQtWUMd6n5sngfSsvWNl7AzMY+hAPekVF8rszBg1QWxNtOx2twp3c1o6BfbHZCQFySAeormpLRZQ4YgSrzkjtVe1vDDMrEkjJDDNXyhKVmekG7JBLkAg8EGop74jceg6E9q5y3vVkJZCSp9O1Pa6VjyxDdiKXKJGqLpmUfLgA4JzkflVGW+MTMrS5A6BTVCa7JyCGZvVT1+tUp7hmUEFUfuOpq4xuKTSLtxdOCr8AMM8Hp9apSXH7wEuS55xndWfPdLs3Mc88ZB61Vl1FfLBEhMhJyOmBWyiYTqpdS88zEuFcbuTtJxwPeqVxcoDu5bjJBPFU45bm8m8uyt5JXPACDNdDpngTVr0B76RLWM8lQdzY/pRdRWrMPaym7QVzm7i6CuQSoJ6Af0qfT9H1XVW/0S0fYf+Wj8AV6tongnTbFVb7MryjrJLhz/APWrrrbT1iONq56DuDWTxC6I0jhZS1mzyzRvh7GwDajK88meUU4Un09a7nT/AAxb2CbY4YbaPPYc/l3rq4tKZzmONsoMsG+UfWpbexL5KAvjJJUZIA/mKxlOUtzop0oU/hVjATTYgdsZJccg9N3tis/VLRU2zsBGFYZ4PFduNNQW4mluYIYm+6rH5wfoKyb6KBFKTbZT0Yrzx61DTNoySehlaRCbp33YcswAGOoreuLTylRmaMgLu2djjsa5/SImtNTUCVmgMm5VzgkH0+ldUVLqEwEy+0nPL4PY+tVGOhFSWuhQaxknYvBu2kgqR8oVvT6YrXfRXt9dtWVVEd7AdgB27WA/iz15/Op4nin3ZDFvMLMFBy+B6CtG/Hm6PAski7raQNG+Ryp/hPetUlYwbdzgNf0pr+Z5UgX7dE3lSxA4Dq3GSf1rjtKludJ1efTLxSJYGwRntXrGuRJOILrbsEn7icx4Chh90+5rz/xppk1xFPq4uYjfWu2KZM4eWHtIOxIrOavsdFKdtHsbUE4k3eWeOgA71et22qV3tg479/TFcj4d1aC6t4wrDK5DHPJ9OK6GBiZRuUfL39fes7mko20NvcHCrho0yNwz37EUq4VlDnKhixz7dKpxTjdk8HpipoH3g7znIP4c1VybFyBTksQRu5Psvp+NTSYDEFsLj5iOw/uj3qqJGIwFGc/KAefapS2FAX5gp4P95j60BYVwM/N8pxzj+Fe2KY7FWCx8Mwwuf4F7k0wsAWYglR3z99vT6VG5LOyu4GRmVx2HoKpCsV5CsZYrkojHH+23rUELOjgAbpSd7eiE9zUwfARwmW5WJcdPc1WCAJIisRGrfv5c9f8AZFUiWiR5EEcgLZiH+sbvIfQe1QTOYgjfKZXGEQ87B2pWYq8Y2AKvMUXt6mqtwJcutu3mTt99j0WqTsZumjLvuJ1iiO+YnLP2zW1YQAJGBlifunHU92qhFboLpIUbfIfvEfxGuljtcNgEbgoTPUIvf8aakDgloVUt0wMDMSE8j+JvatC2jVFaNgN+NzADHJ9fpUoRUkXYoG1dsaHoB/ePvUyQr5ZZifKzhmPWRvaquNRIol8wA/M6A4CkcyH/AAp0iAKVEhHOZZf5KKsYLAF1MbHgbfvEegFSeUUwihRLGNwTqF9Cx9faobuapWIogBNGUj2knFvCfuj/AGjVmzYbZHlbdDESZGXpK4PA+lRR+XMpk8w7RjzJuhb/AGUFSoG5iKjBBIiI/wBWg/ib/apImTLEcbSPtlystwvmzbhjag5AzRKQyhn+5J87AHOyNegpkkmQ8u9me4b5gTkpEP8AGoDL5wEarhpm4xxiNe39abZCu9QT5JIjKDu5uZMcgD+Ee1V1YLDEZCdzBrh8evRcVYbzriBt2Fa8bqBjEa9/pTWRZNsiqPLmkCIScHy1FSyr3IpwViljySWmUscfxY5AFVJ9rO7HlpLgBQPQdauIVlMDYOCzzNk9QOlQQJvaBmOG+aXHp16VLGijJt3hl/56nAHpVPJkViPmBUYP0arcybYYQASQGc4+8MmooowkG8ZDCMlh1xhqkG9Dgb+aOz8ROsuQXwuQmT1PJ9q7zw1ctLZBVyAJ2YZXOMn73+FcTqsIk8T21zLJtjc7OBwQexzXd6Wpgt1B3FElcMi9/wC7k/WqghV7Kx08EQbzxC7II3DEkd+/HrVx3kkdUdGVA5UDHysQO2P61VgV0QJ5sW+YplRyo7k+9XoJJRGnlTR7g7M0hzx2z/8AWrY5XsQR7PKjzFIF/ePt7Z9/aqcdv5j/AGqPCFgEgJxkE8F8enpVrdLeNDbqTHbKW3TsMF/UfU024miFosvy+bHII48DlQOn50wMyS1ubq6kYRyz+USpeMZy30ri/G+garPcmeysrh1fBkVYjxz6fzr0FQ9nphUzOssj5k2nBDe9Zuq2FvawXdxfatqziLCTGLohbuBnoPWhJMzcnFnBabay2DtBcQS20mC4Rl2kdxxRU+vbLC+khSe5uRGqFZblt7OCuQ2fQgjFFYt2djpjqrmXPMocqiKFxjB5P1NV57wiMAMenPNZN9f5GVYKq8HHcVnTXgZMIWJPOQavkNOaxqC5RLgjcQrjjFV3nVpAqksCayzLhN5fJzkDpimz6iI4/l4I71XIyZVLFbUMR6iHU4DcHNUb2EQOZUHXqPam6perImc5PUYqlNqSyWu3A3AYNaxic9SskXrC5UDZx6g56+1XWuAw4PzAc1x0F80cvOMAVZl1PcQ2cEDg4qvZmMMWras3pLs/8A9R2rNnuuSRtA9TVfT4tQ1mYRabbyTP3IGAPcmu40H4etI0cmrSGV85aKPhB9TUScYblKc6z9w4ezgvdTlENhC8zeq8BfxruvD3wzeQJNrEm5P+eUY4/E16fomgQWkSpbQIAvGIxgV0ttpqYYqWuHHzbE4QY9WrGVZy+E1jhorWerOT0fw7aWUZS2t0iQDAHTP4dTWvBphlJUJuU+vyj9a3zamTYSUAUfcRdqKP949aQr5jbSwlb7oXGcD2J4FZO73OmKS2KVpaICqfIqY5WLCnj1Jq3ZxxxMfscQLsfuGPf+p4qYRFZZIxFGHBGVb53P8AQVOqTKuySZmXr5bDace1CRdyN7eVwwnKBkIOJj0Hpgdah2M5KhpXUMRhBjb9B3HtVhtigtE2Tt538MPpTUkMkgMEdzPxhnHyFT70WEQwadDG7SThGBPzBF38epPY0l3a7d7xwny1G3B25Yg/KWA696vQpqETDYIocoWBGNrj396rTzrCqf6QGkU71WJck56gmqsTdt7nOa3Agj+0RFYgvBVF3E89M/WrVk0dxah4kbe65DbT1HUD0p93ZPNGwDIPNyc45qloqziSS1mdyyN8uGx2p3uTaxtw3QVgsKyDcMhSOQeh+orXgkcxp5tsLWCTiX5A3b72OoqhYE29yIwVYvyjddrexrfgZpLcyuHllcHcWGFYev1FVFETsc/qGnJc2RtsKdmWikwRn3965i/06yvHVpEjYiMZjJOCR1B9q7yaJWgw7glGzGV78Vk6vbRf2rBJEiqssJU4z19TUyj1KjJrQ8R1+2g8P+KYDYEfZrgbwgOTGOmK7GO5UpEwf75wR9KyPH9hJdpa2Vs4N9AzSxHYEyM8qWzzx0rH0PWUuY2RnAnjbaQ3Udj+NZyXU7E3KKb6HdrL+83k5BbGO9WLOQ7gCCOuBWTFICEAyOT17Vct5QSu5s7QTjHepEzXik8vcWPI+UDuSamMowUHRByQepqhbtkISfujJPqxqUrtXBIJzlvr6VSIuWDnIwP3mPkXPCj1qGVo9pxykZ7fxtTGZ8EMdrHl2/pVdskqFGGP3V/uj1NMCeQgljIdsm394R0RfQe9VjIoEYCgMc+TEf8A0JqjkmiiVmf5oE6esj/4VJbRPPKxYBpJfm25xsX61SYNdyRYGMUhV+T9+YjOT/dWllsnMONv2e3Y8k/ear0ETbht2sI85Y8IvsPWrbgvHLcoS5jH+sPRc+g709jK5iaTAvnO/l+WinbnqT7V0NqAGbeNmOAo5wPf1NVNLj+TczjzCclz0X6VcUlJP3fBH3S3T/ePvREp6smjjQggxkM33Ih1Pux9KkEC/wB4HZ1f+BB7epqGGXjZ84VvX70n1PYVISzA42BVzgk/Io9AO9W2A6FEGW+cE8AgfO/uPQUrgFDGfLIXqqt8qntuPc+wpwDsQxSRg64LMwQt/gtD5RkYNFsAwH2YVT/sjufeoC7KdmT5gQN+/Un52GBGvqBVz9ykfzDzYC+WkP3p2HYd8VCyiOQRsHCy/ME6yS/U9hU0pkMgwqNdAYVFOFhH1/rTRLVyOffJK32nEZfDSADG1Ow+tVTmSQrEAHnO1fZBVkIjRsCTMCcZ/wCe0n90f7IqEb0aaYuHkbEIKjgnuB7DpSGibcZEZgWKvi2hz2UdTiluFWQFYMbdwgiZhkAfxGlLCIt5Iz5IEEXP8Z6n8KjdxG+I/mit42ijPq5GSaQiCUhkcooIjgKDI6c44+tNmIgSUBmHlQBBz1Y9anY5i8pCNrBIsg/jTJ9irlsDfKW5GeFGBTC5UkQp5qMVJEcakbfU1Wm3I22PIL5V1I6/P29KnWJkhy4JZljcd881BnN0u8sf33Qfwjr/ADqeULnKeMrdLYrc4ACyHaB2GcV0EU6wzLDOshaaEMvPLcZGD9azfG6ifRxsHIi3Mc/xZJzUvh27GpnT5GdPMjj+WQjowXBH4elOKtcmbbimzuIyIL5CrbZQo98kj19ParVuvnPAqZDh2fGOFz3P64rJ064HmxpdEl1OWJPC+3vWofMt0BgO3DkkHqBjpj6VqjJIkWc/JHndAgaX5uC5zxzWfCBOxmuB+6t1LjHdzyBTHu3nREZQhSEqSTjC56j14qC+lCIfJDRxRxKGU9yeuf0ouDRV1m4muLmK33lnfDtgfjzVvWL901WC1u7OIrfQBZI2l2biTwxP8J4FZ9hM0aS3kmPOlOxcrkKBUPiQ6RqRn1K41P7GsoCskkLOysOu3HWiNzOaTaRx3jU31x4ilKW6wtFsiaEHlFUYA/Lv3oqTxLqCXmsxXFmGWELHEruMOyqoUFvc46UVNRamkJNJKx5XPfjcQ/yKeeuc1TfU9hzxx0asG5uGfkEKR6nmqwn5ySSfeupROOeKdzak1J36uSKrPdsWyST+NZrXAGTnjvUTXGeMgeg9apRMHiGy7JcEjGT6Yqq0u0kDge9X9K0PUtVcfZ4NkZ43vwK9C8N+AbeFw9yhup+gMn3V98VEqkYFU6NStrayPO9K0PUdYc/ZIGWMDmVxhQP616B4c+G8O6OTUGe6lJ/1S8LXpWmaPFAh2oW2YGQMKD6+9btjp5Z2WJThRuY9B9Sa55V5S2O6lg4U3d6sytI0S1skWNIo41HG1MYB9Ca6GLS0WJXlAAz8uOg/DqasWcItY0lwGGeHZcrn/Z9TV4PKryB/kLLlnfG/BPr2/Csd9zptbYSGBLdiJo2XPGQfnJ9+y/SpZMFSMKYyML/Co/4D3+tJbLu2sCysvJdhuJ/3V/rVt40jjyymNnGeMO7/AOFPUZAPnYCZlk2r8om4A+gFRXIUzlGMr7R8qAd/5YqRFmkkaOKIqhAPlxndn/ePY1M9l5aBZ22Dqsac4/woGrXsZ+6WSNPLUvGnP7oYx+NSCGUktcuBE4++vzMPbNXJZXEhMTmPd3xkfkKhNqUZJZFYSHvK3yv9AKPQq4yOSFEwkb3GOkyDGDVki+crJ+7t3YZV+8nsRUnni3UM0iZbIAC7QfUEdRVSS6kaGVbW3b7McHMg5iPqO+PenoQ7vYi+w3E5l89trx/MYQeTnuOwrQSO0htc24jzgSb8FmHqDUIspTIGu5fMuI08xDn5XXuM0SXUXnpFpkbOGO5QRhQSOR7j607JESd2Q3zPN5zpAAch8lu3YgVzmsebFLDdQ/8ALT5Gweh7GutjjmRo5ppM3CEgAEAL6AisrV7YTNI8aMlnJuJVh91u4xTAZBcG5t4WaWIIyhsg4w2e9b1reLckTGN3kTCtCPuq3976VwenzpZTyWsrtIz8o+3nn0rpEupEaOS3RgdvlyO/GQfUU1KwnG+h093cBYylxsGeHCLu2GuY1Cd8QyMxYJIY9p6jI5PvmrksixjMx81v4zIdoI7ED0rGvbxZmVZGVgQVJ7cdKUpDhG2iOT8UwRzbLiNCDCxJIb1rgvF9lFZXMOqWW3MoBmCJtCn1/GvSrsqEZCTtkUg+9efayiv51tIw8vHylu5rFuzO2nrt0NLTNVS7toyrfNjArR+0FC7K3KDGPU15toF99lufs0wcOpIx1A9Oa6xLwSSquQo6e5puIJanY2t2Q6FjwATj1NX458Z5DNnp3J965O1ZZHEhY4J6Z9OgrYsplGSD+8YZdj1A9KDOSRozy4iJIBVTnA6u1UTKyrKXfrzI+f0FSyzOYVjRF3s2Ux1HHeqEamV/KA3Rxcl24BaqCK7k8BDypLIPnziOIjIHua3NORvmAUMM5ldvlUn0+lUrPaFOAcEEO5HLnsB7e9a9tMgQghCU6L/Ag7k+poQTlfoWVAbD4L4/ifiMewHemXMP+rhyZJGIG0cbfbFIkxuCv2c72zgsTzjtj0qSOZpr/wCcxuIh5a+R3H1psyVyw+2NQhUExgYwfkT/ABNII2XayO8ijqF+978f1qWRkkUZQOiniNBhfxNKEcMz24O8/wAER4H1anYpMQNG6bAm45+WNDnHuTTnjYOSWCvj5A3zMfovanx/ZpAFlXB/uwcfmTQoktmwh8yMjkQcuB7mmIWRFwiTnZnk/wAUrVIqGNVkd44l2/K8pDEf7qjpUcc0bFRGyW4bnCAvIT9e1RhCVYwwqNp5mnbOD/I0kDF3GPMoPkxyAL50hzK/rtFLKyCDBDR25wRFuzJN9fSmh23PMCspxg3MnCj/AHR3qCWbaDs3ncQUDfedh/EfQUXFYtNvY7HZY5AnzAfdt4/b/aNRLMizfukOIkC28Wc/M3QsPXvVFrnK7VUyJI3VjzJJ6/QU7zzEWMYU+WSA/dpG/i/KhDtYsCUW8u2Qq5gQscHILnrUaADakiZEMZdscZZvWqsODHJn5VY7Qx5+7yT+NOaVmSQhTvd1yDycUrgkXoT5c9uJGAKKZS3TnHFI4GNzgblhLHjuarNN5hm38hRt6e9TTthpzywKDbt7D6+lC1E1YiuZGCsrDBZEBAPWqDOUcHOMyZXjtmtK5Ut5pUiNWaNdvsPT2rOuEJEceFwV3ZBzgZP6mmIxdZjZ7XylXJYMhVvTNZ/gDypJ4raVVkaOXJOcAKDkg/hXQohkmMrjKKD2zlmX/wCtXGWt3JoupziIylWPKIM7s+tOD1FKPNGyPV4Ps7X7SKd8HMYcp19KtwSPERG7YTzNvB5H4+nNc3pN3ItnCxORI6yMxGdhzwDXReYrKyyAFmkJ47ZWrMVsZ2oIjoWjPzBDgZ9DjNZEzF7z7K7AbsGRu20c1tStGsKu5yBGeAcVmSoIrWSS4AM04yD1KrnioK6EE1+4SeCJwsL7Qcjt1H0rS8QTanA9vEPEmlWrOV+WSHk5/wCA8Zrk9QYxSqqMSQchiKt6raWXiSZdRltNbQHDSrb2vmxsR12v2BxVwbMqkErMqeLtOv42uL25vba8lgZEufJGwxH+EsmAMHpkUVm+IvEtnLHqgWCZLu+EdskWfligjIxk9S/GKKc1d6FU9rM+bpZunJNQ+az8Y/Ktuz8OSSH/AEhsMOQqf1qez0dYblPNzt3HGa6nOKPLjh6knsUdN0O7vWXAKKfXnj6V6F4f8FW9uQ80Qlk65I71taJYIzQBVwo4Y/yrt7G3XYcKu5uhWuOpXctEerQwcKWr1Zm6RpiQhQIxhR0966SDT9wU84B4A4z9afa27DZkAHPWuj06GPbmQkkqSBnjPvWFm3qdMnbYz4oCqxKwBDHKgDAzV0QbImM+NoxiIHrz1b61ZWISNHzldmRt49e/YVHFCRbmTggfM2eFYDoPeqsSh5WS4kcgqSoG1ugQeij2qeOMu6XB5Q/KZGXIU+3qaIG3Xscr/NuTBBGAPbH0pWkaS3SNOQGwuOAvPWgPIlQrCzGJgpXrIeWfPp7VLbwqf3mSsLcs+cvn61BBt83b5Zmnj79APoKsNCoPmXMxdDyVU8g/SjcHoh5lUHyrEZcHOUJBP1PekFlKx3ySbcnBRfvk/wBatW6ecu1F8tEHCuNpP4024mSNBEi+Zn3+6fdu9X6mfM72iIkUFsdsRG8Dl15P1YdqpySLOwitVYMeBGpyG9w3anPFJK227kVixH7teA/sCO9OuJoLRCqFdv8AFDj94v0NHSw1o9Nyr5RkhmXyFdweRn5o/wAe9TTz3KPH+7QyKMCRiMOnoaj+1TNGjQIIkPEUrnk+zf8A16rXF4izKqg3UgJMkfRM+1K9th2vuSeS8kRmYMUQ58vONgPXA9OKsSXNpbW8sAkBYkSQrByM+hPXisyZmMqy3lwVglH3Izkj0GKLeRYwyQxKk0Z3LI/Jx6Yoi7ahKNy/9ommKtCkdnbSNkvjOH7Ek1TlkheVWLNJnMcjucqH/vY6VDdXtvlZpd86ydVbja/qAKpPOxLPfuVjTCGMDDMvY+lPmBRMTXrdnVWVyXhI3AHaD78dRU2jauLyEJJIrFBt2ntj+dTSyyXUDiCMrGOT7jtXH6i40i+E8X3X5KD196yk7G8YqWh2r3BMZSWRg6Dbjvisy+uCHIZ1LDBVl5BrMOqrOIzvAyME1SuJ2EZdQSVyp+lK9ylC25dvZ3bIVm+RcgelcnrkYukG8HzFHy571oG7ZmfYxwU5z3rOvLhZbZV+4R3PWqii17pw2pSE3PnEFZM4JFbFtfAwq/3ig+Ws/VWVi8bALIT1rKhneMjY3Kdvat1C6MKlVRlqd/peoBTGWPyKu7B9a6azulyC+MHDNz19BXlOn6liUKXGJGB+mK6uy1MogYAHHr3J6VEoWD2kamx3ykMxYHDOuWb+6PSnwBSQu3MZOEQd/c1h21+rQKpBIJxk9WP+FX7a6yWAO05yzenstQ1YSbNnq43jdIP4QcKtWBKoBICttPPZRWdbzqWIcED+4O31p7SngHDKDwi8gD3qbmsVcvfa8RzbVVwegUbV/wDr1Y0vKgDaNrcnnA/E96y3/fSICvIPfp+VbER342dQOOM//qouVJJI0llTaAzbh0wDtFTNMFXD8AcBWO39Kz1K5K7grD+J+SD36VI75RgWDAevf+pqrmNiydsrD5Wkx2HyqKT7QYwVjdsd0j4HPqarfOyElGdR3f5QKS3PmKV3SOB0VBtX8zRco0GSKVNwaOKTAyEbagHfcepNQxzBgqzRA7CRGZDhF9wP61EqIOQ0cYHQIm8n69qgvZDJDvaNnk6DdJlyf90dqd+pKVy5NLufEeLl0Gd5+WOP2ArPnuvORwcnd/rJWPX2FQGczKqSu7ODxDF1P1NTKCCIpPKHlnhAMxx8fePqam9yrcu5DHP8+8Eq2Nka4+4O5pnm7QNpJQbmBPU+hqN1HOwsGPy8jt6/jSouXUYzltvToBQPcuqA0QTgMAqYA5J706QZOexkwABzx602BmZowR/eckdamgP+rC7VKxmQhemfehEJ2IYyxQKA6th2+uat4OyQoxI8sDOMAe3vUMcZaPhmyI85z6mrstuI0nztXaBGCD1OOtNIGyqSu/lTvLqAO3Sqk0LKojjYgMp3Y9Qegq7tjdi5b5gFIGeMd6IhHDEZZAzOSVjA6YzyfpVIhlJgnlxqMgfIPct0zXIarItr4nMzD5QDkMOG56V17bJEyeDtIx3BBrl9dgb7ILs53GchSepA7UtrFR6rublnmGVJIH3WjuHCnnBxnFb9s5nbf5rKDIzD5eoxXFaFfSOq25w8Y5JLchu/NdTBcL9lRVIBLkkA5xx6VpFnPJcrsSXBWVkjIySqqMHGQTzmqF+5d3DkYChAvoOgFTm4REYiY7gqgEfrVC5dWLInzc53EdfSk0BSv4g0RWReXPzY/ujt+VS65pmvan4nW40uaWTSdi/ZXhuAkcAwMAgHgjnOagnkcRu0pJIOBxXHXSz7L1weH46kc1aZHLcrfFC8gk8bMbeVZwERZpYTw8wUB2H496Kz/H8ltp3jWGKOOKJBZ25KKPlJeIFj+JNFact9RRmkkjXTQNl4pb5QVIAHJrI1jRFiniJDBM4Ixyc16UbZVkXYSzjk5FUNX08yNDLtBAfOBzmuS7O2NkcT4avfsl/9huyVUHKk/wAVei6Oym23KQMHOfasDXvDAvpFe0ASQcq5HH5+tL4cuWia7srhgLmPI2dCKGupTaktNzuLYFowerDn9a1YMLu53McFR6n0rBtbj9zGVbcwGTzjNalqTuTpyCyc/d9qRk9Ua8m1mLjBXytwUDCg+pokPnksxIPk9hwvXpRasjxYK73ZGXZjjjk5qfcA8MroHAThV4A5/WrEnYqlfNjtmYMluMjPQnuasK+2CWGKPZGjblZvvY7cU7yneERysxdF3qvb2zTnX99bzynzBIvlk9gaTVx37jIVIR2QGPZyxzywq7EIYdsip5glGPm5JP8A9eoVfy7uUSZKYALHHQjgU2MDyjbbP3q8oC3fsaEgauWWjeTdHLKduPlHt9aYJ4raHBIQk42DncfpSEkwRzXMgRU5wD09Ris64uoWneOygM7N8wdv4SKL23Ek3oTS3Mkygwr5UbNtIfj5vY9qpC5SMrHb5nnz98dQfQnuKZLFJcqZbyYsG++qnARu3HrToYiqOqAcICyp04PXP+FK7bLskMm8+5kzezFImJ328PZh7U2PKqjIFt4on2GYj5jn2+lXbiS2iDM8scaY3AAEtkjpk9apDdfNI+FhjZP9ZIemOyj/AAosTchlaGL7QgVi7HdHJIMY+gpgkWPy5pVK4JEm843E/wBKZ9pKzwzWcbyTY2tLJjAPqB/jUcjRQS3Bnla7nA3AEfIh7n/61Gw9xwDTmRLSAAM3DudoUe2aolre2cyXxN3KhKugb5PYj1p9/qEtzbq0xKvEBhCMYX2rJMiSsXlcpA44A4OaVxxTLlzq73gAJVGjAUBAAu30wK5rWws0TwkA5+ZW7mrFzPwphAj2fKwHNZcz8SIzfNnK0tWawsnoYlnd/ZJzBMSOcKT3q9c3b/MN3yuMYrH1wGSP7RGf3iHkY4FVbfUvNtUPG9etXGGhpKRcmuwApRumc1k3d4VRVZSecdfWmXV6zBhGwETcdKoSyYBLHLED8K3jAxnUKmoSs7tk5rMkZkODwvY96vXTgqTnOazriTKjJBOK1SPKxE7u5BPKVYMvDDoRW3o+tAhVf7wPP8q5yZsHr1qqWKPuVsEHtV8iaOOFedOV0et2V+rwgKxJU7Vx+tbulXfTJGT0A5/KvIdN1h1UJIxB+tdx4bumu5MBlGBuJPQj046GuWpTaPZoYiFRaHo0LBgxZQATxluvuasxzjeFVsAenArAEqovJQnHGOav6WkkzEnKp2IHWuWTtodkVpc6SwjDIztjJ4BzjitGMrtAB+buR0xWSi7WwN+B7dKvwOWXKZPPbNCJlrqWQcAsflTHOxcfqaUSMpBHnbj3AwcVHz5YC53nrgYNCopbEyhHHUNL/hVJklkbsgtEpzgAu24j8KeZN4xJGWBHBdggH4CqrNHGAM2+SMdzTonUHkROO5Uc/r0qkQyQuBH+7uGYjPyxphV+pqvypXY+7IziAZYn3anzujoAzck4AMm7j0wBUYt5CnzfaWXBKgLtA/A0WBNFKZQAXV0hYfwJlmP1Pan2twHRo5fkCncIgMb/AKmrH2ltwjyUQYG9sIie+AOfxpIrNHLLBKrqvzyXHTIzgKAfU1NnfQ1TVveAZMgJbou9ieRnsKUKBtVyPkTJwehNNKS2+EkRZCzYYKd3TsaltnV0UKckyb2B9un5ULzJeg1Iig4YjA2/8CxnFWvLKiba6lRGvX396rLk3AZCFZmblugqRElijBZch4zznI60ITLxhkj8xXx8oUHbzjPSp5jG0rBxjDqcZ4xTTKVEzBsE7MfWnzyB55BNGOHV27Ej0zWiMytsEkuxTgDOe+QDUt+xlJEIURckBTjgY60joGl2QHYd5yTxx9apKxEKAltxDZDng/jQKxDeYjRvLTYyuefXPSs3xPbltEFuwCuseRjjnOa0pmLhABl2wQPpUOrD7Q7FuSWH6jpSa0bGnqmcv4bQRwJJEreYBiVgK6e31QtEu4DAbhtuSc9c1x+lXUFhqlxayyDY3TPrW6JDEV5yhAIU9KpMmcfedzV+1s8JDBBhQAoQZOD61kXl05Z1AUEnPAp8kgEWz+LbkH0NYt7cssu0Dn1z0obJjC5q2GsXunvM1lIqllw25Ac46dahbxjrnkOTcp8uc/uU/wAKdpFtZXMN7cX7Si0s1VmSI/PIzHAAJ6fWoLqxs7jSZtR0OSV7aI/6Vby4MsHo2R95T61qrnPNRXQ8n8YX93rPiZ72/PmzlVDPsA4UYHA9BRWj8UdLj0vxb5NizLC8EEg3tn5mQMefTJoraN7Gd4roexXG0RO0SsApAyeOakng8yJ2uMlVxxGO3tW+dCie1nSRZVLAurEZJA5yR2qK6nhtbQERIfmVCh6hfrXLyW3O1zXQy7Im5sZofK3OpwFztzjpnHauJ8U6ZJaL/bULq7qwWf7OmIwDxy38677XpQbP+3tI2eZbkLcWoGAUxyce3rWVF4l05NHgh1OJ7jRndlmQEYAcZ3cckA1pGKtZkc0780UYujXpBjjlIwV+VvVT711WnzmWMQsf3i/6skYzg9PfNeQ2l7Lp+rS6dOx8tHLQNzyh+6QfpivQdJvZGtl3NsCkMOP4vUmsJKzsdEY8yujs7GUvODnAc78AZww7VpDzZF2o0aZG9doz1B4x26da5y0uwU3wvkkiQgdh3x71uwhvIJWLdsB2bm2kg8g+4xTiRJNFtHYxR3Ck7QNjqeCPc+1QyZNopV/MVJRwv3QPWqj6iTLvj/eHG11QcZ6dfcVXAleVoJJBFGw6AZOO35UPyEr9TUuZY4/tC3EgUuodAOecVSa7nnljlto8Hbs3nrT4rMeVKGQCSLnMh/QCpbprZWiVpDM7rgqo6egAo33KTRAIszESyNclegHCgn1NSyxbU2vIqLHwdgAyT79ajma4kmbfCIUCjIY7R9cCq8Q81163Dk7ig+VRjuakfS46Vox5nkKZAvyhyuEU+vuaYzTXkzmEllCfPLIcKuPSiadGUrO73EmdqwxHCj1471XuJixLXmI4d2PJHBYAdPahgS2jwRN+6Q3dw0X32HC59qZdvHYmJr9TI8eAId3Y/SqUtzcyowtkFvbn5CduAMnjPdqp3EqQSv5JMs+R++YZP4DtSvYOW71NG/klNkxnHkx7sxQAfM2f5D61kXMm2SaMkKdo+VecfjVS5uJHaVpGcuwyxY8n/Cmoxn2MNyQqMF2GenYetLc0UeVXJXaMLEyt58jKVJ6Kpqi5IILyAFWKnI4ANV9RvTbxMEDKFcNgtzWXfXbXLTlX4KhvpQFm9SxPPEDtdgByhPrXO3mo/OFjJbymx9B61Bf324SKjZyM7j2NYl3dKrv5bfKQMt71rGFy3Zas0L69UeYM7g/DD0rDkKQzMY/uEZ+tVJbrcSCTg/e96ry3JZSCeMcVtFWOapWSL7zBQAGIP3selUp5gSSDn1JPWqUlzgnLHPrVaS4yDWiiefUxPYsyTAZ6VRml6jAwaiebtUDtya0UThnU5hWYFqibFGecd/Sr+naNd30wSNCgPVmGP0qm1HczinPRIr2FlNfTiKBSSOSf7or0DwrFcabP9jK+bI4yHGMfjV/w3pltp2nMqwKXYjdKSd2e/Fak9t5Ewv4Ey6AcMM5/CuWrVvoexhMG6fvPc3tP0xmkD3hwR0QDg1uwRRwqFXYFHIGTxWTo96LqJG3B/l6f0FbAiV1UAPwckA4rk3PQfZlvAdRyo4zyx5qzFIqIBwuB0BOfzqjCGQFd525xtx/nNPaRlcYQqx/ACpsO1zRYgDOAxPo2akFwqrt+VPQCPPP41nGbflYyXkA7AZ/MVat4N5RriQnp8ivyPzpryHbuXIXd5QEG4nhd4Sq15Obd1V1O8nBGFP8AKpsZbyrZSfXdGDt/KkSNLYPIWQzbujRGquSktyKBGUpJKEBI4BmAI/LpUsrLM+CYt3YBGkY/TNNWSOaMu1vEQCfuRnn8RUyCIY8hG+0cgNFLux/wE0CGxW4gYzPatIy8nzsbF/4COtRcfaFKl2ZjucMAv0AFShllkRFjjlc8BSNhye+aRgIJfkJVc8h+qsOOaBptvUS3doZY3RgSMljjOPWlDQyNDlAPlK5Bxz2amoN+DyoD4PPrUHlmHDA70V8kk8rU3KSXUljidViKsJQ2WyP1zU8MmEQoAflbOTx9KjaUK4Nv9zfxg9c0+H/VoSCMhvYE0yZFsSb2YEnmIYBHpU0jIZZS3IKA59cVQ80jZjABjI+mKsiYlFRW+U4JHrxVRZkyVpESZ2JyvDdO1Qu6FiSoIEnHOc5qvJJxtBySpHT0PFQmX93IOMlQwIqibEsJVblGChQhZRz3rPnZir/MMMufyNOaTAdwTuMgJOeoxVW4uNrJu5GSp9s0XKtqcXrMYttcjmJDJJz0rsofLmt4xHgg8ZPrXMeLID9jikjT7p5A5IGeTWho115unwtjGcZx7UIqeqTLUjuh8vqc856Vi6mu8DY3zAn8K2bhfNRtvv8AMD0rFuGZMK33dwANAR11JtE1iXTjKHhS6jmXy54JVLLIucjOOmCODWNp+tXmkatJcWgdX5HlmIsrKeqMO47VvaJrU/h+9W5t2JiOEuIwf9Yv9GHY1ha5458Q2+oSSWusX4s9xCeaoDbe2eMZrWOxhUTu1Y5r4k6+dX137U1stqxijVo1ztUKuBjPNFc94y1S61jU2vdSuGnuZFVTM3UgDCj8qK6EeVWm1KyPrbTllaDdfXH7hMboM7FCY+8T3rIuJvtkl1DpVmWikA3TzHZEg7E+tRXMUksyDU52BDcQoOo78dhT7rUIoYltNMtTPKCRCM7QCe+B94/XiuVS6HruOpkJbS2sqz6gyrEzBJzK3y7CcEKvesWGwTTta1HSEhMlvIPMgnuItzLGc4wB/Ot26tvOt5DfjN04bBwWAI6n0NSa9ZTxWHhnVZZVEMg+yu8bYwDzgk9BxRsmwcle3c4fxpbPc6Zb6lHcSXF1priGVWiCqsPRCuO/sas+H7nz1WPKsSOTng12/wBhW60+axa1T7Peo8IdmBVT95DnqWPIz6V574Ti8iJ45cK6MU25+7zU1F1LoVLprsd/aRIFDFR5YIEiHgrnv9K24NzzrE0pZ4V+RS2AR2x6isaxlLpvfDFVCtjjemeefWrtsQGK+aV8pg8bnsD7VK0CWpqIoRCzJ5Sv/HE3IP09KiW5kJe2lC7wchoxkj059DSNLCHBlQyb/mWRhwfw9KbcTrv2ySAf3TENoI/wqiWOnmlJkW5Kx7U27QTlvSiB3CRvCqpHux5pX/OaoOyW9yFYyvKPuhFGSccetIGuHtS0scUYQ/fnJLfQClcNi3e7PNlee5kmwATtIAz7n09qrteR+YEghWTIwIo2LD/gRqlM8EcitJJJcMy4Xd8oH0HemyX0oHlKvlYG0LGuCfc96L2Kv3JpZr0KJB5Vkmdq7W+b9KpvNbIzeXvnc8B5OcevH+NJLbyRB2mxFtHJnbGM+3Wsxrh5f3duskwA5wDtH1qCk1Ytz37SNk7snnI6YFUJbwu6rGwZ/ugqeOfU1HeC0gL+ezTSKowsR2op9CeprGvNXYoiJtVUGdi8CixUbPY2rp4bdXDyrPIABuBOweoHrWfdX5+YEgBF2qAeAK5281IZCK27JyR71j3Oo7UfzGO5j0qlBsqyWrNzV7+Ng/mMSSvb9KwL3VQsa7m2qUGNvesm71VmDAACM9u5rGluGbG48DpWsaZlPERgrF+61CSXIX5VqhNO2MZwPrVWSYZ6mq0k/GSeK2jA82ti2yw8/vmoHnGOtVGkJbjJye3P6Vs6f4W1fUCjx2/lQvyrycZH0rTRbnJzTqO0dTHeXnvTEDzyhIkd2PAVRkmvSdI+HMCsh1KV5mzgqvArvdJ8N21kAlraRxAj723tWMsRGOx1U8vqS+N2PGdO8E61fEM0H2aMngynn8q6mx+GaIA15LJKevA2ivXLTTA8gwCCM/NWpDpu8jaN2Rwe2axliZPRHXDAUoPXU8rt/CNpDsWO3UbRlSBkj60k2irHMJMPGwwE4HX3r1qPTQvEi4JOMe9MuNGR0YiPdgc9ABWPPN7nVFQjsjyk2F3bMWmjZgWBReBk+4rVPnqgMlpJgjndjJrsNV0fbp4DWxeZiNhL4ZPqPpzUmgot1JBYzHyJXUbTJxvU8cZ/rT30L50ldHnml3Bs9RkRo2S3ds7ivIJ7V3NrcqAWjBOR0HJqe+8PWjm90+/KxXQXfbPICDJz0B71T8OrbsjQlPKuE+Vkf7pwfXtSs0TKcZak/wBoSQ5yF4wVHGPwNSRSDbtDEqeMAY/+tV0mOHcFgUOg2ssgG7HuP4h7ioVSIZeNAoY52xcgH/dNFu4KS6DgQdplAVlHAA2k/j3qcYkYIXwg6/N/jUC4YAblYg5weD/gaWKUKzDbgDggf1X/AAoHuaUexfkVIw3Y52E/iOM03eRIcPdLIcjDLv4qKJUlfqTzn92cEf8AATSsqAs67HVeysVYe+KYhtsrOzOiI3JJ8p9jY+lDupIRdpOThZhhv++hTBuuisMSCYt03AK4PsalhBjjaMgOxwGjnXkY9GoAmjj2ZQt5YI4SQZB9lNMniGMMGXPBB6j3z3pytglQGKDnY3UfQ0yV0ZQxbKjqT1x6GhhG9yAIRhhn5uGGeARSoPOEhBx5qlSue45BouHIBVWy7EBe3IqJS+4EIEyoI9iOtKxa1GxobeONifMGcgj2q1NtKjDHO/OM9AfSk+8rrwQ/zqPcVWlAlw8IGwrkgnoR6UC3ZIrHcAW4Vihz2zT1k4hYj5kbafWqsUwmidc4ZuRn1FO3llYpgkgOPqKaIkupYaQqARyUkIx7VWclcAEA5ZSCfXtRPJlZDz8wDLjoD3qnczMJGJwSQG+lU2QtxGkIjwoOSMY9CKoXk7NIgXPOJBx6U+5m2yFhwuQ34HrVSBj5hkVx8rFBn0NKxotFcNdw9hMuSpxmqPhq4D2K9PlPftV2UiRGjfrtK8+orD0dvInnhQjGSOT2p9Q5bxsdTPICrE8Yb+lZlxIrKcAEcHB7VJLOVUljngGs29lZfmUcZ2n2FUZJWOg8LwH/AImkljBFcaqkStaQygMDz8zKp4LAdBVG+1D4gPIUtoLuaTdgQyWSsp9iCuMflVPSbaGeK+vtRuZ7ewsY1dmt+ZWJbCqvoSe9HiV7+40dtV0TWdSvNJTC3EEspWa2J6bwDgqf7wraGxzVFqed/FyCztfF88FlHDEfLiaeOE5jinKgyKvsGzRVX4paXb6R4lazsxIYfs8E2XOW3OgY8/U0VueZUfvH0DHDJfQC5aVY1XiQMpyTn8zWhp1+iWclpp1ugkcFnmOARz0yaR7eYXMM8rpdWUpMbYbYGbqFIFSfu4Lo7QNpGSipgKemBmuLlse05cysWJtL1C7tjF5sDK6FC8ceFQf7LHqfpU95ozan8O7q0gLSfZFE8Iz94pyQR/OrVmZriZGuA8z7SUZn2xp74Hf2qxb3ZtppIg8ksMhJJXAJOOw961irHPNvp0Mqzu7W/wDDVpczwNvSMOvljnjB47Dv15ry++lsovG179nkCW1x88bgEKD9D+VdTp19JpGuXWjyhzC7mWFAuQM9gO/p7VwHjS/m/t+NrqKONIztARAMgnue5pN3jY2owan6noWkyiVWhkAR14GemD3q/FPIgBbPmxnnj7y+1c3pt0JrdM58xBlW9PY1fWbJyrfN0OaxZqjZ88DClsKfmUk5I+lOivB5bRqp3ZyAOpNZ0cq7ACASOhXkioY3nmnaKLAz0ZiFH4mhCsaj3VwiboRDZhPvO7ncc8dOvFU55rfczTXE9wzdwNoJxzjNQOkUcIaa9UlyQyQqXI9yeBVImLHLoinhZJCWZfwzgUak6F9b/wAlI/JhWL1k+8x/E9PwqL+1pDbPHag5LZbyxlm+p61kT6lpsNsuEkuJEY5MjYXHsorLufE8z2+23by4V5xENo/H1qkmU1c3Lq6ZH867jMucnZI2MntnuayrvVpWjFusjMp+YpEMD2rDfUYyhacSSqeW52jPb3NZt3q8jW7RxukSZGVXg+2R1NNQuF7bm9cXiMW89xGU5IUbi3sK5m9vUR87OPUnnNZU+oMMncy+hY1mXl9uXOT7+matQJddR6mnd6kVbIJP0rHuLtiS27bVK4uy+ADmqUs4I+lbKBw1cW3oi5JNkdyarSTj8frUMCzXcwjto3kkPQIM12egeAJ7nEuqOyg8+TH1P1PanJxhuc8VVrO0UcbCLi7mWO1ieR24AUZrq9C8BX1+4a+byE67FHzY969R0Hw5Z2MaRQxJFkduCfqa6aCwSIHYgPH3j1/CsJ4l/ZO2lgYr49WcPo3g3TtNIMNuCw58yXkn6V1OnaZ8wwAo75HWtqKwLSBmAHQHPtya0obUIpZVK45ye5PpXM5Snuz0IqMFZIyEtVj5C8Y4JGM1cgsyxwFJfhQue2K1ntYxGfM++PuovLcevpmrH2cxrKHj8tY3VzCOfrlqXKDkUre0RCqLiVsbgq/KoI6gk/0q6sHm/MGVo8BhHGCAq98e4qysYDukbKzKQ9uqnI56ioBsSQBmKEZbaucqSfut7VVrE7lhYYov+WaHAGd/JkB7r7irqrEYl2yqLRgVWURglT6OPSspNhMzhSq9SGb5lPqvtSvqDvuS3USSONjbf9XL+HrVRkkRKLexNNHKpjEaqJInWRoQ33lxtO09+DWF4ksBK9vJppmWe2JAEqjD9SVbuTgVtTxk2gjuNssQ42nh4fy6Csi8ils4BIVcqwIF1G3BB7MBSfkCWtzmvEF9ceINNj+yxRx31o+6MB2ZwcY2AHscVzMmtkRrctD9luogI7mJwVZz6/Wuvkmnsb0XwYQTNGY8LGcInQOuOCfrVPVL2O01l5po1u7C8QCZLwbyWxwx9M+1J+ZqtHa2n9aE+makmoxxrJKh6KqMNoA9n9frVmWzdJdgcBlwQknDYPTBHBrllaDT9cKpCkcEwDRRA5VQOo9q6lI47xv+JewiuWH/AB6nlX/3WPT8aFK+gSVrNbMa0EofyZNokHGyTqR14NSRxgqFYjeOkcnUfQ00+Y6SRFDmP70Tn94h9R61NbO2AG2PHnjeDg/j2p2BMnihYsFG4t12sMN+BonC7SAdwH8WMOn1HekEr7QgVj38t+vsVNPaQvsLMVK8b+4Po1KwakinzIvLxEQB1b1/2WqMEyttIL+qt95foe9QYyWPCgcuinB9yKeJF4+Znjzzx88fpmgTJiCsQAIlQHoP9YnrUU9ww/ePg9g5HDL7+9LJKEJCkiUDKsON/wBaoyEzTFuMY3YP3X9vrRcqOpOFIhaWQAlBhQf4hn7w+lSElsg5DJ8656GoGnQHADGMDIXPAUntShsIoAJdRkY7rSAkLfLxnB+dMHuOoquWaOb5cDd8yehPenkMCcEgg5XIxg9waq3IZkymePnQ/wAxQVGzdhXYDewODu3r7juKhN0sUhXP3SDx6GkLGROcfPyD6NUJILK78ZGxx79qpA7Fp51CAMeEJX6g1lTXW0kHkxkj6g1DcyvArHO7nY/sOxqhJOj3WwkguuG44P0p21JUepceR5UAAAbaV4pzNsUsMZZQx47ioxIFUYI3L8wHr61XeYCRQM7cHj2NURe5N55YSnIJGHHv61kqqwasx52NyDT2kMSrySVYqfYGqV/Md0bkbjESDjqVpqJXNY1p3aQAKfl5Geue/FZ93cL8wJI7nNM+3hOOg+8melZN3dF2yQMnII9QapRM2zb0bWzpjXC3NvFeWNyghuLeUkBwDlSCOQQehrKtNfuNEvjd2KIylWilt35jmjPVHHcYqz4dtU1A3M+oCVrSBUDxwf6yWRm2pEuehY9+wBNSTNaXmranpl34bsVSxjZpjZXjG5Cr98xsSVlKjkjHY1tGLOOrUSbOH+I+vR69rzX8Vqtruhij8gNuCBFC8HuOKKx/GNi2k63JZecs8eFlinUYE0TqGRx6ZUjiit0jypyu9D6dsH32wsb5MTJkBuu4g9Cen0NaRd0u1j8seaOUkI+Vl965/WSYbmMRkgKGiHOcKMED866SOR7rRt07F2jYlCeorgex7l9jatLqZkGN63CZ2RgbY4ye5Y+tZl/eNLKWkG64GQdvGPrVd7mae0BmldtqjGT71nXvMAY/eyBmm20hKKepynjL7QLxNRMu8oBxjovcfSuc1uaO8a1uCWdCdpUHIx6V3GvohsnQqu3PTHtXl2SqyKpIVW4APSs3ozrpJctzuLCMWy+SG3LjKtntV4z7MEMB2IHf3zWNYkm0jJJzuHf2q5Iflx2pmbbL4uWVSyk46HBqF7lkQMWIA/MVH2/Cs6TlXBzj60ErUuy6kXBKkbjwexP4Vl3moBExGpbHLBqjnYpD8mAQOuOayY1EtxKZPmIHGTVRRN7DmuXuJWFqpctyVXt+NZc92YZDtKhD94A5wfrUOoyvE8ojbYoxwvA/KsYs0sbGQknNbQijKdZ3Ll3qI2uBIcE59zWZcX7GRgpCgjqetV73jgdBWe33vwrVJHFUryehM90c88k96glmPXPFRSnCCoLceZchH5X0p8qscsptk0KzXUgjt4nlf0UZrrdF8Cz3RD6g5RCMmOPr+JrqfDljawQKIoI14HQc/nXZWaKkICqBXPWrOOiPQoYONuaWplaHoVhpyIkEAUdeV5P5V1djY/ITtCjqBjk//WplmqhFIHPrW3AMCbFcjk5as9JxUVZILewET84Y8ZY+p71etoUf7qjA5PPYd80qHMmTzz/SrpUYdcfKkQKgduaaVybjYoUVSSUkIXO5uik+g71PLMUlmkiHmNwocjHboBVi6x9pPA/5Z9qqSk+fLJn5xLgH0ptWHvuXLX5wFAW386I7mb5i5z61TmlSN1eRAQQY5lYk596cVDxOW5KqCp9DntReAQQu0YAZ0+YkZJ/OhAlZlZzLGuZcW4jXhcfO6H09aWKVmdvslu0qgYeVxklT3K9qLJBI6SPlnBABY549PpU+qSvAPNhby33YyvFCQXJI9OnlaJruZZECAxsCOnsO+Ks77ezYMPK2spDKjD51H8XPQ+1c2rvtX5m5IPWnpGrs+4Z4J60J26CUb7m9Jd2zMZBcBpFTKSY3Db/dYevvUduLa6nCw5ikbO6JjmFx9e1N+yQItq6xjdICGPXIxV77PEkz2yoBBJF8ydj/AIVcXdkSVloY9xYGCYi0ieJGyDBOAYwfr6HrWNqejLJEkUtp5K4AZY+Q3HUHsK7BmL21mzHJmVkkB6MAOMjpWdeqsUtzDGMRAAheuPpVOKsEJs4m48PWV7pjS7p1mQYU5ztYDjnsOK59bqS1it7hJyoyY5lLZI9ea9FjiR4btWXK5zjtmuPurO3awuZTCu8yEE//AFqhxTsa05PZ7G3but5bpPJMHzyJfvOg/wBodxUqo6Fo8AGQZCk/JIPY+tczoztFawtGxVt+3I9K6WwPmwXayAMoXcBjoc9vSktkTLR6CrKpTGGKA42H7yfjSpuLZZs7uNx6N7expoZjPExOSQQfcUp+8o4ww5HY807BcjdgFAPzHt/eT/61M3sGGCN7dD2f60bj8p4yDt6dqhcfu39uR7VJVwlLMCgDFepUDJT/AOtR80SbQVDMA2VOd59RWgT5MUDRfIxVssOp+prMjYvACxyVbj2p2CMtbCGYKQRkgnIBHT1FTo3zkKOcblPqKpsSLkgdN9OJICgEjDHFIuRbabacseJO5H8VVBO5OeQAc496SU5hmB6ZrPlYhGIPIAptWIj3Jp5RHMFXHly4I/2TUc83GeisNrj+6fWqcxLF9xzgAj2NOblhn+JPm9+KaGyK8YyL8wB3jY+f0Ncu8rjUFBJzHkEnsK25Hby25PI5rA1Mn+1vr1rRIcX0NOSdwgCN0IZcDtTQ7GZl3EjhlPvUFp96P3Vs0z+DHPT+tVYxcuhallBy2MB+D7EVQnlGRLjDgAYP8QqGQnbJyfXrWdM7eYPmPIqkjBzZLeXAVG2nAU7lz/KqYnQKTIcZ7ehqrOSZFySeDWdcMcsM9hWqijCdVp2O38H62kElxaS3NvazSyw3NtNM2IhcRMSqueysCRnscVd/soaff3F9Z6FqenXBWQpc6jcRiwst4IaTzBzIAGO0dT715XesQuM8Gsq5LMuGZmVRwpYkD6CtUrHFUqNmt411O21LXC2nlm0+1gis7Z3GGkSNQocjtuOWx2zRWA3eiqOc/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Pyogenic granuloma: the epithelial \"collarette\" can be seen at the base of the lesion.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_60_7112=[""].join("\n");
var outline_f6_60_7112=null;
var title_f6_60_7113="Ambulatory blood pressure monitoring and white coat hypertension in adults";
var content_f6_60_7113=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Ambulatory blood pressure monitoring and white coat hypertension in adults",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/60/7113/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/60/7113/contributors\">",
"     Norman M Kaplan, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/60/7113/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/60/7113/contributors\">",
"     George L Bakris, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/60/7113/contributors\">",
"     Bernard J Gersh, MB, ChB, DPhil, FRCP, MACC",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/60/7113/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/60/7113/contributors\">",
"     John P Forman, MD, MSc",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?6/60/7113/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 18, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ambulatory blood pressure monitoring (ABPM) is being increasingly recommended for routine clinical practice [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7113/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. It may be particularly useful in evaluating the patient with variable blood pressure readings in the office, or the patient with wide discrepancies between the blood pressure readings at home and the physician's office (ie, \"white coat\" hypertension). ABPM and, in particular, nocturnal blood pressure readings, may also provide prognostic data [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7113/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic provides an overview of ABPM, white coat hypertension, indications for ABPM, and its utility in clinical practice. An overview of issues related to hypertension and the initial evaluation of hypertensive patients are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/36/32330?source=see_link\">",
"     \"Overview of hypertension in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/26/422?source=see_link\">",
"     \"Initial evaluation of the hypertensive adult\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     MEASUREMENT OF ABPM",
"    </span>",
"    &nbsp;&mdash;&nbsp;ABPM is determined using a device worn by the patient that takes blood pressure (BP) measurements over a 24 to 48 hour period, usually every 15 to 20 minutes during the daytime and every 30 to 60 minutes during sleep [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7113/abstract/1\">",
"     1",
"    </a>",
"    ]. These blood pressures are recorded on the device, and the average day (diurnal) or night (nocturnal) blood pressures are determined from the data by a computer. The percentage of BP readings exceeding the upper limit of normal can also be calculated.",
"   </p>",
"   <p>",
"    However, ABPM is not available in most clinicians' offices. This is due to a combination of factors, including lack of knowledge regarding its utility, its expense, and minimal reimbursement by third-party payers. In addition, ABPM is still only a one-time measure of a variable factor that must be followed over time.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     INTERPRETATION OF ABPM",
"    </span>",
"    &nbsp;&mdash;&nbsp;Unique data provided by ABPM include: 24-hour average blood pressure (BP); daytime (awake) BP; nighttime (asleep) BP; systolic blood pressure load; diastolic blood pressure load; and nocturnal dipping of the BP. Dipping is discussed in more detail below.",
"   </p>",
"   <p>",
"    One of the unresolved issues in ambulatory monitoring is the definition of what constitutes normal and elevated blood pressure (BP). A meta-analysis of normotensive subjects found mean 24-hour and daytime values to be",
"    <span class=\"nowrap\">",
"     118/72",
"    </span>",
"    and",
"    <span class=\"nowrap\">",
"     123/76",
"    </span>",
"    mmHg, respectively; the former is lower since the BP normally falls with sleep [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7113/abstract/4\">",
"     4",
"    </a>",
"    ]. Most experts agree that 24 hour blood pressure",
"    <span class=\"nowrap\">",
"     &lt;130/80",
"    </span>",
"    mmHg is probably normal, and",
"    <span class=\"nowrap\">",
"     &ge;135/85",
"    </span>",
"    mmHg is probably abnormal [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7113/abstract/1,5\">",
"     1,5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Definition of hypertension",
"    </span>",
"    &nbsp;&mdash;&nbsp;After reviewing multiple large cohorts of individuals who underwent ABPM, consensus has been reached on the thresholds used to define normotension and hypertension based upon the data obtained from ABPM [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7113/abstract/1,2,4-6\">",
"     1,2,4-6",
"    </a>",
"    ]. These thresholds depend upon the time span over which the BP was measured:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      24-hour average BP &minus; Normotension is defined as a BP less than",
"      <span class=\"nowrap\">",
"       130/80",
"      </span>",
"      mmHg, and hypertension is defined as a BP greater than or equal to",
"      <span class=\"nowrap\">",
"       135/85",
"      </span>",
"      mmHg.",
"     </li>",
"     <li>",
"      Daytime (awake) BP &minus; Normotension is defined as a BP less than",
"      <span class=\"nowrap\">",
"       135/85",
"      </span>",
"      mmHg, and hypertension is defined as a BP greater than or equal to",
"      <span class=\"nowrap\">",
"       140/90",
"      </span>",
"      mmHg.",
"     </li>",
"     <li>",
"      Nighttime (asleep) BP &minus; Normotension is defined as a BP less than",
"      <span class=\"nowrap\">",
"       120/70",
"      </span>",
"      mmHg, and hypertension is defined as a BP greater than or equal to",
"      <span class=\"nowrap\">",
"       125/75",
"      </span>",
"      mmHg.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Blood pressure load",
"    </span>",
"    &nbsp;&mdash;&nbsp;The BP load is defined as the percentage of ambulatory systolic and diastolic pressures exceeding 140 mmHg and 90 mmHg during the daytime, and 120 mmHg and 80 mmHg during sleep [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7113/abstract/7\">",
"     7",
"    </a>",
"    ]. The overall BP load may also be a determinant of cardiovascular risk [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7113/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The systolic BP load in normotensive subjects increases from approximately 9 percent of readings in young adults to as high as 80 percent in the elderly [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7113/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. The diastolic BP load averages 3 to 4 percent of readings and does not appear to vary significantly with age. Studies in untreated hypertensive subjects suggest that the likelihood of developing cardiac abnormalities is markedly increased when the daily BP load is 40 percent or more [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7113/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     PROGNOSTIC VALUE OF ABPM",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Prediction of cardiovascular risk",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of studies have suggested that the risk of hypertensive cardiovascular complications correlates more closely with 24-hour, daytime, or nighttime ABPM than with the office pressure [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7113/abstract/3,10-12\">",
"     3,10-12",
"    </a>",
"    ]. However, the difference in prognostic accuracy between ABPM and office readings might be diminished by obtaining repeated blood pressure (BP) measurements during the same visit, or by measuring BP in a standardized fashion with appropriate equipment [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7113/abstract/13-16\">",
"     13-16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This more accurate assessment of cardiovascular risks with 24-hour monitoring was illustrated in the following studies [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7113/abstract/10,11,17\">",
"     10,11,17",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a prospective study of 1963 treated hypertensive patients, an increased risk for a new cardiovascular event was observed in patients with a 24-hour ambulatory systolic blood pressure of greater than 135 mmHg (relative risk 1.75, 95% CI 1.15 to 2.63 compared with less than 135 mmHg) [",
"      <a class=\"abstract\" href=\"UTD.htm?6/60/7113/abstract/17\">",
"       17",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In two separate community-based studies with 1700 and 5292 participants, multivariate analysis demonstrated that ambulatory blood pressures were more predictive than office blood pressures of cardiovascular and all-cause mortality after a mean follow-up of over eight years [",
"      <a class=\"abstract\" href=\"UTD.htm?6/60/7113/abstract/10,11\">",
"       10,11",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    ABPM also has predictive value in patients with resistant hypertension. At an equivalent level of office BP, patients with higher ambulatory values are at greater cardiovascular risk [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7113/abstract/18-20\">",
"     18-20",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/55/36728?source=see_link&amp;anchor=H5#H5\">",
"     \"Definition, risk factors, and evaluation of resistant hypertension\", section on 'White coat hypertension'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Progression of kidney disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;A cohort study of 217 patients suggested that elevated blood pressure by ABPM correlated more strongly with progression to end-stage renal disease (ESRD) than clinic systolic blood pressure [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7113/abstract/21\">",
"     21",
"    </a>",
"    ]. In addition, night ambulatory blood pressure was a strong predictor of the composite outcome of death and ESRD.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Masked hypertension",
"    </span>",
"    &nbsp;&mdash;&nbsp;As many as 10 to 40 percent of patients who are normotensive by conventional clinic measurement are hypertensive by ABPM [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7113/abstract/22-24\">",
"     22-24",
"    </a>",
"    ]. This phenomenon is called masked hypertension or isolated ambulatory hypertension. It has only been identified by screening clinical studies, since patients who are normotensive by office readings do not typically undergo ambulatory monitoring.",
"   </p>",
"   <p>",
"    Masked hypertension has been associated with an increased long-term risk of sustained hypertension and cardiovascular morbidity [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7113/abstract/24-28\">",
"     24-28",
"    </a>",
"    ]. Because of the risk associated with masked hypertension, ambulatory blood pressure monitoring should be considered in patients referred for possible hypertension (for a variety of reasons, such as left ventricular hypertrophy) despite repeatedly normal BP when measured in the clinic.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Nocturnal blood pressure and nondippers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Considerable data suggest that measurement of nighttime BP yields additional prognostic data in terms of all cause mortality and cardiovascular events [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7113/abstract/11,17,29,30\">",
"     11,17,29,30",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A cohort study of 7458 patients in six countries from Europe, Asia, and South America found that both daytime and nighttime BP predicted all cardiovascular events [",
"      <a class=\"abstract\" href=\"UTD.htm?6/60/7113/abstract/29\">",
"       29",
"      </a>",
"      ]. Nighttime blood pressure, adjusted for daytime BP, predicted total, cardiovascular, and noncardiovascular mortality. In contrast, daytime blood pressure, adjusted for blood pressure measured during sleep, only predicted noncardiovascular mortality.",
"     </li>",
"     <li>",
"      Similar findings were noted in a second cohort of 3957 patients who underwent ambulatory monitoring: blood pressures obtained during sleep were more predictive of all-cause mortality than those obtained during waking hours [",
"      <a class=\"abstract\" href=\"UTD.htm?6/60/7113/abstract/30\">",
"       30",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The average nocturnal BP is approximately 15 percent lower than daytime values in both normals and hypertensive patients [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7113/abstract/31\">",
"     31",
"    </a>",
"    ]. Failure of the BP to fall by at least 10 percent during sleep is called nondipping. The underlying mechanisms of nondipping are unknown, but intrinsic renal defects may contribute [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7113/abstract/32-34\">",
"     32-34",
"    </a>",
"    ]. There is also some evidence suggesting that melatonin plays a role. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/46/13034?source=see_link&amp;anchor=H28#H28\">",
"     \"Physiology and clinical use of melatonin\", section on 'Nocturnal blood pressure'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Independent of the degree of hypertension, nondipping is a risk factor for the development of left ventricular hypertrophy (LVH), heart failure and other cardiovascular complications [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7113/abstract/3,35-38\">",
"     3,35-38",
"    </a>",
"    ]. However, extreme \"dipping\" (eg, &gt;20 percent nocturnal decline in BP) and a large morning increase in BP are also potentially deleterious [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7113/abstract/37,39\">",
"     37,39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Nondipping has also been associated with microalbuminuria and faster progression of nephropathy in patients with diabetes mellitus [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7113/abstract/40,41\">",
"     40,41",
"    </a>",
"    ]. More importantly, nondipping may be a risk factor for decline in glomerular filtration rate, and ESRD and death among patients with chronic kidney disease [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7113/abstract/21,42\">",
"     21,42",
"    </a>",
"    ]. The presence of sleep apnea should also be considered in nondippers. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/47/18169?source=see_link&amp;anchor=H2#H2\">",
"     \"Cardiovascular effects of obstructive sleep apnea\", section on 'Systemic hypertension'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Whether reversal of nondipping is possible or beneficial is uncertain.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     WHITE COAT HYPERTENSION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many patients are anxious when visiting the physician, leading to an office blood pressure (BP) that may be substantially higher than BP during normal daily activities. The diagnosis of white coat hypertension (also called isolated clinic or office hypertension) is applied to patients with office readings that average more than",
"    <span class=\"nowrap\">",
"     140/90",
"    </span>",
"    mmHg and reliable out of office readings that average less than",
"    <span class=\"nowrap\">",
"     140/90",
"    </span>",
"    mmHg. Having the BP in the office taken by a nurse or technician, rather than the physician, may minimize the white coat effect (",
"    <a class=\"graphic graphic_figure graphicRef73781 \" href=\"UTD.htm?24/2/24621\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7113/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Sequential studies have shown that, in patients diagnosed as being hypertensive on a first visit to a new physician, there is a mean 15 and 7 mmHg fall in the systolic and diastolic BP, respectively, by the third visit [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7113/abstract/44\">",
"     44",
"    </a>",
"    ], with some patients not reaching a stable value until the sixth visit [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7113/abstract/45\">",
"     45",
"    </a>",
"    ]. Thus, it has been recommended that a patient with mild to moderate elevation in BP should not be diagnosed with hypertension unless the BP remains elevated after three to six visits,",
"    <strong>",
"     unless",
"    </strong>",
"    there is evidence of ongoing end-organ damage.",
"   </p>",
"   <p>",
"    In cross-sectional studies, the prevalence of white coat hypertension ranges from 10 to more than 20 percent, and appears to be higher in children and the elderly [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7113/abstract/24,46,47\">",
"     24,46,47",
"    </a>",
"    ]. White coat hypertension can also be seen in patients with apparently resistant hypertension [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7113/abstract/48\">",
"     48",
"    </a>",
"    ]. The likelihood of normal ambulatory pressures is low (less than 5 percent) in patients with office diastolic pressures &ge;105 mmHg [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7113/abstract/49\">",
"     49",
"    </a>",
"    ], but such patients may still have a white coat effect that underestimates the efficacy of therapy",
"   </p>",
"   <p>",
"    A white coat hypertension effect may also occur in patients with apparently resistant hypertension. As an example, in one study of nearly 500 treated hypertensive patients (over 60 percent on three or more antihypertensive agents), 37 percent had normal BP on ABPM [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7113/abstract/48\">",
"     48",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/55/36728?source=see_link&amp;anchor=H5#H5\">",
"     \"Definition, risk factors, and evaluation of resistant hypertension\", section on 'White coat hypertension'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Prognosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The cardiovascular risk associated with white coat hypertension may be slightly higher compared with persistent normotension but well below the risks associated with either masked or sustained hypertension [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7113/abstract/24,28,50-55\">",
"     24,28,50-55",
"    </a>",
"    ]. As examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a study of 6000 subjects followed for a median of 5.4 years after having ABPM, stroke rates were significantly higher in patients with sustained hypertension compared with those who had persistent normotension (0.65 versus 0.35 percent per year) [",
"      <a class=\"abstract\" href=\"UTD.htm?6/60/7113/abstract/51\">",
"       51",
"      </a>",
"      ]. Stroke rates were also higher in those who had white coat hypertension (0.59 versus 0.35 percent per year), but this was not statistically significant.",
"     </li>",
"     <li>",
"      In the HARVEST trial, echocardiography was performed in 119 subjects with white coat hypertension, 95 normotensive age- and sex-matched controls, and 603 patients with stage I hypertension (mean office BP",
"      <span class=\"nowrap\">",
"       146/94)",
"      </span>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?6/60/7113/abstract/54\">",
"       54",
"      </a>",
"      ]. The left ventricular mass index was 82, 89 and 94",
"      <span class=\"nowrap\">",
"       g/m2",
"      </span>",
"      in normotensives, white coat hypertensives and sustained hypertensives, respectively.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Patients with white coat hypertension are also at high risk for developing sustained hypertension. In a study of 81 patients with office hypertension (mean BP",
"    <span class=\"nowrap\">",
"     154/97",
"    </span>",
"    mmHg) and normal 12 hour ambulatory BP (mean BP",
"    <span class=\"nowrap\">",
"     125/77",
"    </span>",
"    mmHg), 60 had a mean ambulatory BP above",
"    <span class=\"nowrap\">",
"     140/90",
"    </span>",
"    mmHg after five to six years of follow-up (74 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7113/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In summary, the optimal approach to patients with white coat hypertension is uncertain. If therapy is withheld because of a normal home or ambulatory BP, careful monitoring is still indicated for the possible development of worsening hypertension or of end-organ damage, while the patient is encouraged to modify unhealthy lifestyle habits.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     INDICATIONS FOR ABPM",
"    </span>",
"    &nbsp;&mdash;&nbsp;In accordance with published practice guidelines and expert panel recommendations, ambulatory monitoring should be considered in the following circumstances [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7113/abstract/6,44,57\">",
"     6,44,57",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Suspected white coat hypertension",
"     </li>",
"     <li>",
"      Suspected episodic hypertension (eg, pheochromocytoma)",
"     </li>",
"     <li>",
"      Hypertension resistant to increasing medications",
"     </li>",
"     <li>",
"      Hypotensive symptoms while taking antihypertensive medications",
"     </li>",
"     <li>",
"      Autonomic dysfunction",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    There are a number of other potential indications advocated by some, which include [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7113/abstract/5,6,58\">",
"     5,6,58",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      To establish nondipper status or nocturnal hypertension",
"     </li>",
"     <li>",
"      Large variations in self-measured blood pressure values",
"     </li>",
"     <li>",
"      To evaluate whether antihypertensive therapy is moderating the early morning blood pressure surge",
"     </li>",
"     <li>",
"      Elevated office blood pressure in pregnant women, with preeclampsia suspected",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    If there is significant hypertension on ABPM, or resistance to antihypertensive therapy, an echocardiogram to screen for left ventricular hypertrophy (LVH) may be indicated, as LVH may be an early sign of end-organ damage which is otherwise undetectable. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/34/17959?source=see_link&amp;anchor=H8#H8\">",
"     \"Clinical implications and treatment of left ventricular hypertrophy in hypertension\", section on 'Indications for echocardiography in hypertensive patients'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Mostly due to issues of cost and inconvenience, ABPM is not recommended for the evaluation of patients with uncomplicated hypertension or to screen for hypertension [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7113/abstract/5,6,44\">",
"     5,6,44",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     INFLUENCE ON THERAPY OF HYPERTENSION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Therapeutic decisions can be made according to the ambulatory blood pressure (BP) findings. When used for the above appropriate indications, one report found that antihypertensive therapy was changed in nearly half of the patients, and office BP control was improved in most patients within three months of ABPM [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7113/abstract/59\">",
"     59",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Ambulatory or self-recorded home readings may detect the early morning BP surge that may contribute to the increased incidence of sudden death, myocardial infarction, and stroke in the early morning hours [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7113/abstract/39,60,61\">",
"     39,60,61",
"    </a>",
"    ]. Modulation of this early morning surge in BP may not occur with supposedly long-acting, \"once-daily\" agents which do not provide 24-hour coverage. Such drugs, including",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/46/30440?source=see_link\">",
"     atenolol",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/19/8505?source=see_link\">",
"     enalapril",
"    </a>",
"    , may lose much of their effect during the early morning hours [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7113/abstract/62,63\">",
"     62,63",
"    </a>",
"    ], and therefore may need to be taken twice daily. Preferably, long-acting medications with effects that truly last for 24 hours should be substituted [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7113/abstract/64\">",
"     64",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Furthermore, in those with nocturnal hypertension or nondipping, ABPM may help determine the best timing of administration of antihypertensive agents. In one study,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/4/31815?source=see_link\">",
"     valsartan",
"    </a>",
"    taken before bedtime reestablished the nocturnal reduction in BP [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7113/abstract/65\">",
"     65",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The effect of repeated ambulatory monitoring on the treatment of hypertension was assessed in a randomized trial from Belgium in which 419 patients with untreated diastolic hypertension (average &ge;95 mmHg) had their subsequent antihypertensive therapy determined by conventional office BP or ABPM at one, two, four, and six months [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7113/abstract/66\">",
"     66",
"    </a>",
"    ]. The mean reduction in BP in the two groups was the same at the end of the study, averaging about",
"    <span class=\"nowrap\">",
"     14/10",
"    </span>",
"    mmHg. The following significant benefits were noted with the use of ABPM:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Fewer required multidrug therapy (27 versus 43 percent).",
"     </li>",
"     <li>",
"      More patients were able to stop antihypertensive drugs (26 versus 7 percent), suggesting a 19 percent incidence of white coat hypertension.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The observation of no difference between the two groups in echocardiographic assessment of left ventricular mass at six months suggested that therapy was not withdrawn inappropriately.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     COST",
"    </span>",
"    &nbsp;&mdash;&nbsp;The cost of ambulatory BP monitoring is mainly the initial investment in purchasing the monitors and computer software. The average cost (in American dollars) in 2011 for equipment is $2500 to $5000 for each monitor and $2000 to $3000 for the computer software. The monitors are relatively simple to use and additional costs in training personnel are relatively small. Physician charges to patients for the use of this modality ranged widely. At this time, Medicaid and Medicare in the United States provide limited payment for ambulatory monitoring, but only for the evaluation of possible white coat hypertension.",
"   </p>",
"   <p>",
"    However, the money saved by not prescribing antihypertensive medications to patients with white coat hypertension may more than offset the cost of monitoring [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7113/abstract/67,68\">",
"     67,68",
"    </a>",
"    ]. Home, self-recorded measurements with inexpensive semi-automatic devices will provide most of the information (other than for nocturnal readings) at far less cost [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7113/abstract/69\">",
"     69",
"    </a>",
"    ], but require more time and care to obtain the information provided in one day by ambulatory monitoring.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     HOME BP MEASUREMENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In view of the cost and limited availability of ambulatory monitoring, increasing attention is being given to home monitoring with inexpensive ($40 to $60) semi-automatic devices. Such self-recorded casual blood pressure (BP) measurements taken at home or work correlate more closely with the results of 24-hour or daytime ambulatory monitoring than with the BP taken in the physician's office [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7113/abstract/1,32,70,71\">",
"     1,32,70,71",
"    </a>",
"    ]. Furthermore, home BP measurements may be more predictive of adverse outcomes (eg, stroke, end-stage renal disease) than clinic blood pressures [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7113/abstract/21,72,73\">",
"     21,72,73",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition, patient self-monitoring of BP at home may improve BP control, especially if combined with behavioral interventions [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7113/abstract/74-76\">",
"     74-76",
"    </a>",
"    ]. A 2011 meta-analysis of 37 trials that randomly allocated patients to home BP monitoring or standard clinic based monitoring found the following significant benefits associated with home based monitoring [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7113/abstract/74\">",
"     74",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A greater decrease in BP by",
"      <span class=\"nowrap\">",
"       2.6/1.7",
"      </span>",
"      mmHg",
"     </li>",
"     <li>",
"      A two-fold increase in the frequency of reduction in antihypertensive therapy",
"     </li>",
"     <li>",
"      An 18 percent reduction in the relative risk of therapeutic inertia, defined as the clinician not intensifying the antihypertensive regimen in response to an elevated BP",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    If the blood pressure is taken at home to establish the diagnosis of hypertension or to assess blood pressure control, the optimal schedule is unclear. Increasing evidence suggests that at least 12 to 14 measurements should be obtained, with both morning and evening measurements taken over one week [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7113/abstract/1,31-33,77-81\">",
"     1,31-33,77-81",
"    </a>",
"    ]. Thereafter, frequency of home BP monitoring depends upon the stability of the BP and whether the regimen is changed.",
"   </p>",
"   <p>",
"    In addition to improved control of the BP, potential advantages of home BP monitoring include identification of white coat hypertension, assessment of the response to antihypertensive medications, and improvement in patient compliance. A possible problem with home BP monitoring is that self-reported BP values may be erroneous compared with the actual measurements concurrently stored in memory-equipped BP measuring devices [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7113/abstract/82\">",
"     82",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The potential problems with outpatient BP measurements can be minimized by providing adequate training, and periodically checking the machine for accuracy [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7113/abstract/1,83,84\">",
"     1,83,84",
"    </a>",
"    ]. Accuracy can be tested by having the patient or spouse take the BP in the office with their home monitor at the same time that physician health professional measures the BP in the other arm.",
"   </p>",
"   <p>",
"    As with ambulatory monitoring, the BP taken by the patient varies widely during the day, being influenced by factors such as stress (particularly at work), smoking, caffeine intake, natural circadian variation, and exercise [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7113/abstract/85\">",
"     85",
"    </a>",
"    ]. Thus, multiple readings should be taken to determine the average level. Several measurements should be taken daily until the BP is controlled. If nearly all BP measurements are below the goal BP, the frequency of home measurements can be reduced to once weekly.",
"   </p>",
"   <p>",
"    The timing of antihypertensive medications must also be considered. With short-acting drugs (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/59/9145?source=see_link\">",
"     captopril",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/46/30440?source=see_link\">",
"     atenolol",
"    </a>",
"    ), the BP may fall to normal or even below normal one to two hours after therapy and then gradually increase to elevated levels until the next dose is taken. This problem can be minimized by having the outpatient BP measured 30 to 60 minutes before taking medications, preferably in the early morning to assess for possible inadequate overnight BP control.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The diagnosis of hypertension based upon ABPM depends upon the time span over which it is interpreted (see",
"      <a class=\"local\" href=\"#H3\">",
"       'Interpretation of ABPM'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      A 24-hour average above",
"      <span class=\"nowrap\">",
"       135/85",
"      </span>",
"      mmHg",
"     </li>",
"     <li>",
"      Daytime (awake) average above",
"      <span class=\"nowrap\">",
"       140/90",
"      </span>",
"      mmHg",
"     </li>",
"     <li>",
"      Nighttime (asleep) average above",
"      <span class=\"nowrap\">",
"       125/75",
"      </span>",
"      mmHg",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cardiovascular complications correlate more closely with 24-hour or daytime ABPM than with the office BP. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Prediction of cardiovascular risk'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Although generally considered benign, white coat hypertension may be associated with an increased risk of stroke, possibly related to later development of sustained hypertension. The risk of cardiovascular complications associated with masked hypertension is similar to that seen with persistent hypertension. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Prognosis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H9\">",
"       'Masked hypertension'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Failure of the BP to fall by at least 10 percent during sleep (nondipping), may also be associated with increased cardiovascular risk. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Nocturnal blood pressure and nondippers'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Although there are no controlled data evaluating the efficacy of treating hypertension in all patients based upon ambulatory values, ABPM may facilitate achieving blood pressure control and reduce unnecessary treatment. Thus, ABPM should be considered in the following situations (see",
"      <a class=\"local\" href=\"#H13\">",
"       'Indications for ABPM'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Suspected white coat hypertension",
"     </li>",
"     <li>",
"      Suspected episodic hypertension",
"     </li>",
"     <li>",
"      Hypertension resistant to increasing medication",
"     </li>",
"     <li>",
"      Hypotensive symptoms while taking antihypertensive medications",
"     </li>",
"     <li>",
"      Autonomic dysfunction",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Self-recorded home blood pressure measurements are an excellent alternative if ABPM is not available or cost is a concern. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Home BP measurements'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/1\">",
"      Pickering TG, Miller NH, Ogedegbe G, et al. Call to action on use and reimbursement for home blood pressure monitoring: executive summary: a joint scientific statement from the American Heart Association, American Society Of Hypertension, and Preventive Cardiovascular Nurses Association. Hypertension 2008; 52:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/2\">",
"      Head GA, Mihailidou AS, Duggan KA, et al. Definition of ambulatory blood pressure targets for diagnosis and treatment of hypertension in relation to clinic blood pressure: prospective cohort study. BMJ 2010; 340:c1104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/3\">",
"      Fan HQ, Li Y, Thijs L, et al. Prognostic value of isolated nocturnal hypertension on ambulatory measurement in 8711 individuals from 10 populations. J Hypertens 2010; 28:2036.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/4\">",
"      Staessen JA, Fagard RH, Lijnen PJ, et al. Mean and range of the ambulatory pressure in normotensive subjects from a meta-analysis of 23 studies. Am J Cardiol 1991; 67:723.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/5\">",
"      Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25:1105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/6\">",
"      O'Brien E, Asmar R, Beilin L, et al. Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens 2005; 23:697.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/7\">",
"      White WB, Dey HM, Schulman P. Assessment of the daily blood pressure load as a determinant of cardiac function in patients with mild-to-moderate hypertension. Am Heart J 1989; 118:782.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/8\">",
"      Zachariah PK, Sheps SG, Bailey KR, et al. Age-related characteristics of ambulatory blood pressure load and mean blood pressure in normotensive subjects. JAMA 1991; 265:1414.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/9\">",
"      Vasan RS, Beiser A, Seshadri S, et al. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. JAMA 2002; 287:1003.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/10\">",
"      Hansen TW, Jeppesen J, Rasmussen S, et al. Ambulatory blood pressure and mortality: a population-based study. Hypertension 2005; 45:499.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/11\">",
"      Dolan E, Stanton A, Thijs L, et al. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension 2005; 46:156.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/12\">",
"      White WB. Relating cardiovascular risk to out-of-office blood pressure and the importance of controlling blood pressure 24 hours a day. Am J Med 2008; 121:S2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/13\">",
"      Fagard RH, Staessen JA, Thijs L. Prediction of cardiac structure and function by repeated clinic and ambulatory blood pressure. Hypertension 1997; 29:22.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/14\">",
"      Campbell NR, Culleton BW, McKay DW. Misclassification of blood pressure by usual measurement in ambulatory physician practices. Am J Hypertens 2005; 18:1522.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/15\">",
"      Stergiou GS, Tzamouranis D, Nasothimiou EG, et al. Are there really differences between home and daytime ambulatory blood pressure? Comparison using a novel dual-mode ambulatory and home monitor. J Hum Hypertens 2010; 24:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/16\">",
"      Myers MG, Godwin M, Dawes M, et al. Measurement of blood pressure in the office: recognizing the problem and proposing the solution. Hypertension 2010; 55:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/17\">",
"      Clement DL, De Buyzere ML, De Bacquer DA, et al. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med 2003; 348:2407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/18\">",
"      Redon J, Campos C, Narciso ML, et al. Prognostic value of ambulatory blood pressure monitoring in refractory hypertension: a prospective study. Hypertension 1998; 31:712.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/19\">",
"      Salles GF, Cardoso CR, Muxfeldt ES. Prognostic influence of office and ambulatory blood pressures in resistant hypertension. Arch Intern Med 2008; 168:2340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/20\">",
"      Muxfeldt ES, Cardoso CR, Salles GF. Prognostic value of nocturnal blood pressure reduction in resistant hypertension. Arch Intern Med 2009; 169:874.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/21\">",
"      Agarwal R, Andersen MJ. Prognostic importance of ambulatory blood pressure recordings in patients with chronic kidney disease. Kidney Int 2006; 69:1175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/22\">",
"      Pickering TG, Davidson K, Gerin W, Schwartz JE. Masked hypertension. Hypertension 2002; 40:795.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/23\">",
"      Mallion JM, Clerson P, Bobrie G, et al. Predictive factors for masked hypertension within a population of controlled hypertensives. J Hypertens 2006; 24:2365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/24\">",
"      Pierdomenico SD, Cuccurullo F. Prognostic value of white-coat and masked hypertension diagnosed by ambulatory monitoring in initially untreated subjects: an updated meta analysis. Am J Hypertens 2011; 24:52.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/25\">",
"      Fagard RH, Cornelissen VA. Incidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: a meta-analysis. J Hypertens 2007; 25:2193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/26\">",
"      Bj&ouml;rklund K, Lind L, Zethelius B, et al. Isolated ambulatory hypertension predicts cardiovascular morbidity in elderly men. Circulation 2003; 107:1297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/27\">",
"      Bobrie G, Chatellier G, Genes N, et al. Cardiovascular prognosis of \"masked hypertension\" detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA 2004; 291:1342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/28\">",
"      Ohkubo T, Kikuya M, Metoki H, et al. Prognosis of \"masked\" hypertension and \"white-coat\" hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study. J Am Coll Cardiol 2005; 46:508.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/29\">",
"      Boggia J, Li Y, Thijs L, et al. Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet 2007; 370:1219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/30\">",
"      Ben-Dov IZ, Kark JD, Ben-Ishay D, et al. Predictors of all-cause mortality in clinical ambulatory monitoring: unique aspects of blood pressure during sleep. Hypertension 2007; 49:1235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/31\">",
"      Staessen JA, Bieniaszewski L, O'Brien E, et al. Nocturnal blood pressure fall on ambulatory monitoring in a large international database. The \"Ad Hoc' Working Group. Hypertension 1997; 29:30.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/32\">",
"      Andersen MJ, Khawandi W, Agarwal R. Home blood pressure monitoring in CKD. Am J Kidney Dis 2005; 45:994.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/33\">",
"      Fujii T, Uzu T, Nishimura M, et al. Circadian rhythm of natriuresis is disturbed in nondipper type of essential hypertension. Am J Kidney Dis 1999; 33:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/34\">",
"      Gatzka CD, Schobel HP, Klingbeil AU, et al. Normalization of circadian blood pressure profiles after renal transplantation. Transplantation 1995; 59:1270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/35\">",
"      Verdecchia P, Schillaci G, Gatteschi C, et al. Blunted nocturnal fall in blood pressure in hypertensive women with future cardiovascular morbid events. Circulation 1993; 88:986.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/36\">",
"      Tsivgoulis G, Vemmos KN, Zakopoulos N, et al. Association of blunted nocturnal blood pressure dip with intracerebral hemorrhage. Blood Press Monit 2005; 10:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/37\">",
"      Metoki H, Ohkubo T, Kikuya M, et al. Prognostic significance for stroke of a morning pressor surge and a nocturnal blood pressure decline: the Ohasama study. Hypertension 2006; 47:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/38\">",
"      Ingelsson E, Bj&ouml;rklund-Bodeg&aring;rd K, Lind L, et al. Diurnal blood pressure pattern and risk of congestive heart failure. JAMA 2006; 295:2859.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/39\">",
"      Kario K, Pickering TG, Umeda Y, et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation 2003; 107:1401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/40\">",
"      Lurbe E, Redon J, Kesani A, et al. Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med 2002; 347:797.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/41\">",
"      V&ouml;r&ouml;s P, Lengyel Z, Nagy V, et al. Diurnal blood pressure variation and albuminuria in normotensive patients with insulin-dependent diabetes mellitus. Nephrol Dial Transplant 1998; 13:2257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/42\">",
"      Davidson MB, Hix JK, Vidt DG, Brotman DJ. Association of impaired diurnal blood pressure variation with a subsequent decline in glomerular filtration rate. Arch Intern Med 2006; 166:846.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/43\">",
"      Mancia G, Parati G, Pomidossi G, et al. Alerting reaction and rise in blood pressure during measurement by physician and nurse. Hypertension 1987; 9:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/44\">",
"      Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289:2560.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/45\">",
"      Watson RD, Lumb R, Young MA, et al. Variation in cuff blood pressure in untreated outpatients with mild hypertension--implications for initiating antihypertensive treatment. J Hypertens 1987; 5:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/46\">",
"      Pickering TG, James GD, Boddie C, et al. How common is white coat hypertension? JAMA 1988; 259:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/47\">",
"      Niiranen TJ, Jula AM, Kantola IM, Reunanen A. Prevalence and determinants of isolated clinic hypertension in the Finnish population: the Finn-HOME study. J Hypertens 2006; 24:463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/48\">",
"      Muxfeldt ES, Bloch KV, Nogueira Ada R, Salles GF. True resistant hypertension: is it possible to be recognized in the office? Am J Hypertens 2005; 18:1534.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/49\">",
"      Verdecchia P, Palatini P, Schillaci G, et al. Independent predictors of isolated clinic ('white-coat') hypertension. J Hypertens 2001; 19:1015.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/50\">",
"      Khattar RS, Senior R, Lahiri A. Cardiovascular outcome in white-coat versus sustained mild hypertension: a 10-year follow-up study. Circulation 1998; 98:1892.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/51\">",
"      Verdecchia P, Reboldi GP, Angeli F, et al. Short- and long-term incidence of stroke in white-coat hypertension. Hypertension 2005; 45:203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/52\">",
"      Verdecchia P, Porcellati C, Schillaci G, et al. Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension 1994; 24:793.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/53\">",
"      Muscholl MW, Hense HW, Br&ouml;ckel U, et al. Changes in left ventricular structure and function in patients with white coat hypertension: cross sectional survey. BMJ 1998; 317:565.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/54\">",
"      Palatini P, Mormino P, Santonastaso M, et al. Target-organ damage in stage I hypertensive subjects with white coat and sustained hypertension: results from the HARVEST study. Hypertension 1998; 31:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/55\">",
"      Cavallini MC, Roman MJ, Pickering TG, et al. Is white coat hypertension associated with arterial disease or left ventricular hypertrophy? Hypertension 1995; 26:413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/56\">",
"      Bidlingmeyer I, Burnier M, Bidlingmeyer M, et al. Isolated office hypertension: a prehypertensive state? J Hypertens 1996; 14:327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/57\">",
"      Hemmelgarn BR, McAllister FA, Myers MG, et al. The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part 1- blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol 2005; 21:645.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/58\">",
"      Pickering TG, Shimbo D, Haas D. Ambulatory blood-pressure monitoring. N Engl J Med 2006; 354:2368.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/59\">",
"      Grin JM, McCabe EJ, White WB. Management of hypertension after ambulatory blood pressure monitoring. Ann Intern Med 1993; 118:833.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/60\">",
"      Muller JE, Abela GS, Nesto RW, Tofler GH. Triggers, acute risk factors and vulnerable plaques: the lexicon of a new frontier. J Am Coll Cardiol 1994; 23:809.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/61\">",
"      Li Y, Thijs L, Hansen TW, et al. Prognostic value of the morning blood pressure surge in 5645 subjects from 8 populations. Hypertension 2010; 55:1040.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/62\">",
"      Neutel JM, Schnaper H, Cheung DG, et al. Antihypertensive effects of beta-blockers administered once daily: 24-hour measurements. Am Heart J 1990; 120:166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/63\">",
"      Meredith PA, Donnelly R, Elliott HL, et al. Prediction of the antihypertensive response to enalapril. J Hypertens 1990; 8:1085.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/64\">",
"      Kario K. Time for focus on morning hypertension: pitfall of current antihypertensive medication. Am J Hypertens 2005; 18:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/65\">",
"      Hermida RC, Calvo C, Ayala DE, et al. Treatment of non-dipper hypertension with bedtime administration of valsartan. J Hypertens 2005; 23:1913.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/66\">",
"      Staessen JA, Byttebier G, Buntinx F, et al. Antihypertensive treatment based on conventional or ambulatory blood pressure measurement. A randomized controlled trial. Ambulatory Blood Pressure Monitoring and Treatment of Hypertension Investigators. JAMA 1997; 278:1065.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/67\">",
"      Krakoff LR, Eison H, Phillips RH, et al. Effect of ambulatory blood pressure monitoring on the diagnosis and cost of treatment for mild hypertension. Am Heart J 1988; 116:1152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/68\">",
"      Krakoff LR. Cost-effectiveness of ambulatory blood pressure: a reanalysis. Hypertension 2006; 47:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/69\">",
"      Rickerby J. The role of home blood pressure measurement in managing hypertension: an evidence-based review. J Hum Hypertens 2002; 16:469.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/70\">",
"      Kleinert HD, Harshfield GA, Pickering TG, et al. What is the value of home blood pressure measurement in patients with mild hypertension? Hypertension 1984; 6:574.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/71\">",
"      Verberk WJ, Kroon AA, Kessels AG, de Leeuw PW. Home blood pressure measurement: a systematic review. J Am Coll Cardiol 2005; 46:743.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/72\">",
"      Asayama K, Ohkubo T, Kikuya M, et al. Prediction of stroke by self-measurement of blood pressure at home versus casual screening blood pressure measurement in relation to the Joint National Committee 7 classification: the Ohasama study. Stroke 2004; 35:2356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/73\">",
"      Niiranen TJ, H&auml;nninen MR, Johansson J, et al. Home-measured blood pressure is a stronger predictor of cardiovascular risk than office blood pressure: the Finn-Home study. Hypertension 2010; 55:1346.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/74\">",
"      Agarwal R, Bills JE, Hecht TJ, Light RP. Role of home blood pressure monitoring in overcoming therapeutic inertia and improving hypertension control: a systematic review and meta-analysis. Hypertension 2011; 57:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/75\">",
"      Cappuccio FP, Kerry SM, Forbes L, Donald A. Blood pressure control by home monitoring: meta-analysis of randomised trials. BMJ 2004; 329:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/76\">",
"      Bosworth HB, Olsen MK, Grubber JM, et al. Two self-management interventions to improve hypertension control: a randomized trial. Ann Intern Med 2009; 151:687.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/77\">",
"      Parati G, Pickering TG. Home blood-pressure monitoring: US and European consensus. Lancet 2009; 373:876.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/78\">",
"      Stergiou GS, Skeva II, Baibas NM, et al. Diagnosis of hypertension using home or ambulatory blood pressure monitoring: comparison with the conventional strategy based on repeated clinic blood pressure measurements. J Hypertens 2000; 18:1745.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/79\">",
"      Parati G, Stergiou GS, Asmar R, et al. European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring. J Hypertens 2008; 26:1505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/80\">",
"      Parati G, Stergiou GS, Asmar R, et al. European Society of Hypertension practice guidelines for home blood pressure monitoring. J Hum Hypertens 2010; 24:779.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/81\">",
"      Niiranen TJ, Johansson JK, Reunanen A, Jula AM. Optimal schedule for home blood pressure measurement based on prognostic data: the Finn-Home Study. Hypertension 2011; 57:1081.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/82\">",
"      Mengden T, Hernandez Medina RM, Beltran B, et al. Reliability of reporting self-measured blood pressure values by hypertensive patients. Am J Hypertens 1998; 11:1413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/83\">",
"      Asmar R, Zanchetti A. Guidelines for the use of self-blood pressure monitoring: a summary report of the First International Consensus Conference. Groupe Evaluation &amp; Measure of the French Society of Hypertension. J Hypertens 2000; 18:493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/84\">",
"      Beevers G, Lip GY, O'Brien E. ABC of hypertension: Blood pressure measurement. Part II-conventional sphygmomanometry: technique of auscultatory blood pressure measurement. BMJ 2001; 322:1043.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7113/abstract/85\">",
"      Pickering TG. The influence of daily activity on ambulatory blood pressure. Am Heart J 1988; 116:1141.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3820 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-197.136.42.3-071942397F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_60_7113=[""].join("\n");
var outline_f6_60_7113=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H17\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      MEASUREMENT OF ABPM",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      INTERPRETATION OF ABPM",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Definition of hypertension",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Blood pressure load",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      PROGNOSTIC VALUE OF ABPM",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Prediction of cardiovascular risk",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Progression of kidney disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Masked hypertension",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Nocturnal blood pressure and nondippers",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      WHITE COAT HYPERTENSION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      INDICATIONS FOR ABPM",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      INFLUENCE ON THERAPY OF HYPERTENSION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      COST",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      HOME BP MEASUREMENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEPH/3820\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/3820|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?24/2/24621\" title=\"figure 1\">",
"      BP by doctor and nurse",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/47/18169?source=related_link\">",
"      Cardiovascular effects of obstructive sleep apnea",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/34/17959?source=related_link\">",
"      Clinical implications and treatment of left ventricular hypertrophy in hypertension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/55/36728?source=related_link\">",
"      Definition, risk factors, and evaluation of resistant hypertension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/26/422?source=related_link\">",
"      Initial evaluation of the hypertensive adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/36/32330?source=related_link\">",
"      Overview of hypertension in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/46/13034?source=related_link\">",
"      Physiology and clinical use of melatonin",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f6_60_7114="Major side effects of inhaled glucocorticoids";
var content_f6_60_7114=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Major side effects of inhaled glucocorticoids",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/60/7114/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/60/7114/contributors\">",
"     Kenneth G Saag, MD, MSc",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/60/7114/contributors\">",
"     Daniel E Furst, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/60/7114/contributors\">",
"     Peter J Barnes, DM, DSc, FRCP, FRS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/60/7114/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/60/7114/contributors\">",
"     Bruce S Bochner, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/60/7114/contributors\">",
"     Robert A Wood, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/60/7114/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/60/7114/contributors\">",
"     Helen Hollingsworth, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?6/60/7114/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 4, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Inhaled glucocorticoids (also called inhaled corticosteroids or ICS) have fewer and less severe adverse effects than orally-administered glucocorticoids and their utility in the management of asthma is undisputed [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/1\">",
"     1",
"    </a>",
"    ]. However, there are concerns about the systemic effects of ICS, particularly as they are likely to be used over long periods of time, in infants and children, and in the elderly [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. The safety of ICS has been extensively investigated since their introduction for the treatment of asthma 30 years ago [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/4-9\">",
"     4-9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic review will present the local and systemic side effects of ICS, and address other concerns that are often raised by patients regarding these medications. The various types of inhalers used for asthma therapy and the numerous side effects of orally administered glucocorticoids are reviewed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/26/18856?source=see_link\">",
"     \"The use of inhaler devices in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/57/36760?source=see_link\">",
"     \"The use of inhaler devices in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/47/27386?source=see_link\">",
"     \"Major side effects of systemic glucocorticoids\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EFFECTS OF LOCAL DEPOSITION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Side effects due to the local deposition of inhaled glucocorticoid in the oropharynx and larynx may occur. The frequency of complaints depends on the dose, frequency of administration, and on the delivery system used.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Dysphonia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dysphonia (hoarse voice) is a common complaint among users of ICS. Reported incidences vary from 1 to 60 percent, depending on the patient population, device, dose, length of observation, and manner of data collection [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/10-13\">",
"     10-13",
"    </a>",
"    ]. Limited data are available for hydrofluoroalkane (HFA)-based metered dose inhalers (MDIs), but it appears that HFA-based inhalers have a lower risk for dysphonia than chlorofluorocarbon (CFC)-based MDIs [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/13\">",
"     13",
"    </a>",
"    ]. Dysphonia is not usually reduced by using spacers with MDIs, but the risk of dysphonia may be lower with some dry powder devices (DPIs) compared with MDIs [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The mechanism of ICS-associated dysphonia may involve factors such as myopathy of laryngeal muscles (manifest as incomplete closure or bowing of the vocal cords on adduction), mucosal irritation, and laryngeal candidiasis [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/14\">",
"     14",
"    </a>",
"    ]. Dysphonia due to myopathy or mucosal irritation is reversible when treatment is withdrawn [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/14\">",
"     14",
"    </a>",
"    ]. Dysphonia may be disabling in singers and lecturers, although it is not troublesome for many patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Topical candidiasis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Oropharyngeal candidiasis (thrush) may be a problem in some patients, particularly elderly patients, patients taking concomitant oral glucocorticoids, and patients inhaling glucocorticoids more often than twice daily [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/15,16\">",
"     15,16",
"    </a>",
"    ]. In a systematic review of trials of ICS for COPD, the risk of oropharyngeal candidiasis was increased among ICS users compared with placebo (OR 2.65, 95% CI 2.03 to 3.46, 5586 participants) [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/16\">",
"     16",
"    </a>",
"    ]. For patients using metered dose inhalers (MDIs), large volume spacer devices may protect against thrush by reducing the amount of drug deposited in the oropharynx. In addition, rinsing the mouth and throat with water and expectorating the rinsate after use of all forms of ICS is preventative. The treatment of oropharyngeal candidiasis is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/19/20793?source=see_link&amp;anchor=H2#H2\">",
"     \"Treatment of oropharyngeal and esophageal candidiasis\", section on 'Oropharyngeal candidiasis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Laryngeal candidiasis is a less common complication of ICS, but has been reported in up to 15 percent of patients complaining of dysphonia during ICS therapy. Isolated laryngeal candidiasis, presenting with dysphonia and sometimes throat pain, has been described in association with ICS in case reports [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/12,17,18\">",
"     12,17,18",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Dysphonia'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H100383861\">",
"    <span class=\"h2\">",
"     Contact hypersensitivity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Allergic contact dermatitis has occasionally been described due to inhaled glucocorticoids, particularly",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/7/32880?source=see_link\">",
"     budesonide",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/19-22\">",
"     19-22",
"    </a>",
"    ]. An erythematous, eczematoid eruption is typically noted around the mouth, nostrils, or eyes. Typically, the patient taking inhaled glucocorticoids is affected, although individuals administering these medications have also been affected in cases of occupational contact hypersensitivity [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/22\">",
"     22",
"    </a>",
"    ]. The diagnosis can be confirmed with patch testing, and most budesonide-allergic patients can be managed by changing to another inhaled glucocorticoid that does not cross-react with budesonide, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?33/7/33904?source=see_link\">",
"     beclomethasone",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/15/36080?source=see_link\">",
"     mometasone",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/45/39632?source=see_link\">",
"     fluticasone",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Other",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cough and throat irritation, sometimes accompanied by reflex bronchoconstriction, may occur when ICS are given via MDIs, due to surfactants in pressurized aerosols. This is usually rectified by switching to a dry powder device.",
"   </p>",
"   <p>",
"    Other unusual local complications of ICS include infectious perioral dermatitis, tongue hypertrophy, and increased thirst [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     SYSTEMIC SIDE EFFECTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A critical issue in the study of systemic side effects from ICS is whether a measurable effect translates into a significant clinical consequence. As biochemical markers of systemic glucocorticoid effects become more sensitive, systemic effects are more readily detectable. However, determining clinical relevance necessitates careful, long-term follow-up studies, which are difficult to perform and are often confounded by the effects of the diseases themselves, the administration of intermittent oral glucocorticoids, and other co-morbidities.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Factors influencing risk",
"    </span>",
"    &nbsp;&mdash;&nbsp;A patient's risk of developing adverse systemic effects from ICS is influenced by several factors, including the dose delivered to the patient, the site of delivery (ie, gastrointestinal tract and lung), the delivery system used, and individual differences in the patient's response to the glucocorticoid. Sporadic case reports of dramatic adverse systemic effects from ICS are likely due to idiosyncratic reactions caused by abnormal pharmacokinetic handling of the drug in a particular individual. Other studies suggest that systemic effects of ICS are less detectable in patients with more severe asthma, perhaps because a lesser amount of drug reaches the lung periphery [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Pharmacokinetics of ICS'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Pharmacokinetics of ICS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pharmacokinetics of ICS administered by MDI are depicted in the figure (",
"    <a class=\"graphic graphic_figure graphicRef59553 \" href=\"UTD.htm?29/3/29747\">",
"     figure 1",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Approximately 80 to 90 percent of a dose delivered from a MDI is deposited in the oropharynx, swallowed, and subsequently absorbed from the gastrointestinal tract [",
"      <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/25\">",
"       25",
"      </a>",
"      ]. Drug that is absorbed from the gastrointestinal tract undergoes \"first pass metabolism\" in the liver, which results in the majority of the absorbed drug being converted into inactive forms for excretion. The remainder enters the systemic circulation and contributes to systemic side effects.",
"     </li>",
"     <li>",
"      Ten to 20 percent of a dose from a MDI enters the lung. This fraction exerts the therapeutic effect and is then absorbed directly into the systemic circulation. Thus, the drug that is absorbed from the lung has relatively greater systemic impact compared to that absorbed through the gut because there is no first pass after lung absorption.",
"     </li>",
"     <li>",
"      The pharmacokinetics of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/45/33488?source=see_link\">",
"       ciclesonide",
"      </a>",
"      are slightly different from other ICS because ciclesonide is delivered to the airways as an inactive compound that is subsequently converted by esterases to the active metabolite. It also has low oral bioavailability and a high clearance rate, potentially decreasing systemic side effects [",
"      <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/26,27\">",
"       26,27",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Skeletal effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;The potential skeletal effects of ICS include growth deceleration in children, and increased risk for osteoporosis in both adults and children.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Growth deceleration",
"    </span>",
"    &nbsp;&mdash;&nbsp;There has been particular concern that ICS are associated with growth deceleration in children. Asthma itself (as with other chronic diseases) has been associated with a deceleration of growth velocity, which is most pronounced with severe disease [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/28\">",
"     28",
"    </a>",
"    ]. However, asthma is also associated with a delayed onset of puberty, such that asthmatic children may continue to grow over a longer period of time [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/29\">",
"     29",
"    </a>",
"    ]. Overall, the effect of ICS on adult height appears small based on a number of studies described below.",
"   </p>",
"   <p>",
"    In clinical trials, growth is often assessed by knemometry, which is considered to be a very sensitive method for assessing short-term leg growth. However, the relationship between knemometric measurements and final height is uncertain, because low doses of oral glucocorticoid, which have no effect on final adult height, cause profound suppression of knemometric parameters.",
"   </p>",
"   <p>",
"    Using techniques such as knemometry, moderate-to-high doses of ICS have been found to cause decreased linear growth velocity [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/3,28-36\">",
"     3,28-36",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a meta-analysis of five studies, moderate doses of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?33/7/33904?source=see_link\">",
"       beclomethasone",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/45/39632?source=see_link\">",
"       fluticasone",
"      </a>",
"      in children with mild to moderate asthma caused a decrease in linear growth velocity of 1.51",
"      <span class=\"nowrap\">",
"       cm/year",
"      </span>",
"      and 0.43",
"      <span class=\"nowrap\">",
"       cm/year,",
"      </span>",
"      respectively [",
"      <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/36\">",
"       36",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In the Childhood Asthma Management Program (CAMP), 1041 children with asthma were randomly assigned to take inhaled",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/7/32880?source=see_link\">",
"       budesonide",
"      </a>",
"      , inhaled",
"      <a class=\"drug drug_general\" href=\"UTD.htm?0/43/691?source=see_link\">",
"       nedocromil",
"      </a>",
"      , or placebo for four to six years [",
"      <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/37\">",
"       37",
"      </a>",
"      ]. A reduction in growth velocity was noted in the budesonide group in the first year, but growth velocities were the same in all groups by the end of the study. The budesonide group had a 1.1 cm lower mean increase in height compared with placebo at the end of the study.",
"     </li>",
"     <li>",
"      In a randomized trial, ninety-four children aged seven to nine years old received inhaled",
"      <a class=\"drug drug_general\" href=\"UTD.htm?33/7/33904?source=see_link\">",
"       beclomethasone",
"      </a>",
"      dipropionate (BDP) (400",
"      <span class=\"nowrap\">",
"       mcg/day)",
"      </span>",
"      or placebo for seven months [",
"      <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/38\">",
"       38",
"      </a>",
"      ]. Treatment had no effect on overnight urinary cortisol production but did reduce growth velocity (0.79 versus 1.14",
"      <span class=\"nowrap\">",
"       mm/week).",
"      </span>",
"      At the end of the seven months of therapy, children receiving BDP had grown 1 cm less than those in the placebo group.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The effect of childhood administration of ICS on adult height does not appear to be progressive or cumulative [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/33,34,39,40\">",
"     33,34,39,40",
"    </a>",
"    ]. In a follow up to the CAMP trial described above [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/37\">",
"     37",
"    </a>",
"    ], the adult height of 943 of the original 1041 participants was assessed at age 24.9 &plusmn; 2.7 years [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/41\">",
"     41",
"    </a>",
"    ]. After controlling for demographic features and asthma severity, the mean adult height was 1.2 cm lower in the",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/7/32880?source=see_link\">",
"     budesonide",
"    </a>",
"    group than in the placebo group, compared with a growth difference of 1.1 cm at the time of the trial.",
"   </p>",
"   <p>",
"    Other smaller studies have found that adult height in people with asthma is normal despite ICS therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/3,34,40\">",
"     3,34,40",
"    </a>",
"    ]. As an example, in a prospective study of 142 children with asthma who had been treated with inhaled",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/7/32880?source=see_link\">",
"     budesonide",
"    </a>",
"    for 3 to 13 years, normal adult height was attained [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/34\">",
"     34",
"    </a>",
"    ]. In addition, the budesonide-treated children reached their predicted adult height to the same degree as their healthy siblings and a control group of children with asthma who did not receive budesonide.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Osteoporosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The effects of oral glucocorticoids on osteoporosis and increased risk of vertebral and rib fractures are well known. Glucocorticoids interfere with bone formation by suppressing osteoblasts, decreasing sex hormone secretion, and altering calcium absorption by the gut and kidney [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/42\">",
"     42",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/54/42855?source=see_link\">",
"     \"Pathogenesis, clinical features, and evaluation of glucocorticoid-induced osteoporosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Studies have not found consistent results regarding the impact of ICS on risk of osteoporosis and the more clinically relevant outcome of increased risk of osteoporotic fracture (",
"    <a class=\"graphic graphic_table graphicRef81103 \" href=\"UTD.htm?28/63/29693\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/43-49\">",
"     43-49",
"    </a>",
"    ]. However, the majority of studies suggest that ICS therapy is associated with an accelerated decrease in bone mineral density. This effect was particularly prominent among postmenopausal women in one study [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/50\">",
"     50",
"    </a>",
"    ]. Cross-sectional studies have shown an inverse correlation between the ICS daily dose and cumulative dose and spine bone density in asthmatics (",
"    <a class=\"graphic graphic_figure graphicRef66311 \" href=\"UTD.htm?7/44/7887\">",
"     figure 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/45,46\">",
"     45,46",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    At least two studies have addressed the issue of fracture and have attempted to eliminate the confounding issues [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/51,52\">",
"     51,52",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One case-control study found that the use of ICS was associated with a small, but significant increase in the odds ratio for hip fracture (OR 1.26). This increased risk persisted after adjustments were made for potential confounders, including the number of courses of oral glucocorticoids a patient required (OR 1.19, 95% CI 1.10-1.28) [",
"      <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/51\">",
"       51",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      ICS use was found to be an independent risk factor for fracture in a longitudinal cohort study of 1,671 subjects with asthma or COPD (mean age, 81 years) [",
"      <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/52\">",
"       52",
"      </a>",
"      ]. The dose-response relationship between ICS exposure and time to first fracture was determined using Cox regression [",
"      <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/52\">",
"       52",
"      </a>",
"      ]. Mean follow-up period was nine years. A dose-related increase in fracture risk with exposure to ICS was identified (rate ratio for mean daily dose &gt;600 mcg, 2.53). The results were similar after adjusting for oral glucocorticoid exposure, airflow obstruction diagnosis, historical fracture, and bronchodilator use and also in the subset of people with no exposure to oral glucocorticoids (rate ratio, 4.54, 95% CI 1.23-16.74).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    However, other prospective studies and a meta-analysis suggest that ICS therapy is not associated with an accelerated decline in bone mineral density or fracture [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/53-58\">",
"     53-58",
"    </a>",
"    ]. It is possible that the duration of follow-up and size of these studies were insufficient to detect an effect because changes in bone mass take years to develop. Alternatively, increased mobility due to improved respiratory status may partially offset the deleterious effects of ICS therapy. Until the risk for osteoporosis and fracture is better defined, measures to decrease the likelihood of osteoporosis due to ICS are warranted. Adult patients receiving chronic therapy with inhaled glucocorticoids and who have a moderate risk of osteoporosis should also undergo bone density measurement to assess the need for preventive therapy, as is recommended for patients receiving inhaled glucocorticoids for COPD (",
"    <a class=\"graphic graphic_table graphicRef70743 \" href=\"UTD.htm?32/11/32955\">",
"     table 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/36/17994?source=see_link\">",
"     \"Prevention and treatment of glucocorticoid-induced osteoporosis\"",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H24\">",
"     'Measures to minimize systemic side effects'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Bone formation in children",
"    </span>",
"    &nbsp;&mdash;&nbsp;Monitoring of sensitive markers for bone metabolism (serum alkaline phosphatase, bone alkaline phosphatase, osteocalcin, carboxypropeptide) demonstrates a dose-dependent reduction in bone formation in older children [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/59,60\">",
"     59,60",
"    </a>",
"    ]. Whether infants are particularly sensitive to glucocorticoid-induced osteopenia is unknown, but doses should be minimized as much as possible.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Adrenal suppression",
"    </span>",
"    &nbsp;&mdash;&nbsp;Systemic administration of glucocorticoids may cause hypothalamic-pituitary-adrenal (HPA) axis suppression by reducing corticotropin (ACTH) production, which reduces cortisol secretion by the adrenal gland. The degree of HPA suppression is dependent on dose, duration, frequency, and timing of glucocorticoid administration. The assessment of a patient for adrenal suppression is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/20/24905?source=see_link\">",
"     \"Evaluation of the response to ACTH in adrenal insufficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There are many studies of HPA axis function in asthmatic adults being treated with ICS, although the results are inconsistent because they have often been uncontrolled and patients have received intermittent courses of oral glucocorticoids (which may affect the HPA axis for weeks) [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, measurement of HPA axis function does demonstrate systemic effects of ICS, as reported in the following studies [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/3,61-63\">",
"     3,61-63",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A meta-analysis of 21 studies of urinary cortisol concentrations and 13 studies of morning plasma cortisol concentrations found evidence of hypothalamic-pituitary-adrenal axis suppression that was most common in the presence of ICS doses greater than 800 mcg daily, although suppression was frequently absent even at higher doses [",
"      <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/3,64\">",
"       3,64",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Adrenal suppression was seen with lower doses of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/45/39632?source=see_link\">",
"       fluticasone",
"      </a>",
"      than with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?33/7/33904?source=see_link\">",
"       beclomethasone",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/7/32880?source=see_link\">",
"       budesonide",
"      </a>",
"      , a finding subsequently reproduced in other studies [",
"      <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/61-63\">",
"       61-63",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/45/33488?source=see_link\">",
"       Ciclesonide",
"      </a>",
"      may theoretically be less likely to cause biochemical evidence of adrenal suppression than other ICS due to differences in pharmacokinetics [",
"      <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/65\">",
"       65",
"      </a>",
"      ]. However, further testing is needed, using well-controlled, dose ranging, long duration studies with relevant clinical outcomes, before these theoretical advantages can be considered clinically important. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Pharmacokinetics of ICS'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Several studies of children have shown a dose-dependent effect of ICS on the hypothalamic-pituitary-adrenal (HPA) axis [",
"      <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/66-70\">",
"       66-70",
"      </a>",
"      ]. One retrospective survey identified several cases of acute adrenal crisis (ie, hypoglycemia, convulsions, coma) in the population of the United Kingdom in association with ICS use (at doses ranging from 500 to 2000 mcg daily), which appeared to occur disproportionately in children and with the use of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/45/39632?source=see_link\">",
"       fluticasone",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/71\">",
"       71",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    While HPA axis function is clearly capable of being affected by ICS, the effect appears infrequent. In a meta-analysis of five randomized trials (732 patients), abnormal adrenal function was found in only 6, 7, 10, and 13 percent of patients taking 500, 1000, 1500, and 2000",
"    <span class=\"nowrap\">",
"     mcg/day",
"    </span>",
"    of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/45/39632?source=see_link\">",
"     fluticasone",
"    </a>",
"    , respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/72\">",
"     72",
"    </a>",
"    ]. This analysis should be interpreted with caution because only one study contained data for fluticasone doses greater than 1000",
"    <span class=\"nowrap\">",
"     mcg/day;",
"    </span>",
"    thus, the data for the higher doses were derived by extrapolation.",
"   </p>",
"   <p>",
"    Thus, clinicians should be aware of the potential for subclinical adrenal suppression in any patient who has been receiving prolonged ICS, and should attempt to reduce the dose of ICS to the lowest dose that maintains symptom control. For patients receiving ICS therapy within the recommended ranges, the risk of symptomatic adrenal suppression or acute adrenal crisis appears to be very small. (See",
"    <a class=\"local\" href=\"#H24\">",
"     'Measures to minimize systemic side effects'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Ocular changes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Systemic glucocorticoids can contribute to increased intraocular pressure and increased risk of cataract formation. A few studies have examined whether ICS can have a similar effect. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/47/27386?source=see_link&amp;anchor=H8#H8\">",
"     \"Major side effects of systemic glucocorticoids\", section on 'Eye'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Intraocular pressure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Conflicting data have been reported regarding whether ICS are associated with an increased risk of ocular hypertension [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/73-75\">",
"     73-75",
"    </a>",
"    ]. In a case control study of 2291 subjects with glaucoma and 13,445 controls, neither current use nor continuous use of high-dose ICS for three or more months were associated with an increased risk of glaucoma [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/75\">",
"     75",
"    </a>",
"    ]. On the other hand, a separate study found an increased risk of ocular hypertension among patients with a family history of glaucoma who were using ICS (OR 2.6, 95% CI 1.2-5.8), particularly those on a high dose of ICS [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/74\">",
"     74",
"    </a>",
"    ]. The investigators suggested that ocular pressure should be monitored in older adults with a family history of glaucoma who are using high dose ICS.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Cataracts",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of systemic glucocorticoids is a definite risk factor for the development of posterior subcapsular cataracts. In contrast, the risk with ICS use is less clear, since the majority of studies could not control for the confounding use of systemic glucocorticoids [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/76-81\">",
"     76-81",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/47/27386?source=see_link\">",
"     \"Major side effects of systemic glucocorticoids\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/19/2362?source=see_link\">",
"     \"Cataract in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A population-based cross-sectional study of 3654 patients from Australia, ages 49 to 97 years, found a higher prevalence of nuclear cataracts and posterior subcapsular cataracts (relative prevalence, 1.5 and 1.9, respectively) among current or previous users of ICS, compared to those who never used ICS [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/76\">",
"     76",
"    </a>",
"    ]. Higher cumulative lifetime doses of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?33/7/33904?source=see_link\">",
"     beclomethasone",
"    </a>",
"    were associated with a greater risk of posterior subcapsular cataracts; the highest prevalence (27 percent) occurred in those whose lifetime dose was above 2000 mg (relative prevalence, 5.5). This dose corresponded to the use of 10 puffs per day for over 10 years. Adjusting for the use of systemic glucocorticoids had little effect on the magnitude of the associations.",
"   </p>",
"   <p>",
"    These results were supported in a subsequent report that found that the prolonged administration (greater than three years) of high doses of ICS (average &gt;1",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?33/7/33904?source=see_link\">",
"     beclomethasone",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/7/32880?source=see_link\">",
"     budesonide",
"    </a>",
"    ) increased the likelihood of undergoing cataract extraction in individuals over the age of 70 [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/77\">",
"     77",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The risk of cataract development was also addressed in a population-based case-control study that matched more than 15,000 patients with and without cataracts to assess the impact of ICS use on this disorder [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/78\">",
"     78",
"    </a>",
"    ]. A linear association between exposure and the development of cataracts was noted. However, the difference between groups was only significant for patients using high-dose ICS (&ge;1600",
"    <span class=\"nowrap\">",
"     mcg/day).",
"    </span>",
"    Coadministration of systemic glucocorticoids was a possible confounder in this study.",
"   </p>",
"   <p>",
"    These studies did not address the effect of ICS on the development of cataracts in children, although children who receive systemic steroids appear to be more susceptible to this complication than adults. However, in a cross-sectional study in patients aged 5 to 25 years taking either inhaled BDP or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/7/32880?source=see_link\">",
"     budesonide",
"    </a>",
"    , no cataracts were found on slit-lamp examination, even in patients taking 2000 mcg daily for over 10 years [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/79\">",
"     79",
"    </a>",
"    ]. Other studies have also found no evidence of increased cataract formation in children [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/37,80\">",
"     37,80",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For all age groups, prospective studies are needed to discern whether this is a true causal relationship.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Other potential concerns",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Skin changes and bruising",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is well-known that oral and topical glucocorticoids cause thinning of the skin, telangiectasia, and easy bruising. This may result from loss of extracellular ground substance within the dermis, due to an inhibitory effect on dermal fibroblasts. There are reports of increased skin bruising and purpura in patients using high doses of inhaled BDP, but the degree to which these patients were also receiving intermittent oral glucocorticoids was not described [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/82\">",
"     82",
"    </a>",
"    ]. Easy bruising in association with ICS is more frequent in elderly patients [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/83\">",
"     83",
"    </a>",
"    ]; there are no reports of this problem in children. Long-term prospective studies with objective measurements of skin thickness are needed to definitively determine if ICS affect the skin.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Myopathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;As mentioned previously, ICS can cause dysphonia resulting from a localized myopathy of the vocal cords due to local deposition. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Dysphonia'",
"    </a>",
"    above.) Whether systemic absorption of ICS can cause more generalized myopathy is less clear. Isolated case reports describe muscle weakness that resolved with cessation of inhaled glucocorticoid therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/84\">",
"     84",
"    </a>",
"    ]. Myopathy is more commonly seen with oral glucocorticoid therapy and is presented in more detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/40/23173?source=see_link\">",
"     \"Glucocorticoid-induced myopathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Adverse airway effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no evidence for atrophy of the airway epithelium; even after 10 years of treatment with ICS, structural changes in the epithelium are not seen.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23216296\">",
"    <span class=\"h3\">",
"     Infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;The possibility of an increased risk of bacterial or mycobacterial infections related to ICS use has also been examined.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Among patients with COPD, a meta-analysis found a slight increase in the risk of pneumonia [",
"      <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/85\">",
"       85",
"      </a>",
"      ]. However, pneumonia was uncommon in the individual studies and often poorly defined. Neither pneumonia-related mortality nor overall mortality was significantly increased. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/21/5463?source=see_link&amp;anchor=H9#H9\">",
"       \"Role of inhaled glucocorticoid therapy in stable COPD\", section on 'Adverse effects'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A retrospective analysis of 14,993 patients with asthma enrolled in clinical trials of inhaled",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/7/32880?source=see_link\">",
"       budesonide",
"      </a>",
"      versus placebo found no increase in the risk of pneumonia [",
"      <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/86\">",
"       86",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a nested case control study that included over 400,000 patients with asthma or COPD (564 cases of tuberculosis), the risk of tuberculosis infection was slightly increased among all users of ICS (RR 1.26, 95% CI 1.18-1.56), particularly those using doses equivalent to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/45/39632?source=see_link\">",
"       fluticasone",
"      </a>",
"      1000 mcg per day or more (RR 1.97, 95% CI 1.18-3.3) [",
"      <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/87\">",
"       87",
"      </a>",
"      ]. It is not known whether this observation was influenced by confounders, such as cigarette smoking, socioeconomic status, or use of medications that inhibit cytochrome p450 3A4, thereby decreasing clearance of ICS.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Psychiatric effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are various reports of psychiatric disturbance, including emotional lability, euphoria, depression, aggressiveness, and insomnia, associated with use of ICS. Few such patients have so far been reported, suggesting that this is very infrequent, and a causal link with ICS has not been established in most of the cases.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Pregnancy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Based on extensive clinical experience, ICS appear to be safe in pregnancy, although controlled studies have not been performed for obvious reasons. There is no evidence for adverse effects of ICS on the pregnancy, the delivery, or on the fetus. In contrast, poorly controlled asthma may increase the incidence of perinatal mortality and retard intrauterine growth, and more effective control of asthma with ICS may reduce these problems. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/34/29226?source=see_link&amp;anchor=H18#H18\">",
"     \"Management of asthma during pregnancy\", section on 'Inhaled'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Effects on glucose and lipid metabolism",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several studies have examined the effect of ICS therapy on glucose and lipid metabolism.",
"   </p>",
"   <p>",
"    Conflicting results have been reported regarding effect of ICS on glucose metabolism, although the bulk of evidence suggests the effect is minimal and limited to those using high doses of ICS [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/88-93\">",
"     88-93",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Fasting glucose and insulin were unchanged in adults after doses of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?33/7/33904?source=see_link\">",
"       beclomethasone",
"      </a>",
"      up to 2000 mcg daily, and in children with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/7/32880?source=see_link\">",
"       budesonide",
"      </a>",
"      up to 800 mcg daily [",
"      <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/88,89\">",
"       88,89",
"      </a>",
"      ]. In normal individuals, high dose inhaled beclomethasone may slightly increase resistance to insulin [",
"      <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/89\">",
"       89",
"      </a>",
"      ]. However, in patients with poorly controlled asthma, high doses of beclomethasone and budesonide paradoxically decreased insulin resistance and improved glucose tolerance, suggesting that the disease itself may lead to abnormalities in carbohydrate metabolism.",
"     </li>",
"     <li>",
"      A cohort study of 1698 adults using ICS for obstructive lung disease found no association between ICS and serum glucose in subjects without diabetes, while a numerical but not statistically significant increase in serum glucose, 1.82",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (95% CI, 0.49-3.15) per 100",
"      <span class=\"nowrap\">",
"       mcg/day",
"      </span>",
"      increase in ICS dose, was noted among those with diabetes [",
"      <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/90\">",
"       90",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a study using a Quebec health insurance database of 388,584 patients treated for respiratory disease, current use of ICS was associated with an increase in the rate of diabetes onset defined as new use of an antidiabetic agent [",
"      <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/91\">",
"       91",
"      </a>",
"      ]. However, the study did not assess the role of obesity, which is associated with more severe asthma, or the effect of potential differences in activity levels between patients with and without respiratory disease.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Minimal to no effect of ICS has been found on lipid metabolism. In a small observational study, neither",
"    <a class=\"drug drug_general\" href=\"UTD.htm?33/7/33904?source=see_link\">",
"     beclomethasone",
"    </a>",
"    2000 mcg daily in adults nor",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/7/32880?source=see_link\">",
"     budesonide",
"    </a>",
"    800 mcg daily in children had any effect on plasma cholesterol or triglycerides [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/88\">",
"     88",
"    </a>",
"    ]. However, in a review of data from the Third National Health and Nutrition Examination Survey (1988-1994), inhaled glucocorticoid use was associated with a slightly higher serum high density cholesterol level among subjects aged 60 or older [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/94\">",
"     94",
"    </a>",
"    ]. A separate study examined the effect of introduction of inhaled budesonide 1600",
"    <span class=\"nowrap\">",
"     mcg/day",
"    </span>",
"    in 11 adults with asthma and found a slight increase in fasting total cholesterol, but no change in fasting triglyceride after four weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/95\">",
"     95",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     MEASURES TO MINIMIZE SYSTEMIC SIDE EFFECTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;To minimize the risk of adverse effects, we recommend the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Step down treatment to the lowest possible dose of ICS that maintains symptom control",
"     </li>",
"     <li>",
"      Increase the medication frequency while decreasing the daily dose",
"     </li>",
"     <li>",
"      Optimize compliance",
"     </li>",
"     <li>",
"      Optimize delivery (use spacer in adults, spacer and facemask in children)",
"     </li>",
"     <li>",
"      Evaluate and treat for complicating features of asthma",
"     </li>",
"     <li>",
"      Maximize nonpharmacologic treatment (eg, trigger avoidance)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Spacers and delivery devices",
"    </span>",
"    &nbsp;&mdash;&nbsp;Efforts should be made to optimize delivery to the lung, as this results in an increased therapeutic effect. If a greater proportion of each dose reaches the lung, the total amount of drug needed to maintain asthma control will be reduced, resulting in a lower risk for systemic side effects. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/20/18762?source=see_link\">",
"     \"Delivery of inhaled medication in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/18/31014?source=see_link\">",
"     \"Delivery of inhaled medication in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/26/18856?source=see_link\">",
"     \"The use of inhaler devices in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/57/36760?source=see_link\">",
"     \"The use of inhaler devices in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Spacers (which are used with MDIs) and certain dry powder inhaler devices, such as the Turbuhaler&reg;, are designed to improve lung delivery. As an example, the Turbuhaler&reg; delivers approximately twice as much glucocorticoid to the lungs as other devices. Although increasing the proportion of drug that is absorbed through the lung means that more of the dose is escaping first-pass metabolism and entering the systemic circulation directly, this is offset by a reduction in the overall required dose. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Pharmacokinetics of ICS'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Use of a large volume spacer device with a MDI can increase the amount of drug delivered to the lung to about 20 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/96\">",
"       96",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      For dry powder inhalers, reductions in systemic effects may be achieved with mouth-washing and discarding the fluid [",
"      <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/97\">",
"       97",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Medication interactions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Medications that inhibit cytochrome p450 3A4 (CYP450 3A4) have the potential to impair the metabolism of inhaled glucocorticoids, particularly",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/7/32880?source=see_link\">",
"     budesonide",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/45/33488?source=see_link\">",
"     ciclesonide",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/45/39632?source=see_link\">",
"     fluticasone",
"    </a>",
"    , and increase their serum levels (",
"    <a class=\"graphic graphic_table graphicRef76992 \" href=\"UTD.htm?9/45/9950\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/98\">",
"     98",
"    </a>",
"    ]. The co-administration of budesonide and the potent CYP450 3A4 inhibitor,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/15/20730?source=see_link\">",
"     itraconazole",
"    </a>",
"    , has been reported to result in adrenal suppression [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/99\">",
"     99",
"    </a>",
"    ]. Co-administration of fluticasone and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/58/12202?source=see_link\">",
"     ritonavir",
"    </a>",
"    has been associated with iatrogenic Cushing syndrome, due to CYP450 3A4 inhibition [",
"    <a class=\"abstract\" href=\"UTD.htm?6/60/7114/abstract/100\">",
"     100",
"    </a>",
"    ]. Clinicians should use caution when combining high-dose ICS with potent CYP450 3A4 inhibitors.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?36/57/37778?source=see_link\">",
"       \"Patient information: Steroid medicines (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?28/25/29075?source=see_link\">",
"       \"Patient information: Asthma inhaler techniques in adults (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?38/63/39925?source=see_link\">",
"       \"Patient information: Asthma treatment in adolescents and adults (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Inhaled glucocorticoids (inhaled GC or ICS) have fewer and significantly less severe adverse effects compared to orally-administered glucocorticoids. Concerns about side effects arise with inhaled GC because these medications are typically used over many years, and are administered to infants and children. (See",
"    <a class=\"local\" href=\"#H1\">",
"     'Introduction'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Local deposition of inhaled GC in the oropharynx and larynx most commonly causes dysphonia or thrush. Dysphonia may be less common with dry powder devices, and thrush can be avoided by use of a large volume spacer with MDIs and rinsing of the mouth thoroughly after each administration with all devices. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Effects of local deposition'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Possible systemic side effects of ICS include short-term growth deceleration in children, osteoporosis in adults, adrenal suppression, and adverse ocular effects. A critical issue in the study of systemic side effects from ICS is whether a measurable short-term effect translates into a significant clinical consequence with long-term use. Careful follow-up studies are needed to determine this. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Systemic side effects'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      An individual's risk of systemic side effects from ICS is influenced by their cumulative dose, the delivery system used, individual differences in the patient's response to the glucocorticoid, and the degree to which the drug is absorbed at different sites (lung versus gastrointestinal tract). The pharmacokinetics of ICS administered by MDI are depicted in the figure (",
"      <a class=\"graphic graphic_figure graphicRef59553 \" href=\"UTD.htm?29/3/29747\">",
"       figure 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Factors influencing risk'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H8\">",
"       'Pharmacokinetics of ICS'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In children, both ICS therapy and untreated asthma itself have been associated with deceleration of growth velocity. The effects are most pronounced with severe asthma. Inhaled GC cause growth deceleration when assessed by very sensitive measures of growth velocity. However, asthmatic children continue to grow over a long period of time, and their ultimate adult height is approximately 1.2 cm less than without ICS. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Skeletal effects'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In adults, the impact of ICS on the risk of osteoporosis and fracture is not well defined. The majority of studies suggest that ICS therapy is associated with an accelerated decrease in bone mineral density, and at least a few studies have detected a small but significant increased risk for fracture. Recommendations for monitoring bone health in patients receiving ICS have been published (",
"      <a class=\"graphic graphic_table graphicRef70743 \" href=\"UTD.htm?32/11/32955\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Osteoporosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Therapy with ICS is capable of affecting HPA axis function, although the effects seem to be infrequent and largely subclinical. For patients receiving ICS therapy within the recommended ranges, the risk of symptomatic adrenal suppression or acute adrenal crisis appears to be very small. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Adrenal suppression'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      ICS can increase intraocular pressure and enhance the formation of cataracts. The magnitude of these effects appears to be small, although prospective studies are required to better define them. Until the risk is better defined, patients receiving ICS therapy over years should be monitored for these complications with regular ophthalmologic exams. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Ocular changes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      To minimize the risk of adverse effects from ICS, we advise use of the lowest dose that maintains asthma control, attention to compliance, and regular evaluation for co-existent conditions and triggers that can exacerbate asthma symptoms. In addition, spacers should be used with metered dose inhalers to optimize delivery to the lung, especially in adults receiving &ge;800 mcg daily and children receiving &ge;400 mcg daily through an MDI device. (See",
"      <a class=\"local\" href=\"#H24\">",
"       'Measures to minimize systemic side effects'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Medications that inhibit cytochrome p450 3A4 should be used with caution in patients receiving high dose ICS, as these may increase systemic levels of glucocorticoid (",
"      <a class=\"graphic graphic_table graphicRef76992 \" href=\"UTD.htm?9/45/9950\">",
"       table 3",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H24\">",
"       'Measures to minimize systemic side effects'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/1\">",
"      Donahue JG, Weiss ST, Livingston JM, et al. Inhaled steroids and the risk of hospitalization for asthma. JAMA 1997; 277:887.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/2\">",
"      Kamada AK, Szefler SJ, Martin RJ, et al. Issues in the use of inhaled glucocorticoids. The Asthma Clinical Research Network. Am J Respir Crit Care Med 1996; 153:1739.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/3\">",
"      Lipworth BJ. Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis. Arch Intern Med 1999; 159:941.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/4\">",
"      Barnes PJ, Pedersen S, Busse WW. Efficacy and safety of inhaled corticosteroids. New developments. Am J Respir Crit Care Med 1998; 157:S1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/5\">",
"      Geddes DM. Inhaled corticosteroids: benefits and risks. Thorax 1992; 47:404.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/6\">",
"      Toogood JH. Complications of topical steroid therapy for asthma. Am Rev Respir Dis 1990; 141:S89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/7\">",
"      Nieto A, Mazon A, Pamies R, et al. Adverse effects of inhaled corticosteroids in funded and nonfunded studies. Arch Intern Med 2007; 167:2047.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/8\">",
"      Camargo CA Jr, Barr RG, Chen R, Speizer FE. Prospective study of inhaled corticosteroid use, cardiovascular mortality, and all-cause mortality in asthmatic women. Chest 2008; 134:546.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/9\">",
"      Lee TA, Pickard AS, Au DH, et al. Risk for death associated with medications for recently diagnosed chronic obstructive pulmonary disease. Ann Intern Med 2008; 149:380.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/10\">",
"      Roland NJ, Bhalla RK, Earis J. The local side effects of inhaled corticosteroids: current understanding and review of the literature. Chest 2004; 126:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/11\">",
"      Buhl R. Local oropharyngeal side effects of inhaled corticosteroids in patients with asthma. Allergy 2006; 61:518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/12\">",
"      Galv&aacute;n CA, Guarderas JC. Practical considerations for dysphonia caused by inhaled corticosteroids. Mayo Clin Proc 2012; 87:901.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/13\">",
"      Rachelefsky GS, Liao Y, Faruqi R. Impact of inhaled corticosteroid-induced oropharyngeal adverse events: results from a meta-analysis. Ann Allergy Asthma Immunol 2007; 98:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/14\">",
"      Williamson IJ, Matusiewicz SP, Brown PH, et al. Frequency of voice problems and cough in patients using pressurized aerosol inhaled steroid preparations. Eur Respir J 1995; 8:590.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/15\">",
"      Toogood JH, Jennings B, Greenway RW, Chuang L. Candidiasis and dysphonia complicating beclomethasone treatment of asthma. J Allergy Clin Immunol 1980; 65:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/16\">",
"      Yang IA, Clarke MS, Sim EH, Fong KM. Inhaled corticosteroids for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2012; 7:CD002991.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/17\">",
"      Sulica L. Laryngeal thrush. Ann Otol Rhinol Laryngol 2005; 114:369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/18\">",
"      Nunes FP, Bishop T, Prasad ML, et al. Laryngeal candidiasis mimicking malignancy. Laryngoscope 2008; 118:1957.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/19\">",
"      Baeck M, Pilette C, Drieghe J, Goossens A. Allergic contact dermatitis to inhalation corticosteroids. Eur J Dermatol 2010; 20:102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/20\">",
"      Garc&iacute;a AP, Tovar V, de Barrio M, et al. Contact allergy to inhaled budesonide. Contact Dermatitis 2008; 59:60.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/21\">",
"      Guillot B. Adverse skin reactions to inhaled corticosteroids. Expert Opin Drug Saf 2002; 1:325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/22\">",
"      Baeck M, Goossens A. Patients with airborne sensitization/contact dermatitis from budesonide-containing aerosols 'by proxy'. Contact Dermatitis 2009; 61:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/23\">",
"      Brutsche MH, Brutsche IC, Munawar M, et al. Comparison of pharmacokinetics and systemic effects of inhaled fluticasone propionate in patients with asthma and healthy volunteers: a randomised crossover study. Lancet 2000; 356:556.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/24\">",
"      Harrison TW, Wisniewski A, Honour J, Tattersfield AE. Comparison of the systemic effects of fluticasone propionate and budesonide given by dry powder inhaler in healthy and asthmatic subjects. Thorax 2001; 56:186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/25\">",
"      Johnson M. Pharmacodynamics and pharmacokinetics of inhaled glucocorticoids. J Allergy Clin Immunol 1996; 97:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/26\">",
"      Mutch E, Nave R, McCracken N, et al. The role of esterases in the metabolism of ciclesonide to desisobutyryl-ciclesonide in human tissue. Biochem Pharmacol 2007; 73:1657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/27\">",
"      Nave R. Clinical pharmacokinetic and pharmacodynamic profile of inhaled ciclesonide. Clin Pharmacokinet 2009; 48:243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/28\">",
"      Wolthers OD, Pedersen S. Growth of asthmatic children during treatment with budesonide: a double blind trial. BMJ 1991; 303:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/29\">",
"      Pedersen S. Do inhaled corticosteroids inhibit growth in children? Am J Respir Crit Care Med 2001; 164:521.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/30\">",
"      Tinkelman DG, Reed CE, Nelson HS, Offord KP. Aerosol beclomethasone dipropionate compared with theophylline as primary treatment of chronic, mild to moderately severe asthma in children. Pediatrics 1993; 92:64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/31\">",
"      Thomas BC, Stanhope R, Grant DB. Impaired growth in children with asthma during treatment with conventional doses of inhaled corticosteroids. Acta Paediatr 1994; 83:196.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/32\">",
"      Turpeinen M, Pelkonen AS, Nikander K, et al. Bone mineral density in children treated with daily or periodical inhaled budesonide: the Helsinki Early Intervention Childhood Asthma study. Pediatr Res 2010; 68:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/33\">",
"      Guilbert TW, Mauger DT, Allen DB, et al. Growth of preschool children at high risk for asthma 2 years after discontinuation of fluticasone. J Allergy Clin Immunol 2011; 128:956.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/34\">",
"      Agertoft L, Pedersen S. Effect of long-term treatment with inhaled budesonide on adult height in children with asthma. N Engl J Med 2000; 343:1064.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/35\">",
"      Varsano I, Volovitz B, Malik H, Amir Y. Safety of 1 year of treatment with budesonide in young children with asthma. J Allergy Clin Immunol 1990; 85:914.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/36\">",
"      Sharek PJ, Bergman DA. The effect of inhaled steroids on the linear growth of children with asthma: a meta-analysis. Pediatrics 2000; 106:E8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/37\">",
"      Long-term effects of budesonide or nedocromil in children with asthma. The Childhood Asthma Management Program Research Group. N Engl J Med 2000; 343:1054.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/38\">",
"      Doull IJ, Freezer NJ, Holgate ST. Growth of prepubertal children with mild asthma treated with inhaled beclomethasone dipropionate. Am J Respir Crit Care Med 1995; 151:1715.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/39\">",
"      Allen DB, Mullen M, Mullen B. A meta-analysis of the effect of oral and inhaled corticosteroids on growth. J Allergy Clin Immunol 1994; 93:967.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/40\">",
"      Silverstein MD, Yunginger JW, Reed CE, et al. Attained adult height after childhood asthma: effect of glucocorticoid therapy. J Allergy Clin Immunol 1997; 99:466.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/41\">",
"      Kelly HW, Sternberg AL, Lescher R, et al. Effect of inhaled glucocorticoids in childhood on adult height. N Engl J Med 2012; 367:904.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/42\">",
"      Efthimiou J, Barnes PJ. Effect of inhaled corticosteroids on bones and growth. Eur Respir J 1998; 11:1167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/43\">",
"      Scanlon PD, Connett JE, Wise RA, et al. Loss of bone density with inhaled triamcinolone in Lung Health Study II. Am J Respir Crit Care Med 2004; 170:1302.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/44\">",
"      Israel E, Banerjee TR, Fitzmaurice GM, et al. Effects of inhaled glucocorticoids on bone density in premenopausal women. N Engl J Med 2001; 345:941.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/45\">",
"      Ip M, Lam K, Yam L, et al. Decreased bone mineral density in premenopausal asthma patients receiving long-term inhaled steroids. Chest 1994; 105:1722.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/46\">",
"      Wong CA, Walsh LJ, Smith CJ, et al. Inhaled corticosteroid use and bone-mineral density in patients with asthma. Lancet 2000; 355:1399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/47\">",
"      Reid DM, Nicoll JJ, Smith MA, et al. Corticosteroids and bone mass in asthma: comparisons with rheumatoid arthritis and polymyalgia rheumatica. Br Med J (Clin Res Ed) 1986; 293:1463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/48\">",
"      Lung Health Study Research Group. Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease. N Engl J Med 2000; 343:1902.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/49\">",
"      Kelly HW, Van Natta ML, Covar RA, et al. Effect of long-term corticosteroid use on bone mineral density in children: a prospective longitudinal assessment in the childhood Asthma Management Program (CAMP) study. Pediatrics 2008; 122:e53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/50\">",
"      Fujita K, Kasayama S, Hashimoto J, et al. Inhaled corticosteroids reduce bone mineral density in early postmenopausal but not premenopausal asthmatic women. J Bone Miner Res 2001; 16:782.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/51\">",
"      Hubbard RB, Smith CJ, Smeeth L, et al. Inhaled corticosteroids and hip fracture: a population-based case-control study. Am J Respir Crit Care Med 2002; 166:1563.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/52\">",
"      Hubbard R, Tattersfield A, Smith C, et al. Use of inhaled corticosteroids and the risk of fracture. Chest 2006; 130:1082.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/53\">",
"      Matsumoto H, Ishihara K, Hasegawa T, et al. Effects of inhaled corticosteroid and short courses of oral corticosteroids on bone mineral density in asthmatic patients : a 4-year longitudinal study. Chest 2001; 120:1468.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/54\">",
"      Tattersfield AE, Town GI, Johnell O, et al. Bone mineral density in subjects with mild asthma randomised to treatment with inhaled corticosteroids or non-corticosteroid treatment for two years. Thorax 2001; 56:272.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/55\">",
"      Hughes JA, Conry BG, Male SM, Eastell R. One year prospective open study of the effect of high dose inhaled steroids, fluticasone propionate, and budesonide on bone markers and bone mineral density. Thorax 1999; 54:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/56\">",
"      Jones A, Fay JK, Burr M, et al. Inhaled corticosteroid effects on bone metabolism in asthma and mild chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2002; :CD003537.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/57\">",
"      Suissa S, Baltzan M, Kremer R, Ernst P. Inhaled and nasal corticosteroid use and the risk of fracture. Am J Respir Crit Care Med 2004; 169:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/58\">",
"      Drummond MB, Dasenbrook EC, Pitz MW, et al. Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis. JAMA 2008; 300:2407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/59\">",
"      Sorva R, Turpeinen M, Juntunen-Backman K, et al. Effects of inhaled budesonide on serum markers of bone metabolism in children with asthma. J Allergy Clin Immunol 1992; 90:808.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/60\">",
"      Meeran K, Hattersley A, Burrin J, et al. Oral and inhaled corticosteroids reduce bone formation as shown by plasma osteocalcin levels. Am J Respir Crit Care Med 1995; 151:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/61\">",
"      Martin RJ, Szefler SJ, Chinchilli VM, et al. Systemic effect comparisons of six inhaled corticosteroid preparations. Am J Respir Crit Care Med 2002; 165:1377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/62\">",
"      Casale TB, Nelson HS, Stricker WE, et al. Suppression of hypothalamic-pituitary-adrenal axis activity with inhaled flunisolide and fluticasone propionate in adult asthma patients. Ann Allergy Asthma Immunol 2001; 87:379.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/63\">",
"      White M, Crisalida T, Li H, et al. Effects of long-term inhaled corticosteroids on adrenal function in patients with asthma. Ann Allergy Asthma Immunol 2006; 96:437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/64\">",
"      Eichenhorn MS, Wise RA, Madhok TC, et al. Lack of long-term adverse adrenal effects from inhaled triamcinolone: Lung Health Study II. Chest 2003; 124:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/65\">",
"      Derom E, Louis R, Tiesler C, et al. Effects of ciclesonide and fluticasone on cortisol secretion in patients with persistent asthma. Eur Respir J 2009; 33:1277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/66\">",
"      Phillip M, Aviram M, Leiberman E, et al. Integrated plasma cortisol concentration in children with asthma receiving long-term inhaled corticosteroids. Pediatr Pulmonol 1992; 12:84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/67\">",
"      Vaz R, Senior B, Morris M, Binkiewicz A. Adrenal effects of beclomethasone inhalation therapy in asthmatic children. J Pediatr 1982; 100:660.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/68\">",
"      Wyatt R, Waschek J, Weinberger M, Sherman B. Effects of inhaled beclomethasone dipropionate and alternate-day prednisone on pituitary-adrenal function in children with chronic asthma. N Engl J Med 1978; 299:1387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/69\">",
"      Mahachoklertwattana P, Sudkronrayudh K, Direkwattanachai C, et al. Decreased cortisol response to insulin induced hypoglycaemia in asthmatics treated with inhaled fluticasone propionate. Arch Dis Child 2004; 89:1055.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/70\">",
"      Paton J, Jardine E, McNeill E, et al. Adrenal responses to low dose synthetic ACTH (Synacthen) in children receiving high dose inhaled fluticasone. Arch Dis Child 2006; 91:808.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/71\">",
"      Todd GR, Acerini CL, Ross-Russell R, et al. Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom. Arch Dis Child 2002; 87:457.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/72\">",
"      Masoli M, Weatherall M, Holt S, et al. Inhaled fluticasone propionate and adrenal effects in adult asthma: systematic review and meta-analysis. Eur Respir J 2006; 28:960.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/73\">",
"      Garbe E, LeLorier J, Boivin JF, Suissa S. Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma. JAMA 1997; 277:722.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/74\">",
"      Mitchell P, Cumming RG, Mackey DA. Inhaled corticosteroids, family history, and risk of glaucoma. Ophthalmology 1999; 106:2301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/75\">",
"      Gonzalez AV, Li G, Suissa S, Ernst P. Risk of glaucoma in elderly patients treated with inhaled corticosteroids for chronic airflow obstruction. Pulm Pharmacol Ther 2010; 23:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/76\">",
"      Cumming RG, Mitchell P, Leeder SR. Use of inhaled corticosteroids and the risk of cataracts. N Engl J Med 1997; 337:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/77\">",
"      Garbe E, Suissa S, LeLorier J. Association of inhaled corticosteroid use with cataract extraction in elderly patients. JAMA 1998; 280:539.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/78\">",
"      Smeeth L, Boulis M, Hubbard R, Fletcher AE. A population based case-control study of cataract and inhaled corticosteroids. Br J Ophthalmol 2003; 87:1247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/79\">",
"      Simons FE, Persaud MP, Gillespie CA, et al. Absence of posterior subcapsular cataracts in young patients treated with inhaled glucocorticoids. Lancet 1993; 342:776.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/80\">",
"      Pelkonen A, Kari O, Selroos O, et al. Ophthalmologic findings in children with asthma receiving inhaled budesonide. J Allergy Clin Immunol 2008; 122:832.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/81\">",
"      Wang JJ, Rochtchina E, Tan AG, et al. Use of inhaled and oral corticosteroids and the long-term risk of cataract. Ophthalmology 2009; 116:652.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/82\">",
"      Capewell S, Reynolds S, Shuttleworth D, et al. Purpura and dermal thinning associated with high dose inhaled corticosteroids. BMJ 1990; 300:1548.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/83\">",
"      Roy A, Leblanc C, Paquette L, et al. Skin bruising in asthmatic subjects treated with high doses of inhaled steroids: frequency and association with adrenal function. Eur Respir J 1996; 9:226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/84\">",
"      Herzog AG. Proximal myopathy associated with inhaled steroids. JAMA 1999; 281:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/85\">",
"      Singh S, Amin AV, Loke YK. Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysis. Arch Intern Med 2009; 169:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/86\">",
"      O'Byrne PM, Pedersen S, Carlsson LG, et al. Risks of pneumonia in patients with asthma taking inhaled corticosteroids. Am J Respir Crit Care Med 2011; 183:589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/87\">",
"      Brassard P, Suissa S, Kezouh A, Ernst P. Inhaled corticosteroids and risk of tuberculosis in patients with respiratory diseases. Am J Respir Crit Care Med 2011; 183:675.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/88\">",
"      Turpeinen M, Sorva R, Juntunen-Backman K. Changes in carbohydrate and lipid metabolism in children with asthma inhaling budesonide. J Allergy Clin Immunol 1991; 88:384.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/89\">",
"      Kiviranta K, Turpeinen M. Effect of eight months of inhaled beclomethasone dipropionate and budesonide on carbohydrate metabolism in adults with asthma. Thorax 1993; 48:974.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/90\">",
"      Slatore CG, Bryson CL, Au DH. The association of inhaled corticosteroid use with serum glucose concentration in a large cohort. Am J Med 2009; 122:472.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/91\">",
"      Suissa S, Kezouh A, Ernst P. Inhaled corticosteroids and the risks of diabetes onset and progression. Am J Med 2010; 123:1001.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/92\">",
"      Faul JL, Wilson SR, Chu JW, et al. The effect of an inhaled corticosteroid on glucose control in type 2 diabetes. Clin Med Res 2009; 7:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/93\">",
"      O'Byrne PM, Rennard S, Gerstein H, et al. Risk of new onset diabetes mellitus in patients with asthma or COPD taking inhaled corticosteroids. Respir Med 2012; 106:1487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/94\">",
"      Choi HK, Seeger JD. Glucocorticoid use and serum lipid levels in US adults: the Third National Health and Nutrition Examination Survey. Arthritis Rheum 2005; 53:528.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/95\">",
"      Yavuz O, T&uuml;rkta�� I, Cevik C. The effect of high-dose inhaled budesonide on lipid profile in asthmatic patients. Gen Pharmacol 1996; 27:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/96\">",
"      Newman SP. Spacer devices for metered dose inhalers. Clin Pharmacokinet 2004; 43:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/97\">",
"      Yokoyama H, Yamamura Y, Ozeki T, et al. Kinetic analysis of effects of mouth washing on removal of drug residues following inhalation of fluticasone propionate dry powder. Biol Pharm Bull 2007; 30:1987.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/98\">",
"      CYP3A and drug interactions. Med Lett Drugs Ther 2005; 47:54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/99\">",
"      Raaska K, Niemi M, Neuvonen M, et al. Plasma concentrations of inhaled budesonide and its effects on plasma cortisol are increased by the cytochrome P4503A4 inhibitor itraconazole. Clin Pharmacol Ther 2002; 72:362.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/60/7114/abstract/100\">",
"      Samaras K, Pett S, Gowers A, et al. Iatrogenic Cushing's syndrome with osteoporosis and secondary adrenal failure in human immunodeficiency virus-infected patients receiving inhaled corticosteroids and ritonavir-boosted protease inhibitors: six cases. J Clin Endocrinol Metab 2005; 90:4394.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 540 Version 21.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-197.136.42.3-E93FDBD5C8-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_60_7114=[""].join("\n");
var outline_f6_60_7114=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H27\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EFFECTS OF LOCAL DEPOSITION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Dysphonia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Topical candidiasis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H100383861\">",
"      Contact hypersensitivity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Other",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      SYSTEMIC SIDE EFFECTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Factors influencing risk",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Pharmacokinetics of ICS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Skeletal effects",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Growth deceleration",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Osteoporosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Bone formation in children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Adrenal suppression",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Ocular changes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Intraocular pressure",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Cataracts",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Other potential concerns",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Skin changes and bruising",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Myopathy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Adverse airway effects",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23216296\">",
"      - Infection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Psychiatric effects",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Pregnancy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Effects on glucose and lipid metabolism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      MEASURES TO MINIMIZE SYSTEMIC SIDE EFFECTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Spacers and delivery devices",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Medication interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PULM/540\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/540|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?29/3/29747\" title=\"figure 1\">",
"      Local and systemic distribution of ICS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?7/44/7887\" title=\"figure 2\">",
"      ICS and bone mineral density",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/540|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?28/63/29693\" title=\"table 1\">",
"      Studies of inhaled glucocorticoids and bone mineral density",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?32/11/32955\" title=\"table 2\">",
"      Osteoporosis prevention in COPD",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?9/45/9950\" title=\"table 3\">",
"      Inhibitors and inducers of cytochrome P450 3A4",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/19/2362?source=related_link\">",
"      Cataract in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/20/18762?source=related_link\">",
"      Delivery of inhaled medication in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/18/31014?source=related_link\">",
"      Delivery of inhaled medication in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/20/24905?source=related_link\">",
"      Evaluation of the response to ACTH in adrenal insufficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/40/23173?source=related_link\">",
"      Glucocorticoid-induced myopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/47/27386?source=related_link\">",
"      Major side effects of systemic glucocorticoids",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/34/29226?source=related_link\">",
"      Management of asthma during pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/54/42855?source=related_link\">",
"      Pathogenesis, clinical features, and evaluation of glucocorticoid-induced osteoporosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?28/25/29075?source=related_link\">",
"      Patient information: Asthma inhaler techniques in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?38/63/39925?source=related_link\">",
"      Patient information: Asthma treatment in adolescents and adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?36/57/37778?source=related_link\">",
"      Patient information: Steroid medicines (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/36/17994?source=related_link\">",
"      Prevention and treatment of glucocorticoid-induced osteoporosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/21/5463?source=related_link\">",
"      Role of inhaled glucocorticoid therapy in stable COPD",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/26/18856?source=related_link\">",
"      The use of inhaler devices in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/57/36760?source=related_link\">",
"      The use of inhaler devices in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/19/20793?source=related_link\">",
"      Treatment of oropharyngeal and esophageal candidiasis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f6_60_7115="Ideal char urin reservoir";
var content_f6_60_7115=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F54033&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F54033&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Ideal characteristics of a urinary reservoir",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Characteristic",
"       </td>",
"       <td class=\"subtitle1\">",
"        Comments",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Low pressure system",
"       </td>",
"       <td>",
"        Higher internal pressure in the reservoir may overcome the external sphincter mechanisms that maintain continence",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Stores a functional amount of urine (approximately 500 mL)",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Reliable, complete continence",
"       </td>",
"       <td>",
"        Detubularization of intestinal segments limits the ability to generate a peristaltic pressure wave. These waves can contribute to incontinence.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Complete voluntary control of voiding",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        No absorption of urinary waste products by the reservoir walls",
"       </td>",
"       <td>",
"        Minimizes the likelihood of metabolic complications",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_60_7115=[""].join("\n");
var outline_f6_60_7115=null;
var title_f6_60_7116="Adv prostate ca treat";
var content_f6_60_7116=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F60321&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F60321&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    The advantages of the main treatment options for early prostate cancer",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       External beam radiation therapy (EBRT)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Cancer can be controlled long-term",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Very low risk of urinary incontinence (leaking urine)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Can be used to cure men of nearly any age, even men who have underlying medical problems",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Good chance for a cure in men with high-risk prostate cancer when combined with androgen deprivation therapy",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Treatments can get rid of cancer cells that have grown through the covering of the prostate (called the prostate capsule)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Brachytherapy",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Chance of controlling cancer similar to surgery (prostatectomy) and EBRT for men whose cancer has not spread outside the prostate",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Quicker than EBRT (single treatment)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Risk of leaking urine is low as long as the man has not had previous prostate surgery",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Can be used to cure men of nearly any age, even in men who have certain underlying medical problems",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Radical prostatectomy",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Cancer can be controlled long-term",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Can predict chance of cure and risk that cancer will come back more precisely than other types of treatment",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Nearby lymph nodes can be examined and removed (if needed) during surgery",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Active surveillance (\"watch and wait\")",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Reduces the chance that you will get unnecessary treatment",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Avoids or delays complications that can happen during treatment",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Has no effect on work or social activities",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Vogelzang NJ, Scardino PT, Shipley WU, et al. Comprehensive textbook of genitourinary oncology, 3rd Edition. Lippincott Williams &amp; Wilkins 2005. Copyright &copy; 2005 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_60_7116=[""].join("\n");
var outline_f6_60_7116=null;
var title_f6_60_7117="Risk of death or MI in UA";
var content_f6_60_7117=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F55745&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F55745&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    ACC/AHA guidelines: Short-term risk of death or nonfatal myocardial infarction in patients with symptoms suggesting unstable angina",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        High risk",
"       </td>",
"       <td class=\"subtitle1\">",
"        Intermediate risk",
"       </td>",
"       <td class=\"subtitle1\">",
"        Low risk",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        At least one of the following",
"features must be present",
"       </td>",
"       <td>",
"        No high-risk feature but must",
"have any of the following",
"       </td>",
"       <td>",
"        No high- or intermediate-risk",
"feature but may have any of the following",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\" rowspan=\"1\">",
"        History",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Accelerating tempo of ischemic symptoms in preceding 48",
"hours",
"       </td>",
"       <td>",
"        Prior MI, peripheral or cerebrovascular disease, CABG,",
"or prior aspirin use",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\" rowspan=\"1\">",
"        Character",
"of pain",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"1\" rowspan=\"3\">",
"        Prolonged (&gt;20 min) and ongoing rest pain",
"       </td>",
"       <td>",
"        Prolonged rest angina (&gt;20 min), now resolved,",
"with moderate or high likelihood of CAD",
"       </td>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        Angina provoked at a low threshold, increased angina frequency, severity or duration. New onset angina with onset two weeks to two months prior to presentation.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Rest angina (&gt;20 min) or relieved with rest or",
"sublingual NTG",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nocturnal angina",
"       </td>",
"       <td>",
"        New or progressive class III or IV angina in past two weeks without prolonged (&gt;20 min) rest pain but with intermediate or high likelihood of CAD.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\" rowspan=\"1\">",
"        Clinical",
"findings",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Pulmonary edema, most likely due to ischemia",
"       </td>",
"       <td colspan=\"1\" rowspan=\"5\">",
"        Age &gt;70 years",
"       </td>",
"       <td colspan=\"1\" rowspan=\"5\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        New or worsening mitral regurgitation murmur",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        S3 or new or worsening rales",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hypotension, bradycardia, tachycardia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Age &gt;75 years",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\" rowspan=\"1\">",
"        ECG",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Angina at rest with transient ST segment changes",
"&gt;0.5 mV",
"       </td>",
"       <td>",
"        T-wave changes",
"       </td>",
"       <td colspan=\"1\" rowspan=\"3\">",
"        Normal or unchanged ECG",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        New or presumed new bundle branch block",
"       </td>",
"       <td>",
"        Pathologic Q waves or resting ST depression less than 1 mm in multiple lead groups",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Sustained ventricular tachycardia",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\" rowspan=\"1\">",
"        Cardiac",
"markers",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Markedly elevated (eg, cTnT or cTnI &gt;0.1 ng/mL)",
"       </td>",
"       <td>",
"        Slightly elevated (eg, cTnT &gt;0.01 but",
"&lt;0.1 ng/mL)",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Anderson J, Adams C, Antman E, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 2002 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, American College of Physicians, Society for Academic Emergency Medicine, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2007; 50:e1.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_60_7117=[""].join("\n");
var outline_f6_60_7117=null;
var title_f6_60_7118="Brand burn";
var content_f6_60_7118=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F60768&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F60768&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Brand burn",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 216px; height: 183px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Note the imprint in the shape of a clothes iron.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Joan E Shook, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_60_7118=[""].join("\n");
var outline_f6_60_7118=null;
var title_f6_60_7119="Mycosis fungoides TNMB classification";
var content_f6_60_7119=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F75768%7EHEME%2F53711&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F75768%7EHEME%2F53711&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Mycosis Fungoides Cooperative Group TNMB classification of cutaneous T-cell lymphoma (CTCL)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"2\">",
"        Skin (T)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        T",
"        <sub>",
"         1",
"        </sub>",
"       </td>",
"       <td>",
"        Limited patches*, papules, and/or plaques",
"        <sup>",
"         &bull;",
"        </sup>",
"        covering &lt;10 percent of the skin surface; may further stratify into T",
"        <sub>",
"         1a",
"        </sub>",
"        (patch only) versus T",
"        <sub>",
"         1b",
"        </sub>",
"        (plaque &plusmn; patch)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        T",
"        <sub>",
"         2",
"        </sub>",
"       </td>",
"       <td>",
"        Patches, papules, or plaques covering &ge;10 percent of the skin surface; may further stratify into T",
"        <sub>",
"         2a",
"        </sub>",
"        (patch only) versus T",
"        <sub>",
"         2b",
"        </sub>",
"        (plaque &plusmn; patch)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        T",
"        <sub>",
"         3",
"        </sub>",
"       </td>",
"       <td>",
"        One or more tumors",
"        <sup>",
"         &Delta;",
"        </sup>",
"        (&ge;1 cm diameter)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        T",
"        <sub>",
"         4",
"        </sub>",
"       </td>",
"       <td>",
"        Confluence of erythema covering &ge;80 percent body surface area",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"2\">",
"        Node (N)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        N",
"        <sub>",
"         0",
"        </sub>",
"       </td>",
"       <td>",
"        No clinically abnormal lymph nodes",
"        <sup>",
"         &loz;",
"        </sup>",
"        ; biopsy not required",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        N",
"        <sub>",
"         1",
"        </sub>",
"       </td>",
"       <td class=\"sublist_other_start\">",
"        Clinically abnormal lymph nodes; histopathology Dutch grade 1 or NCI LN0-2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        N",
"        <sub>",
"         1a",
"        </sub>",
"       </td>",
"       <td class=\"sublist_other\">",
"        Clone negative",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        N",
"        <sub>",
"         1b",
"        </sub>",
"       </td>",
"       <td class=\"sublist_other\">",
"        Clone positive",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        N",
"        <sub>",
"         2",
"        </sub>",
"       </td>",
"       <td class=\"sublist_other_start\">",
"        Clinically abnormal lymph nodes; histopathology Dutch grade 2 or NCI LN3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        N",
"        <sub>",
"         2a",
"        </sub>",
"       </td>",
"       <td class=\"sublist_other\">",
"        Clone negative",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        N",
"        <sub>",
"         2b",
"        </sub>",
"       </td>",
"       <td class=\"sublist_other\">",
"        Clone positive",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        N",
"        <sub>",
"         3",
"        </sub>",
"       </td>",
"       <td>",
"        Clinically abnormal lymph nodes; histopathology Dutch grades 3-4 or NCI LN4; clone positive or negative",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        N",
"        <sub>",
"         X",
"        </sub>",
"       </td>",
"       <td>",
"        Clinically abnormal lymph nodes; no histologic confirmation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"2\">",
"        Visceral (M)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        M",
"        <sub>",
"         0",
"        </sub>",
"       </td>",
"       <td>",
"        No visceral organ involvement",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        M",
"        <sub>",
"         1",
"        </sub>",
"       </td>",
"       <td>",
"        Visceral involvement (must have pathology confirmation",
"        <sup>",
"         &yen;",
"        </sup>",
"        and organ involved should be specified)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"2\">",
"        Blood (B)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        B",
"        <sub>",
"         0",
"        </sub>",
"       </td>",
"       <td class=\"sublist_other_start\">",
"        No significant blood involvement: &le;5 percent of S&eacute;zary cells. For clinical trials, B",
"        <sub>",
"         0",
"        </sub>",
"        may also be defined as &lt;250/microL S&eacute;zary cells; CD4+CD26- or CD4+CD7- cells or CD4+CD26- and CD4+CD7- cells &lt;15 percent by flow cytrometry.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        B",
"        <sub>",
"         0a",
"        </sub>",
"       </td>",
"       <td class=\"sublist_other\">",
"        Clone negative",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        B",
"        <sub>",
"         0b",
"        </sub>",
"       </td>",
"       <td class=\"sublist_other\">",
"        Clone positive",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        B",
"        <sub>",
"         1",
"        </sub>",
"       </td>",
"       <td class=\"sublist_other_start\">",
"        Low blood tumor burden: Does not meet the criteria of B",
"        <sub>",
"         0",
"        </sub>",
"        or&nbsp;B",
"        <sub>",
"         2",
"        </sub>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        B",
"        <sub>",
"         1a",
"        </sub>",
"       </td>",
"       <td class=\"sublist_other\">",
"        Clone negative",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        B",
"        <sub>",
"         1b",
"        </sub>",
"       </td>",
"       <td class=\"sublist_other\">",
"        Clone positive",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        B",
"        <sub>",
"         2",
"        </sub>",
"       </td>",
"       <td>",
"        High blood tumor burden: Positive clone",
"        <sup>",
"         ������",
"        </sup>",
"        plus one of the following: &ge;1000/microL&nbsp;S&eacute;zary cells; CD4/CD8 &ge;10; CD4+CD7- cells &ge;40 percent; or CD4+CD26- cells &ge;30 percent. For clinical trials, B",
"        <sub>",
"         2",
"        </sub>",
"        may also be defined as &gt;1000/microL CD4+CD26- or CD4+CD7- cells.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * For skin, patch indicates any size lesion without significant elevation or induration. Presence/absence of hypo- or hyperpigmentation, scale, crusting, and/or poikiloderma should be noted.",
"     <br>",
"      <font class=\"bullet\">",
"       &bull;",
"      </font>",
"      For skin, plaque indicates any size skin lesion that is elevated or indurated. Presence or absence of scale, crusting, and/or poikilderma should be noted. Histologic features such as folliculotropism or large-cell transformation (&gt;25 percent large cells), CD30+ or CD30-, and clinical features such as ulceration are important to document.",
"      <br>",
"       &Delta; For skin, tumor indicates at least one 1 cm diameter solid or nodular lesion with evidence of depth and/or vertical growth. Note total number of lesions, total volume of lesions, largest size lesion, and region of body involved. Also note if histologic evidence of large-cell transformation has occurred. Phenotyping for CD30 is encouraged.",
"       <br>",
"        <font class=\"lozenge\">",
"         &loz;",
"        </font>",
"        For node, abnormal lymph node(s) indicates any lymph node that on physical examination is firm, irregular, clustered, fixed, or 1.5 cm or larger in diameter or on imaging is &gt;1.5 cm in the long axis or &gt;1 cm in the short axis. Node groups examined on physical examination include cervical, supraclavicular, epitrochlear, axillary, and inguinal.",
"        <br>",
"         &sect; A T-cell clone is defined by PCR or Southern blot analysis of the T-cell receptor gene.",
"         <br>",
"          &yen; For viscera, spleen and liver may be diagnosed by imaging criteria alone.",
"          <br>",
"           &Dagger; The clone in the blood should match that of the skin. The relevance of an isolated clone in the blood or a clone in the blood that does not match the clone in the skin remains to be determined.",
"          </br>",
"         </br>",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     This research was originally published in Blood. Olsen E, Vonderheid E, Pimpinelli N, et al. Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 2007; 110:1713. Copyright &copy; the American Society of Hematology.",
"     <br>",
"      Additional data from:&nbsp;Olsen EA, Whittaker S, Kim YH, et al. Clinical end points and response criteria in mycosis fungoides and S&eacute;zary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer. J Clin Oncol 2011; 29:2598.",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Clinical staging system for mycosis fungoides",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Clinical stage",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"4\">",
"        TNMB classification",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IA",
"       </td>",
"       <td>",
"        T",
"        <sub>",
"         1",
"        </sub>",
"       </td>",
"       <td>",
"        N",
"        <sub>",
"         0",
"        </sub>",
"       </td>",
"       <td>",
"        M",
"        <sub>",
"         0",
"        </sub>",
"       </td>",
"       <td>",
"        B",
"        <sub>",
"         0",
"        </sub>",
"        or B",
"        <sub>",
"         1",
"        </sub>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IB",
"       </td>",
"       <td>",
"        T",
"        <sub>",
"         2",
"        </sub>",
"       </td>",
"       <td>",
"        N",
"        <sub>",
"         0",
"        </sub>",
"       </td>",
"       <td>",
"        M",
"        <sub>",
"         0",
"        </sub>",
"       </td>",
"       <td>",
"        B",
"        <sub>",
"         0",
"        </sub>",
"        or B",
"        <sub>",
"         1",
"        </sub>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IIA",
"       </td>",
"       <td>",
"        T",
"        <sub>",
"         1",
"        </sub>",
"        or T",
"        <sub>",
"         2",
"        </sub>",
"       </td>",
"       <td>",
"        N",
"        <sub>",
"         1",
"        </sub>",
"        or N",
"        <sub>",
"         2",
"        </sub>",
"       </td>",
"       <td>",
"        M",
"        <sub>",
"         0",
"        </sub>",
"       </td>",
"       <td>",
"        B",
"        <sub>",
"         0",
"        </sub>",
"        or B",
"        <sub>",
"         1",
"        </sub>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IIB",
"       </td>",
"       <td>",
"        T",
"        <sub>",
"         3",
"        </sub>",
"       </td>",
"       <td>",
"        N",
"        <sub>",
"         0",
"        </sub>",
"        to N",
"        <sub>",
"         2",
"        </sub>",
"       </td>",
"       <td>",
"        M",
"        <sub>",
"         0",
"        </sub>",
"       </td>",
"       <td>",
"        B",
"        <sub>",
"         0",
"        </sub>",
"        or B",
"        <sub>",
"         1",
"        </sub>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IIIA",
"       </td>",
"       <td>",
"        T",
"        <sub>",
"         4",
"        </sub>",
"       </td>",
"       <td>",
"        N",
"        <sub>",
"         0",
"        </sub>",
"        to N",
"        <sub>",
"         2",
"        </sub>",
"       </td>",
"       <td>",
"        M",
"        <sub>",
"         0",
"        </sub>",
"       </td>",
"       <td>",
"        B",
"        <sub>",
"         0",
"        </sub>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IIIB",
"       </td>",
"       <td>",
"        T",
"        <sub>",
"         4",
"        </sub>",
"       </td>",
"       <td>",
"        N",
"        <sub>",
"         0",
"        </sub>",
"        to N",
"        <sub>",
"         2",
"        </sub>",
"       </td>",
"       <td>",
"        M",
"        <sub>",
"         0",
"        </sub>",
"       </td>",
"       <td>",
"        B",
"        <sub>",
"         1",
"        </sub>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IVA1",
"       </td>",
"       <td>",
"        T",
"        <sub>",
"         1",
"        </sub>",
"        to T",
"        <sub>",
"         4",
"        </sub>",
"       </td>",
"       <td>",
"        N",
"        <sub>",
"         0",
"        </sub>",
"        to N",
"        <sub>",
"         2",
"        </sub>",
"       </td>",
"       <td>",
"        M",
"        <sub>",
"         0",
"        </sub>",
"       </td>",
"       <td>",
"        B",
"        <sub>",
"         2",
"        </sub>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IVA2",
"       </td>",
"       <td>",
"        T",
"        <sub>",
"         1",
"        </sub>",
"        to T",
"        <sub>",
"         4",
"        </sub>",
"       </td>",
"       <td>",
"        N",
"        <sub>",
"         3",
"        </sub>",
"       </td>",
"       <td>",
"        M",
"        <sub>",
"         0",
"        </sub>",
"       </td>",
"       <td>",
"        B",
"        <sub>",
"         0",
"        </sub>",
"        to B",
"        <sub>",
"         2",
"        </sub>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IVB",
"       </td>",
"       <td>",
"        T",
"        <sub>",
"         1",
"        </sub>",
"        to T",
"        <sub>",
"         4",
"        </sub>",
"       </td>",
"       <td>",
"        N",
"        <sub>",
"         0",
"        </sub>",
"        to N",
"        <sub>",
"         3",
"        </sub>",
"       </td>",
"       <td>",
"        M",
"        <sub>",
"         1",
"        </sub>",
"       </td>",
"       <td>",
"        B",
"        <sub>",
"         0",
"        </sub>",
"        to B",
"        <sub>",
"         2",
"        </sub>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    To be used in conjunction with the TNMB classification system for mycosis fungoides.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Modified from: Olsen E, Vonderheid E, Pimpinelli N, et al. Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 2007; 110:1713.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_60_7119=[""].join("\n");
var outline_f6_60_7119=null;
